Publications published since 2000 from OUS - Department of Haematology

1143 publications found (only first 1000 shown)

Publications 2023

  1. Ahmed M, Muhoozi GKM, Atukunda P, Westerberg AC, Iversen PO, Wangen KR (2023)
    Cognitive development among children in a low-income setting: Cost-effectiveness analysis of a maternal nutrition education intervention in rural Uganda
    PLoS One, 18 (8), e0290379
    DOI 10.1371/journal.pone.0290379, PubMed 37594989
  2. Al Hamed R, Ngoya M, Galimard JE, Sengeloev H, Gedde-Dahl T, Kulagin A, Platzbecker U, Yakoub-Agha I, Byrne JL, Valerius T, Socie G, Kröger N, Blaise D, Bazarbachi A, Sanz J, Ciceri F, Nagler A, Mohty M (2023)
    Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia-Improved outcomes over time: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party study
    Cancer, 129 (17), 2645-2654
    DOI 10.1002/cncr.34843, PubMed 37269074
  3. Ali MM, Gedde-Dahl T, Osnes LT, Perrier F, Veierød MB, Tjønnfjord GE, Iversen PO (2023)
    Extracorporeal Photopheresis as Graft-versus-Host Disease Prophylaxis: A Randomized Controlled Trial
    Transplant Cell Ther, 29 (6), 364.e1-364.e11
    DOI 10.1016/j.jtct.2023.02.023, PubMed 36878428
  4. Arnold DM, Clerici B, Ilicheva E, Ghanima W (2023)
    Refractory immune thrombocytopenia in adults: Towards a new definition
    Br J Haematol, 203 (1), 23-27
    DOI 10.1111/bjh.19075, PubMed 37642211
  5. Arvanitakis A, Holme PA, Berntorp E, Astermark J (2023)
    Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health-related quality of life in patients with severe haemophilia A
    Haemophilia, 29 (4), 1032-1038
    DOI 10.1111/hae.14806, PubMed 37252898
  6. Astermark J, Baghaei F, Strandberg K, Toplican PG, Birkedal MF, Grahn EE, Hansson C, Kampmann P, Lehtinen AE, Täckström K, Holme PA, Magnusson M (2023)
    Infrastructural considerations of implementing gene therapy for hemophilia in the Nordic context
    Ther Adv Hematol, 14, 20406207231202306
    DOI 10.1177/20406207231202306, PubMed 37859645
  7. Ayuda-Durán P, Hermansen JU, Giliberto M, Yin Y, Hanes R, Gordon S, Kuusanmäki H, Brodersen AM, Andersen AN, Taskén K, Wennerberg K, Enserink JM, Skånland SS (2023)
    Standardized assays to monitor drug sensitivity in hematologic cancers
    Cell Death Discov, 9 (1), 435
    DOI 10.1038/s41420-023-01722-5, PubMed 38040674
  8. Bach-Gansmo T, Hodt A, Schjesvold FH, Gude E, Wien TN (2023)
    Bone scintigraphy reduces the need for biopsy in suspected cardiac amyloidosis
    Tidsskr Nor Laegeforen, 143 (9)
    DOI 10.4045/tidsskr.22.0644, PubMed 37341415
  9. Bazarbachi A, Labopin M, Gedde-Dahl T, Remenyi P, Forcade E, Kröger N, Socié G, Craddock C, Bourhis JH, Versluis J, Yakoub-Agha I, Salmenniemi U, El-Cheikh J, Bug G, Esteve J, Nagler A, Ciceri F, Mohty M (2023)
    Improved Posttransplant Outcomes in Recent Years for AML Patients with FLT3-ITD and Wild-type NPM1: A Report from the EBMT Acute Leukemia Working Party
    Clin Cancer Res, 29 (21), 4441-4448
    DOI 10.1158/1078-0432.CCR-23-0954, PubMed 37603683
  10. Cooper N, Ghanima W, Vianelli N, Valcárcel D, Yavaşoğlu İ, Melikyan A, Ruiz EY, Haenig J, Somenzi O, Lee J, Clark J, Zhang Y, Zaja F (2023)
    Sustained response off-treatment in eltrombopag-treated adult patients with ITP who are refractory or relapsed after first-line steroids: Primary, final, and ad-hoc analyses of the Phase II TAPER trial
    Am J Hematol (in press)
    DOI 10.1002/ajh.27131, PubMed 38014779
  11. Danielsen AS, Franconeri L, Page S, Myhre AE, Tornes RA, Kacelnik O, Bjørnholt JV (2023)
    Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models
    BMC Infect Dis, 23 (1), 247
    DOI 10.1186/s12879-023-08182-3, PubMed 37072711
  12. Dusingizimana T, Ramilan T, Weber JL, Iversen PO, Mugabowindekwe M, Ahishakiye J, Brough L (2023)
    Predictors for achieving adequate antenatal care visits during pregnancy: a cross-sectional study in rural Northwest Rwanda
    BMC Pregnancy Childbirth, 23 (1), 69
    DOI 10.1186/s12884-023-05384-0, PubMed 36703102
  13. Enden T (2023)
    In training or at work?
    Tidsskr Nor Laegeforen, 143 (2)
    DOI 10.4045/tidsskr.23.0031, PubMed 36718885
  14. Enden T (2023)
    Equality under the Health Research Act
    Tidsskr Nor Laegeforen, 143 (9)
    DOI 10.4045/tidsskr.23.0386, PubMed 37341395
  15. Enden T (2023)
    Peer reviewers, commonship and ownership
    Tidsskr Nor Laegeforen, 143 (17)
    DOI 10.4045/tidsskr.23.0751, PubMed 37987061
  16. Ettingshausen CE, Hermans C, Holme PA, Cid AR, Khair K, Oldenburg J, Négrier C, Botha J, Lelli A, Windyga J (2023)
    Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study
    Ther Adv Hematol, 14, 20406207231184323
    DOI 10.1177/20406207231184323, PubMed 37529276
  17. Fagerhol MK, Schultz NH, Mirlashari MR, Wiedmann MKH, Nissen-Meyer LSH, Søraas AVL, Hetland G (2023)
    DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV-19 vaccination and in normal unvaccinated blood donors
    Scand J Immunol, 98 (1), e13274
    DOI 10.1111/sji.13274, PubMed 37676118
  18. Federico L, Tvedt THA, Gainullin M, Osen JR, Chaban V, Lund KP, Tietze L, Tran TT, Lund-Johansen F, Kared H, Lind A, Vaage JT, Stratford R, Tennøe S, Malone B, Clancy T, Myhre AEL, Gedde-Dahl T, Munthe LA (2023)
    Robust spike-specific CD4+ and CD8+ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study
    Front Immunol, 14, 1210899
    DOI 10.3389/fimmu.2023.1210899, PubMed 37503339
  19. Fløisand Y, Remberger M, Bigalke I, Josefsen D, Vålerhaugen H, Inderberg EM, Olaussen RW, Gjertsen BT, Goedkoop R, Geiger C, Prinz PU, Schnorfeil FM, Pinkernell K, Schendel DJ, Kvalheim G (2023)
    WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy
    Leukemia, 37 (9), 1842-1849
    DOI 10.1038/s41375-023-01980-3, PubMed 37507426
  20. Geelen IGP, Gullaksen SE, Ilander MM, Olssen-Strömberg U, Mustjoki S, Richter J, Blijlevens NMA, Smit WM, Gjertsen BT, Gedde-Dahl T, Markevärn B, Koppes MMA, Westerweel PE, Hjorth-Hansen H, Janssen JJWM (2023)
    Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects
    Ann Hematol, 102 (6), 1395-1408
    DOI 10.1007/s00277-023-05199-1, PubMed 37119314
  21. Giannakopoulou E, Lehander M, Virding Culleton S, Yang W, Li Y, Karpanen T, Yoshizato T, Rustad EH, Nielsen MM, Bollineni RC, Tran TT, Delic-Sarac M, Gjerdingen TJ, Douvlataniotis K, Laos M, Ali M, Hillen A, Mazzi S, Chin DWL, Mehta A, Holm JS, Bentzen AK, Bill M, Griffioen M, Gedde-Dahl T et al. (2023)
    A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo
    Nat Cancer, 4 (10), 1474-1490
    DOI 10.1038/s43018-023-00642-8, PubMed 37783807
  22. Gleditsch J, Jervan Ø, Klok F, Holst R, Hopp E, Tavoly M, Ghanima W (2023)
    Does the clot burden as assessed by the Mean Bilateral Proximal Extension of the Clot score reflect mortality and adverse outcome after pulmonary embolism?
    Acta Radiol Open, 12 (6), 20584601231187094
    DOI 10.1177/20584601231187094, PubMed 37426515
  23. Groen K, Schjesvold FH, van der Holt B, Levin MD, Seefat MR, Hansson M, Leys MBL, Regelink JC, Waage A, Szatkowski D, Axelsson P, Hieu Do T, Svirskaite A, van der Spek E, Haukas E, Knut-Bojanowska D, Ypma PF, Blimark CH, Mellqvist UH, van de Donk NWCJ, Sonneveld P, Klostergaard A, Vangsted AJ, Abildgaard N, Zweegman S (2023)
    Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13
    Hemasphere, 7 (9), e940
    DOI 10.1097/HS9.0000000000000940, PubMed 37663673
  24. Gudmundstuen AM, Efficace F, Tjønnfjord GE, Skaarud KJ, Cottone F, Hjermstad MJ, Iversen PO (2023)
    The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial
    Ann Hematol, 102 (4), 927-935
    DOI 10.1007/s00277-023-05149-x, PubMed 36864210
  25. Gundesen MT, Asmussen JT, Schjesvold F, Vangsted AJ, Helleberg C, Haukås E, Silkjær T, Teodorescu EM, Jensen BA, Slørdahl TS, Nahi H, Waage A, Abildgaard N, Lund T, Nordic Myeloma Study Group (2023)
    Potential value of pre-planned imaging of bone disease in multiple myeloma
    Blood Cancer J, 13 (1), 105
    DOI 10.1038/s41408-023-00880-0, PubMed 37419876
  26. Harrison SP, Siller R, Tanaka Y, Chollet ME, de la Morena-Barrio ME, Xiang Y, Patterson B, Andersen E, Bravo-Pérez C, Kempf H, Åsrud KS, Lunov O, Dejneka A, Mowinckel MC, Stavik B, Sandset PM, Melum E, Baumgarten S, Bonanini F, Kurek D, Mathapati S, Almaas R, Sharma K, Wilson SR, Skottvoll FS et al. (2023)
    Scalable production of tissue-like vascularized liver organoids from human PSCs
    Exp Mol Med, 55 (9), 2005-2024
    DOI 10.1038/s12276-023-01074-1, PubMed 37653039
  27. Hasanaliyeva G, Sufar EK, Wang J, Rempelos L, Volakakis N, Iversen PO, Leifert C (2023)
    Effects of Agricultural Intensification on Mediterranean Diets: A Narrative Review
    Foods, 12 (20)
    DOI 10.3390/foods12203779, PubMed 37893672
  28. Hermans C, Astermark J, Carvalho M, Dolan G, d'Oiron R, Fontana P, Holme PA, Kenet G, Klamroth R, Mancuso ME, Marquardt N, Nunez R, Katsarou O, Pabinger-Fasching I, Quintavalle G, Rodgers R, van der Valk P, Windyga J, Jimenez Yuste V, Preložnik Zupan I (2023)
    Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe
    Haemophilia, 29 (3), 913-916
    DOI 10.1111/hae.14761, PubMed 36802089
  29. Hermansen JU, Yin Y, Urban A, Myklebust CV, Karlsen L, Melvold K, Tveita AA, Taskén K, Munthe LA, Tjønnfjord GE, Skånland SS (2023)
    A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine
    Cell Death Discov, 9 (1), 125
    DOI 10.1038/s41420-023-01426-w, PubMed 37055391
  30. Hernández-Boluda JC, Eikema DJ, Koster L, Kröger N, Robin M, de Witte M, Finke J, Finazzi MC, Broers A, Raida L, Schaap N, Chiusolo P, Verbeek M, Hazenberg CLE, Halaburda K, Kulagin A, Labussière-Wallet H, Gedde-Dahl T, Rabitsch W, Raj K, Drozd-Sokolowska J, Battipaglia G, Polverelli N, Czerw T, Yakoub-Agha I et al. (2023)
    Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
    Bone Marrow Transplant, 58 (12), 1357-1367
    DOI 10.1038/s41409-023-02094-1, PubMed 37679647
  31. Hillarp A, Holme PA, Wåland EP, Le MS, Henriksson CE, Tjønnfjord GE, Måseide RJ (2023)
    Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII
    J Thromb Haemost, 21 (10), 2771-2775
    DOI 10.1016/j.jtha.2023.07.019, PubMed 37543216
  32. IRF4 International Consortium, Fornes O, Jia A, Kuehn HS, Min Q, Pannicke U, Schleussner N, Thouenon R, Yu Z, de Los Angeles Astbury M, Biggs CM, Galicchio M, Garcia-Campos JA, Gismondi S, Gonzalez Villarreal G, Hildebrand KJ, Hönig M, Hou J, Moshous D, Pittaluga S, Qian X, Rozmus J, Schulz AS, Staines-Boone AT, Sun B et al. (2023)
    A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency
    Sci Immunol, 8 (79), eade7953
    DOI 10.1126/sciimmunol.ade7953, PubMed 36662884
  33. Jervan Ø, Dhayyat A, Gleditsch J, Haukeland-Parker S, Tavoly M, Klok FA, Rashid D, Stavem K, Ghanima W, Steine K (2023)
    Demographic, clinical, and echocardiographic factors associated with residual perfusion defects beyond six months after pulmonary embolism
    Thromb Res, 229, 7-14
    DOI 10.1016/j.thromres.2023.06.004, PubMed 37356172
  34. Jervan Ø, Haukeland-Parker S, Gleditsch J, Tavoly M, Klok FA, Steine K, Johannessen HH, Spruit MA, Atar D, Holst R, Astrup Dahm AE, Sirnes PA, Stavem K, Ghanima W (2023)
    The Effects of Exercise Training in Patients With Persistent Dyspnea Following Pulmonary Embolism: A Randomized Controlled Trial
    Chest, 164 (4), 981-991
    DOI 10.1016/j.chest.2023.04.042, PubMed 37149257
  35. Jørgensen CT, Brækkan SK, Førsund E, Pettersen HH, Tjønnfjord E, Ghanima W, Tavoly M (2023)
    Incidence of venous thromboembolism, recurrence, and bleeding after isolated superficial vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital
    J Thromb Haemost (in press)
    DOI 10.1016/j.jtha.2023.10.017, PubMed 37913911
  36. Jørgensen CT, Tavoly M, Førsund E, Pettersen HH, Tjønnfjord E, Ghanima W, Brækkan SK (2023)
    Incidence of bleeding and recurrence in isolated distal deep vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital
    J Thromb Haemost, 21 (10), 2824-2832
    DOI 10.1016/j.jtha.2023.06.028, PubMed 37394122
  37. Kihlberg K, Baghaei F, Bruzelius M, Funding E, Andre Holme P, Lassila R, Nummi V, Ranta S, Gretenkort Andersson N, Berntorp E, Astermark J (2023)
    No difference in quality of life between persons with severe haemophilia A and B
    Haemophilia, 29 (4), 987-996
    DOI 10.1111/hae.14759, PubMed 36791275
  38. Kreyberg I, Schrumpf E, Fredrik von Krogh C, Lilleng R, Tjønnfjord GE (2023)
    Successful treatment of subcorneal pustular dermatosis targeting an underlying monoclonal IgA gammopathy
    JAAD Case Rep, 41, 33-36
    DOI 10.1016/j.jdcr.2023.08.036, PubMed 37842157
  39. Kristoffersen I, Holte K, Antonsen LP, Ho APT, Kvenshagen LN, Løgavlen VV, Murugaiah P, Tjønnfjord E, Værnesbranden MR (2023)
    A pregnant woman in her thirties with abdominal pain, seizures and haemorrhagic shock
    Tidsskr Nor Laegeforen, 143 (5)
    DOI 10.4045/tidsskr.22.0282, PubMed 36987892
  40. Kverneland M, Nakken KO, Hofoss D, Skogan AH, Iversen PO, Selmer KK, Lossius MI (2023)
    Health-related quality of life in adults with drug-resistant focal epilepsy treated with modified Atkins diet in a randomized clinical trial
    Epilepsia, 64 (5), e69-e74
    DOI 10.1111/epi.17585, PubMed 36923995
  41. Köhn-Luque A, Myklebust EM, Tadele DS, Giliberto M, Schmiester L, Noory J, Harivel E, Arsenteva P, Mumenthaler SM, Schjesvold F, Taskén K, Enserink JM, Leder K, Frigessi A, Foo J (2023)
    Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data
    Cell Rep Methods, 3 (3), 100417
    DOI 10.1016/j.crmeth.2023.100417, PubMed 37056380
  42. Larsen TL, Svalastoga M, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Paulsen PQ, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2023)
    Arterial events in cancer patients treated with apixaban for venous thrombosis
    Thromb Res, 228, 128-133
    DOI 10.1016/j.thromres.2023.05.017, PubMed 37327527
  43. Ludwig H, Terpos E, van de Donk N, Mateos MV, Moreau P, Dimopoulos MA, Delforge M, Rodriguez-Otero P, San-Miguel J, Yong K, Gay F, Einsele H, Mina R, Caers J, Driessen C, Musto P, Zweegman S, Engelhardt M, Cook G, Weisel K, Broijl A, Beksac M, Bila J, Schjesvold F, Cavo M et al. (2023)
    Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
    Lancet Oncol, 24 (6), e255-e269
    DOI 10.1016/S1470-2045(23)00159-6, PubMed 37269857
  44. Matlary RED, Grydeland M, Glosli H, Rueegg CS, Holme PA (2023)
    Physical activity in Norwegian teenagers and young adults with haemophilia A compared to general population peers
    Haemophilia, 29 (2), 658-667
    DOI 10.1111/hae.14752, PubMed 36723510
  45. Matlary RED, Grydeland M, Glosli H, Rueegg CS, Holme PA (2023)
    Factors associated with physical activity in young people with haemophilia A on prophylaxis
    Haemophilia, 29 (3), 900-909
    DOI 10.1111/hae.14776, PubMed 36913380
  46. Meshkovska B, Gebremariam MK, Atukunda P, Iversen PO, Wandel M, Lien N (2023)
    Barriers and facilitators to implementation of nutrition-related actions in school settings in low- and middle-income countries (LMICs): a qualitative systematic review using the Consolidated Framework for Implementation Research (CFIR)
    Implement Sci Commun, 4 (1), 73
    DOI 10.1186/s43058-023-00454-y, PubMed 37370179
  47. Molteberg E, Thorsby PM, Kverneland M, Iversen PO, Selmer KK, Hofoss D, Nakken KO, Taubøll E (2023)
    Stress biomarkers in adult patients with drug-resistant epilepsy on a modified Atkins diet: A prospective study
    Epilepsia Open, 8 (4), 1331-1339
    DOI 10.1002/epi4.12808, PubMed 37574592
  48. Moore KLF, Turesson I, Genell A, Klausen TW, Knut-Bojanowska D, Redder L, Sverrisdottir I, Thorsen J, Vangsted AJ, Blimark CH (2023)
    Improved survival in myeloma patients-a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden
    Haematologica, 108 (6), 1640-1651
    DOI 10.3324/haematol.2021.280424, PubMed 36300775
  49. Myklebust-Hansen HJ, Hasvik E, Solyga VM, Ghanima W (2023)
    The feasibility of self-performing measurements of peripheral oxygen saturation and respiratory exercises in home-isolated COVID-19 patients-a single-arm prospective trial
    Pilot Feasibility Stud, 9 (1), 195
    DOI 10.1186/s40814-023-01415-x, PubMed 38042811
  50. Måseide RJ, Berntorp E, Astermark J, Olsson A, Bruzelius M, Frisk T, Nummi V, Lassila R, Tjønnfjord GE, Holme PA (2023)
    Health-related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study)
    Haemophilia (in press)
    DOI 10.1111/hae.14899, PubMed 37983883
  51. Nagler A, Labopin M, Kröger N, Schroeder T, Gedde-Dahl T, Eder M, Franke GN, Blau IW, Salmenniemi U, Socie G, Schetelig J, Stelljes M, Ciceri F, Mohty M (2023)
    The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT
    Bone Marrow Transplant, 58 (12), 1339-1347
    DOI 10.1038/s41409-023-02095-0, PubMed 37660157
  52. Nagler A, Labopin M, Mielke S, Passweg J, Blaise D, Gedde-Dahl T, Cornelissen JJ, Salmenniemi U, Yakoub-Agha I, Reményi P, Socié G, van Gorkom G, Labussière-Wallet H, Huang XJ, Rubio MT, Byrne J, Craddock C, Griškevičius L, Ciceri F, Mohty M (2023)
    Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMT
    Bone Marrow Transplant, 58 (7), 791-800
    DOI 10.1038/s41409-023-01980-y, PubMed 37045942
  53. Nahalomo A, Iversen PO, Andreassen BA, Kaaya A, Rukooko AB, Rukundo PM (2023)
    Food insecurity, dietary diversity and the right to adequate food among households in landslide-prone communities in Eastern Uganda: A cohort study
    PLoS One, 18 (4), e0283078
    DOI 10.1371/journal.pone.0283078, PubMed 37053147
  54. Nezvalova-Henriksen K, Langebrake C, Bauters T, Moreno-Martinez ME, Ahnfelt E, Ekelund H, Domingos V, Pires V, Bonnin A, Bojanić I, Cabrerizo Y, Terwel S, Tam A (2023)
    Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group
    Bone Marrow Transplant, 58 (10), 1069-1074
    DOI 10.1038/s41409-023-02072-7, PubMed 37528237
  55. Nyquist OE, Dalgaard J, Spetalen S, Torkildsen S, Frøen H, Galteland E, Klungsøyr O, Bergrem A, Vo C, Sørbø H, Eiken B, Lerdal H, Solvang AK, Jensvoll H, Pandzic T, Baliakas P, Dybedal I (2023)
    Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML
    Br J Haematol (in press)
    DOI 10.1111/bjh.19226, PubMed 38016923
  56. Nørgaard JN, Abildgaard N, Lysén A, Tsykunova G, Vangsted AJ, João C, Remen N, Nielsen LK, Osnes L, Stokke C, Connelly JP, Revheim MR, Nordic Myeloma Study Group (NMSG), Schjesvold F (2023)
    Intensifying treatment in PET-positive multiple myeloma patients after upfront autologous stem cell transplantation
    Leukemia, 37 (10), 2107-2114
    DOI 10.1038/s41375-023-01998-7, PubMed 37568010
  57. Panagopoulos I, Andersen K, Wik HS, Tandsæther MR, Micci F, Heim S (2023)
    Acute Undifferentiated Leukemia With a Balanced t(5;10)(q35;p12) Resulting in Fusion of HNRNPH1 With MLLT10
    Cancer Genomics Proteomics, 20 (4), 354-362
    DOI 10.21873/cgp.20387, PubMed 37400142
  58. Pedersen S, Kverneland M, Rudi K, Gervin K, Landmark CJ, Iversen PO, Selmer KK (2023)
    Decreased serum concentrations of antiseizure medications in children with drug resistant epilepsy following treatment with ketogenic diet
    Epilepsia Open, 8 (3), 858-866
    DOI 10.1002/epi4.12746, PubMed 37057954
  59. Plesner T, Harrison SJ, Quach H, Lee C, Bryant A, Vangsted A, Estell J, Delforge M, Offner F, Twomey P, Choeurng V, Li J, Hendricks R, Ruppert SM, Sumiyoshi T, Miller K, Cho E, Schjesvold F (2023)
    Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma
    Clin Hematol Int, 5 (1), 43-51
    DOI 10.1007/s44228-022-00023-5, PubMed 36656461
  60. Pour L, Szarejko M, Bila J, Schjesvold FH, Spicka I, Maisnar V, Jurczyszyn A, Grudeva-Popova Z, Hájek R, Usenko G, Thuresson M, Norin S, Jarefors S, Bakker NA, Richardson PG, Mateos MV (2023)
    Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study
    Haematologica (in press)
    DOI 10.3324/haematol.2023.283509, PubMed 37646660
  61. Pradier M, Rodger MA, Ghanima W, Kovacs MJ, Shivakumar S, Kahn SR, Sandset PM, Kearon C, Mallick R, Delluc A (2023)
    Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation Study
    Thromb Haemost, 123 (7), 692-699
    DOI 10.1055/a-2039-3388, PubMed 36809776
  62. Reding MT, Pabinger I, Holme PA, Maas Enriquez M, Mancuso ME, Lalezari S, Miesbach W, Di Minno G, Klamroth R, Hermans C (2023)
    Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hoc analysis from the PROTECT VIII study
    Ther Adv Hematol, 14, 20406207231166779
    DOI 10.1177/20406207231166779, PubMed 37113811
  63. Rempelos L, Wang J, Sufar EK, Almuayrifi MSB, Knutt D, Leifert H, Leifert A, Wilkinson A, Shotton P, Hasanaliyeva G, Bilsborrow P, Wilcockson S, Volakakis N, Markellou E, Zhao B, Jones S, Iversen PO, Leifert C (2023)
    Breeding Bread-Making Wheat Varieties for Organic Farming Systems: The Need to Target Productivity, Robustness, Resource Use Efficiency and Grain Quality Traits
    Foods, 12 (6)
    DOI 10.3390/foods12061209, PubMed 36981136
  64. Rinde FB, Jørgensen CT, Pettersen HH, Hansen JB, Ghanima W, Braekkan SK (2023)
    Low D-dimer levels at diagnosis of venous thromboembolism are associated with reduced risk of recurrence: data from the TROLL registry
    J Thromb Haemost, 21 (7), 1861-1868
    DOI 10.1016/j.jtha.2023.03.026, PubMed 37004791
  65. Robin C, Cordonnier C, Tridello G, Knelange N, Xhaard A, Chantepie S, Tanguy-Schmidt A, Schouten HC, Yesherun M, Rocha V, Srour M, Kröger N, Ledoux MP, Dalgaard J, Thiebaut A, Giardino S, Calore E, Zuckerman T, Groll AH, Raida L, Avcin S, Vicent MG, Kaare A, Drozd-Sokolowska J, Turlure P et al. (2023)
    Pneumocystis pneumonia after allogeneic hematopoietic cell transplantation: A case-control study on epidemiology and risk factors on behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
    Transplant Cell Ther (in press)
    DOI 10.1016/j.jtct.2023.11.017, PubMed 38007092
  66. Roman G, Stavik B, Lauritzen KH, Sandset PM, Harrison SP, Sullivan GJ, Chollet ME (2023)
    "iPSC-derived liver organoids and inherited bleeding disorders: Potential and future perspectives"
    Front Physiol, 14, 1094249
    DOI 10.3389/fphys.2023.1094249, PubMed 36711019
  67. Ruggeri A, De Wreede LC, Müller CR, Crivello P, Bonneville EF, Petersdorf EW, Socié G, Dubois V, Niittyvuopio R, Peräsaari J, Yakoub-Agha I, Cornelissen JJ, Wieten L, Gedde-Dahl T, Forcade E, Crawley CR, Marsh SGE, Gandemer V, Tholouli E, Bulabois CE, Huynh A, Choi G, Deconinck E, Itäla-Remes M, Lenhoff S et al. (2023)
    Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation
    Haematologica, 108 (2), 645-652
    DOI 10.3324/haematol.2021.280055, PubMed 35546480
  68. Rørvik SD, Abrahamsen IW, Myhre AE, Vo CD, Ødegaard EM, Bruserud Ø, Gedde-Dahl T, Tvedt THA (2023)
    [Chronic graft-versus-host disease]
    Tidsskr Nor Laegeforen, 143 (4)
    DOI 10.4045/tidsskr.22.0525, PubMed 36919292
  69. Raab MS, Cohen YC, Schjesvold F, Aardalen K, Oka A, Spencer A, Wermke M, Souza AD, Kaufman JL, Cafro AM, Ocio EM, Doki N, Henson K, Trabucco G, Carrion A, Bender FC, Juif PE, Fessehatsion A, Fan L, Stonehouse JP, Blankenship JW, Granda B, De Vita S, Lu H (2023)
    Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody
    Leukemia, 37 (6), 1349-1360
    DOI 10.1038/s41375-023-01883-3, PubMed 37024520
  70. Raab MS, Zamagni E, Manier S, Rodriguez-Otero P, Schjesvold F, Broijl A (2023)
    Difficult-to-treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results
    EJHaem, 4 (4), 1117-1131
    DOI 10.1002/jha2.743, PubMed 38024633
  71. Sanz J, Labopin M, Pabst T, Versluis J, Van Gorkom G, Meijer E, Gedde-Dahl T, Montoro J, Arcese W, Pérez-Simón JA, Schaap N, Maertens J, Vrhovac R, Lanza F, Gorin NC, Mohty M, Ciceri F (2023)
    Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
    Bone Marrow Transplant, 58 (11), 1197-1202
    DOI 10.1038/s41409-023-02075-4, PubMed 37553468
  72. Schjesvold FH, Ludwig H, Mateos MV, Larocca A, Abdulhaq H, Norin S, Thuresson M, Bakker NA, Richardson PG, Sonneveld P (2023)
    Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators: A subgroup analysis from the OCEAN study
    Eur J Haematol (in press)
    DOI 10.1111/ejh.14127, PubMed 37968873
  73. Schultz NH, Bechensteen AG, Tjønnfjord EB, Akkök ÇA, Berg MH (2023)
    New interest group for red blood cell disorders
    Tidsskr Nor Laegeforen, 143 (3)
    DOI 10.4045/tidsskr.22.0731, PubMed 36811425
  74. Shapiro AD, Nakar C, Parker JM, Thibaudeau K, Crea R, Sandset PM (2023)
    Plasminogen, human-tvmh for the treatment of children and adults with plasminogen deficiency type 1
    Haemophilia, 29 (6), 1556-1564
    DOI 10.1111/hae.14849, PubMed 37674358
  75. Sonneveld P, Richardson PG, Ludwig H, Dimopoulos MA, Schjesvold FH, Hájek R, Abdulhaq H, Thuresson M, Norin S, Bakker NA, Mateos MV (2023)
    Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies
    Clin Lymphoma Myeloma Leuk, 23 (9), 687-696
    DOI 10.1016/j.clml.2023.05.004, PubMed 37355418
  76. Spyridonidis A, Labopin M, Gedde-Dahl T, Ganser A, Stelljes M, Craddock C, Wagner-Drouet EM, Versluis J, Schroeder T, Blau IW, Wulf GG, Dreger P, Olesen G, Sengeloev H, Kröger N, Potter V, Forcade E, Passweg J, de Latour RP, Maertens J, Wilson KMO, Bourhis JH, Finke J, Brissot E, Bazarbachi A et al. (2023)
    Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
    Bone Marrow Transplant (in press)
    DOI 10.1038/s41409-023-02139-5, PubMed 37978322
  77. Terpos E, Musto P, Engelhardt M, Delforge M, Cook G, Gay F, van de Donk NWCJ, Ntanasis-Stathopoulos I, Vangsted AJ, Driessen C, Schjesvold F, Cerchione C, Zweegman S, Hajek R, Moreau P, Einsele H, San-Miguel J, Boccadoro M, Dimopoulos MA, Sonneveld P, Ludwig H (2023)
    Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)
    Leukemia, 37 (6), 1175-1185
    DOI 10.1038/s41375-023-01920-1, PubMed 37142661
  78. Tholin B, Ghanima W, Selle ML, Stavem K (2023)
    Incidence and determinants of venous thromboembolism over 90 days in hospitalized and nonhospitalized patients with COVID-19
    J Intern Med, 294 (6), 721-729
    DOI 10.1111/joim.13706, PubMed 37518983
  79. Tislevoll BS, Hellesøy M, Fagerholt OHE, Gullaksen SE, Srivastava A, Birkeland E, Kleftogiannis D, Ayuda-Durán P, Piechaczyk L, Tadele DS, Skavland J, Baliakas P, Hovland R, Andresen V, Seternes OM, Tvedt THA, Aghaeepour N, Gavasso S, Porkka K, Jonassen I, Fløisand Y, Enserink J, Blaser N, Gjertsen BT (2023)
    Early response evaluation by single cell signaling profiling in acute myeloid leukemia
    Nat Commun, 14 (1), 115
    DOI 10.1038/s41467-022-35624-4, PubMed 36611026
  80. Tislevoll BS, Hellesøy M, Fagerholt OHE, Gullaksen SE, Srivastava A, Birkeland E, Kleftogiannis D, Ayuda-Durán P, Piechaczyk L, Tadele DS, Skavland J, Baliakas P, Hovland R, Andresen V, Seternes OM, Tvedt THA, Aghaeepour N, Gavasso S, Porkka K, Jonassen I, Fløisand Y, Enserink J, Blaser N, Gjertsen BT (2023)
    Author Correction: Early response evaluation by single cell signaling profiling in acute myeloid leukemia
    Nat Commun, 14 (1), 1767
    DOI 10.1038/s41467-023-37488-8, PubMed 36997540
  81. Tjønnfjord SKV, Ali MM, Tjønnfjord GE (2023)
    Chronic neutropenia in adults
    Tidsskr Nor Laegeforen, 143 (9)
    DOI 10.4045/tidsskr.22.0491, PubMed 37341406
  82. Troensegaard H, Khoury J, Westerberg AC, Tonstad S, Roeters van Lennep J, Veierød MB, Iversen PO, Holven KB, Retterstøl K (2023)
    Protocol for a 20-year follow-up after a randomized controlled trial of a Mediterranean diet in pregnancy: maternal and offspring risk factors for cardiovascular disease
    Front Pediatr, 11, 1256815
    DOI 10.3389/fped.2023.1256815, PubMed 37920793
  83. Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M et al. (2023)
    Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
    Crit Care, 27 (1), 9
    DOI 10.1186/s13054-022-04205-8, PubMed 36627655
  84. van de Donk NWCJ, Minnema MC, van der Holt B, Schjesvold F, Wu KL, Broijl A, Roeloffzen WWH, Gadisseur A, Pietrantuono G, Pour L, van der Velden VHJ, Lund T, Offidani M, Grasso M, Giaccone L, Razawy W, Tacchetti P, Mancuso K, Silkjaer T, Caers J, Zweegman S, Hájek R, Benjamin R, Vangsted AJ, Boccadoro M et al. (2023)
    Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study
    Lancet Oncol, 24 (10), 1119-1133
    DOI 10.1016/S1470-2045(23)00405-9, PubMed 37717583
  85. Vinnes EW, Lillemoen PKS, Klingenberg O, Fjeld B, Iversen PO, Brodwall KM, Bechensteen AG (2023)
    [Sickle cell disease – clinical manifestations and diagnostics]
    Tidsskr Nor Laegeforen, 143 (3)
    DOI 10.4045/tidsskr.22.0353, PubMed 36811424
  86. Vo CD, Myhre AE, Abrahamsen IW, Remberger M, Mattsson J, Fløisand Y, Grønvold BCL, Tjønnfjord GE, Tvedt THA, Gedde-Dahl T (2023)
    Allogeneic stem cell transplantation in adults 2015-21
    Tidsskr Nor Laegeforen, 143 (4)
    DOI 10.4045/tidsskr.22.0521, PubMed 36919291
  87. Warlo EMK, Kalstad AA, Myhre PL, Solheim S, Arnesen H, Tveit A, Holme PA, Seljeflot I, Bratseth V (2023)
    von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction
    Res Pract Thromb Haemost, 7 (4), 100164
    DOI 10.1016/j.rpth.2023.100164, PubMed 37255854
  88. Westhrin M, Blazevski J, Textor A, Abdollahi P, Gopalakrishnan RP, Ngo LT, Hofgaard PO, Heinzelbecker J, Bobic S, Fossum E, Spång HCL, Braathen R, Bogen B (2023)
    Id-neoantigen vaccine induces therapeutic CD8+ T cells against multiple myeloma: H chain-loss escapees cause FLC MM
    J Immunother Cancer, 11 (8)
    DOI 10.1136/jitc-2023-006944, PubMed 37607769
  89. Ågnes C, Schwartz T, Quist-Paulsen E, Bhatti R, Njaastad AM, Fuglestved J, Wibetoe G (2023)
    Drug-induced aseptic meningitis
    Tidsskr Nor Laegeforen, 143 (1)
    DOI 10.4045/tidsskr.22.0286, PubMed 36655954

Publications 2022

  1. Albert MH, Sirait T, Eikema DJ, Bakunina K, Wehr C, Suarez F, Fox ML, Mahlaoui N, Gennery AR, Lankester AC, Beier R, Bernardo ME, Bigley V, Lindemans CA, Burns SO, Carpenter B, Dybko J, Güngör T, Hauck F, Lum SH, Balashov D, Meisel R, Moshous D, Schulz A, Speckmann C et al. (2022)
    Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study
    Blood, 140 (14), 1635-1649
    DOI 10.1182/blood.2022015506, PubMed 35344580
  2. Arvanitakis A, Holme PA, Berntorp E, Astermark J (2022)
    Clinical outcome and adherence rate in Scandinavian patients with intermediate-intensity prophylaxis before and after the switch of standard half-life FVIII products to BAY 81-8973
    Haemophilia, 28 (2), 223-229
    DOI 10.1111/hae.14489, PubMed 35005818
  3. Berentsen S, Tjønnfjord GE (2022)
    Current Treatment Options in Cold Agglutinin Disease: B-Cell Directed or Complement Directed Therapy?
    Transfus Med Rev, 36 (4), 181-187
    DOI 10.1016/j.tmrv.2022.05.001, PubMed 36127205
  4. Berge-Seidl S, Nielsen NV, Rodriguez Alfonso AA, Etscheid M, Kandanur SPS, Haug BE, Stensland M, Thiede B, Karacan M, Preising N, Wiese S, Ständker L, Declerck PJ, Løset GÅ, Kanse SM (2022)
    Identification of a Phage Display-Derived Peptide Interacting with the N-Terminal Region of Factor VII Activating Protease (FSAP) Enables Characterization of Zymogen Activation
    ACS Chem Biol, 17 (9), 2631-2642
    DOI 10.1021/acschembio.2c00538, PubMed 36070465
  5. Bistervels IM, Bavalia R, Beyer-Westendorf J, Ten Cate-Hoek AJ, Schellong SM, Kovacs MJ, Falvo N, Meijer K, Stephan D, Boersma WG, Ten Wolde M, Couturaud F, Verhamme P, Brisot D, Kahn SR, Ghanima W, Montaclair K, Hugman A, Carroll P, Pernod G, Sanchez O, Ferrari E, Roy PM, Sevestre-Pietri MA, Birocchi S et al. (2022)
    Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin
    Res Pract Thromb Haemost, 6 (5), e12748
    DOI 10.1002/rth2.12748, PubMed 35992565
  6. Bistervels IM, Buchmüller A, Wiegers HMG, Ní Áinle F, Tardy B, Donnelly J, Verhamme P, Jacobsen AF, Hansen AT, Rodger MA, DeSancho MT, Shmakov RG, van Es N, Prins MH, Chauleur C, Middeldorp S, Highlow Block writing committee, Highlow Investigators (2022)
    Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial
    Lancet, 400 (10365), 1777-1787
    DOI 10.1016/S0140-6736(22)02128-6, PubMed 36354038
  7. Cui XY, Stavik B, Thiede B, Sandset PM, Kanse SM (2022)
    FSAP Protects against Histone-Mediated Increase in Endothelial Permeability In Vitro
    Int J Mol Sci, 23 (22)
    DOI 10.3390/ijms232213706, PubMed 36430180
  8. de la Morena-Barrio ME, Suchon P, Jacobsen EM, Iversen N, Miñano A, de la Morena-Barrio B, Bravo-Pérez C, Padilla J, Cifuentes R, Asenjo S, Deleuze JF, Trégouët DA, Lozano ML, Vicente V, Sandset PM, Morange PE, Corral J (2022)
    Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays
    Blood, 140 (2), 140-151
    DOI 10.1182/blood.2021014708, PubMed 35486842
  9. Delluc A, Ghanima W, Kovacs MJ, Shivakumar S, Kahn SR, Sandset PM, Kearon C, Mallick R, Rodger MA (2022)
    Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER)
    Thromb Res, 213, 119-124
    DOI 10.1016/j.thromres.2022.03.014, PubMed 35344784
  10. Diep PP, Rueegg CS, Burman MM, Brinch L, Bø K, Fosså K, Landrø L, Loge JH, Lund MB, Massey RJ, Myrdal OH, Pathak M, Rimstad L, Tanem KE, Tjønnfjord GE, Aaløkken TM, Ruud E (2022)
    Graft-Versus-Host-Disease and Health-Related Quality of Life in Young Long-term Survivors of Cancer and Allogeneic Hematopoietic Stem Cell Transplantation
    J Adolesc Young Adult Oncol, 12 (1), 66-75
    DOI 10.1089/jayao.2021.0196, PubMed 35544321
  11. Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, Delforge M, Hájek R, Schjesvold F, Cavo M, Goldschmidt H, Facon T, Einsele H, Boccadoro M, San-Miguel J, Sonneveld P, Mey U, EHA Guidelines Committee ESMO Guidelines Committee. Electronic address: (2022)
    Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]
    Ann Oncol, 33 (9), 988
    DOI 10.1016/j.annonc.2022.05.004, PubMed 35810138
  12. Dimopoulos MA, Schjesvold F, Doronin V, Vinogradova O, Quach H, Leleu X, Montes YG, Ramasamy K, Pompa A, Levin MD, Lee C, Mellqvist UH, Fenk R, Demarquette H, Sati H, Vorog A, Labotka R, Du J, Darif M, Kumar S (2022)
    Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial
    Blood Cancer J, 12 (1), 9
    DOI 10.1038/s41408-021-00593-2, PubMed 35075109
  13. Enden T (2022)
    [Not Available]
    Tidsskr Nor Laegeforen, 142
    DOI 10.4045/tidsskr.22.0656, PubMed 36303471
  14. Engh MS, Muhoozi GKM, Ngari M, Skaare AB, Westerberg AC, Iversen PO, Brusevold IJ, Atukunda P (2022)
    Long-Term Effects of a Randomized Maternal Education Trial in Rural Uganda: Implications for Child Oral Health
    Am J Trop Med Hyg, 107 (4), 939-947
    DOI 10.4269/ajtmh.22-0248, PubMed 36067985
  15. Etscheid M, Hanschmann KM, Sandset PM, Kanse SM (2022)
    Development of a Factor VII Activating Protease (FSAP) generation assay and its application in studying FSAP in venous thrombosis
    Thromb Res, 220, 24-34
    DOI 10.1016/j.thromres.2022.09.027, PubMed 36265411
  16. Garabet L, Eriksson A, Tjønnfjord E, Cui XY, Olsen MK, Jacobsen HK, Jørgensen CT, Mathisen ÅB, Mowinckel MC, Ahlen MT, Sørvoll IH, Horvei KD, Ernstsen SL, Lægreid IJ, Stavik B, Holst R, Sandset PM, Ghanima W (2022)
    SARS-CoV-2 vaccines are not associated with hypercoagulability in apparently healthy people
    Res Pract Thromb Haemost, 7 (1), 100002
    DOI 10.1016/j.rpth.2022.100002, PubMed 36448024
  17. Garcia-Horton A, Cyriac SL, Gedde-Dahl T, Floisand Y, Remberger M, Mattsson J, Michelis FV (2022)
    Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups
    Eur J Haematol, 109 (6), 672-679
    DOI 10.1111/ejh.13850, PubMed 36028979
  18. Giliberto M, Thimiri Govinda Raj DB, Cremaschi A, Skånland SS, Gade A, Tjønnfjord GE, Schjesvold F, Munthe LA, Taskén K (2022)
    Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically
    Mol Oncol, 16 (6), 1241-1258
    DOI 10.1002/1878-0261.13191, PubMed 35148457
  19. Gleditsch J, Jervan Ø, Haukeland-Parker S, Tavoly M, Geier O, Holst R, Klok FA, Johannessen HH, Ghanima W, Hopp E (2022)
    Effects of pulmonary rehabilitation on cardiac magnetic resonance parameters in patients with persistent dyspnea following pulmonary embolism
    Int J Cardiol Heart Vasc, 40, 100995
    DOI 10.1016/j.ijcha.2022.100995, PubMed 35345773
  20. Gregersen I, Ueland T, Holter JC, Olsen MB, Michelsen AE, Murphy SL, Tveita AA, Henriksen KN, Hoel H, Nordberg LB, Holten AR, Edvardsen T, Yang K, Heggelund L, Trøseid M, Müller F, Kildal AB, Dyrhol-Riise AM, Barratt-Due A, Dahl TB, Aukrust P, Halvorsen B, NOR-SOLIDARITY consortium, The Norwegian SARS-CoV-2 Study Group investigators (2022)
    CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19
    J Infect, 85 (6), 702-769
    DOI 10.1016/j.jinf.2022.09.029, PubMed 36216188
  21. Grob T, Sanders MA, Vonk CM, Kavelaars FG, Rijken M, Hanekamp DW, Gradowska PL, Cloos J, Fløisand Y, van Marwijk Kooy M, Manz MG, Ossenkoppele GJ, Tick LW, Havelange V, Löwenberg B, Jongen-Lavrencic M, Valk PJM (2022)
    Prognostic Value of FLT3-Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia
    J Clin Oncol, 41 (4), 756-765
    DOI 10.1200/JCO.22.00715, PubMed 36315929
  22. Gundesen MT, Asmussen JT, Haukås E, Schubert M, Abildgaard N, Schjesvold F, Lund T (2022)
    A prospective study of Skeletal survey versus Low-dose whole-body CT for Osteolytic lesions in Multiple Myeloma
    Eur J Haematol, 108 (5), 423-429
    DOI 10.1111/ejh.13749, PubMed 35113466
  23. Haroun-Izquierdo A, Vincenti M, Netskar H, van Ooijen H, Zhang B, Bendzick L, Kanaya M, Momayyezi P, Li S, Wiiger MT, Hoel HJ, Krokeide SZ, Kremer V, Tjonnfjord G, Berggren S, Wikström K, Blomberg P, Alici E, Felices M, Önfelt B, Höglund P, Valamehr B, Ljunggren HG, Björklund A, Hammer Q et al. (2022)
    Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia
    J Immunother Cancer, 10 (11)
    DOI 10.1136/jitc-2022-005577, PubMed 36319065
  24. Helland Å, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, Bjørge L, Blix E, Bjerkehagen B, Brabrand S, Cameron MG, Dalhaug A, Dietzel D, Dønnem T, Enerly E, Flobak Å, Fluge S, Gilje B, Gjertsen BT, Grønberg BH, Grønås K, Guren T, Hamre H, Haug Å, Heinrich D et al. (2022)
    Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
    J Transl Med, 20 (1), 225
    DOI 10.1186/s12967-022-03432-5, PubMed 35568909
  25. Helland Å, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, Bjørge L, Blix E, Bjerkehagen B, Brabrand S, Cameron MG, Dalhaug A, Dietzel D, Dønnem T, Enerly E, Flobak Å, Fluge S, Gilje B, Gjertsen BT, Grønberg BH, Grønås K, Guren T, Hamre H, Haug Å, Heinrich D et al. (2022)
    Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
    J Transl Med, 20 (1), 317
    DOI 10.1186/s12967-022-03518-0, PubMed 35841045
  26. Hetland G, Fagerhol MK, Wiedmann MKH, Søraas AVL, Mirlashari MR, Nissen-Meyer LSH, Istre MS, Holme PA, Schultz NH (2022)
    Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects
    Vaccines (Basel), 10 (8)
    DOI 10.3390/vaccines10081267, PubMed 36016155
  27. Hjertholm KG, Holmboe-Ottesen G, Mdala I, Shi Z, Iversen PO (2022)
    The impact of dietary diversity and seasonality in food availability on the quantile distribution of birth size among pregnant women in rural Malawi - a cross-sectional study
    BMC Pregnancy Childbirth, 22 (1), 602
    DOI 10.1186/s12884-022-04924-4, PubMed 35897009
  28. Horn MA, Myhre AE, Prescott T, Aasly J, Sundal CH, Gedde-Dahl T (2022)
    Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R-Related Leukoencephalopathy
    Mov Disord, 37 (5), 1108-1109
    DOI 10.1002/mds.29011, PubMed 35587623
  29. Huuhtanen J, Ilander M, Yadav B, Dufva OM, Lähteenmäki H, Kasanen T, Klievink J, Olsson-Strömberg U, Stentoft J, Richter J, Koskenvesa P, Höglund M, Söderlund S, Dreimane A, Porkka K, Gedde-Dahl T, Gjertsen BT, Stenke L, Myhr-Eriksson K, Markevärn B, Lübking A, Dimitrijevic A, Udby L, Bjerrum OW, Hjorth-Hansen H et al. (2022)
    IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia
    J Clin Invest, 132 (17)
    DOI 10.1172/JCI152585, PubMed 36047494
  30. Imbery JF, Heinzelbecker J, Jebsen JK, McGowan M, Myklebust C, Bottini N, Stanford SM, Skånland SS, Tveita A, Tjønnfjord GE, Munthe LA, Szodoray P, Nakken B (2022)
    T-helper cell regulation of CD45 phosphatase activity by galectin-1 and CD43 governs chronic lymphocytic leukaemia proliferation
    Br J Haematol, 198 (3), 556-573
    DOI 10.1111/bjh.18285, PubMed 35655388
  31. Iversen PO, Hankin A, Horn J, Pedersen TH, Borgersen R, Frøen HM (2022)
    Deep Compartment Syndrome Without Myonecrosis: A Case Report on a Rare Complication of Sickle Cell Disease
    Cureus, 14 (9), e29164
    DOI 10.7759/cureus.29164, PubMed 36258983
  32. Janssens R, Lang T, Vallejo A, Galinsky J, Morgan K, Plate A, De Ronne C, Verschueren M, Schoefs E, Vanhellemont A, Delforge M, Schjesvold F, Cabezudo E, Vandebroek M, Stevens H, Simoens S, Huys I (2022)
    What matters most to patients with multiple myeloma? A Pan-European patient preference study
    Front Oncol, 12, 1027353
    DOI 10.3389/fonc.2022.1027353, PubMed 36523996
  33. Jønsson V, Awan H, Jones ND, Johannesen TB, Thøgersen K, Steig BÁ, Andorsdottir G, Tjønnfjord GE (2022)
    Meiotic drive in chronic lymphocytic leukemia compared with other malignant blood disorders
    Sci Rep, 12 (1), 6138
    DOI 10.1038/s41598-022-09602-1, PubMed 35413962
  34. Jørgensen CT, Tavoly M, Pettersen HH, Førsund E, Roaldsnes C, Olsen MK, Tjønnfjord E, Gleditsch J, Galovic AG, Vikum SF, Brækkan SK, Ghanima W (2022)
    The venous thrombosis registry in Østfold Hospital (TROLL registry) - design and cohort description
    Res Pract Thromb Haemost, 6 (5)
    DOI 10.1002/rth2.12770, PubMed 35949883
  35. Katenga-Kaunda LZ, Iversen PO, Kamudoni PR, Holmboe-Ottesen G, Fjeld HE (2022)
    Food-based nutrition counselling and education intervention for improved diets of pregnant women in rural Malawi: a qualitative study of factors influencing dietary behaviour change
    Public Health Nutr, 25 (9), 2436-2447
    DOI 10.1017/S1368980022000593, PubMed 35369896
  36. Kihlberg K, Baghaei F, Bruzelius M, Funding E, Holme PA, Lassila R, Martin M, Nummi V, Ranta S, Strandberg K, Andersson NG, Berntorp E, Astermark J (2022)
    Factor IX antibodies and tolerance in hemophilia B in the Nordic countries - The impact of F9 variants and complications
    Thromb Res, 217, 22-32
    DOI 10.1016/j.thromres.2022.06.015, PubMed 35842956
  37. Klamroth R, Ay C, De Moerloose P, Fontana P, Windyga J, Astermark J, Berntorp E, Carvalho M, Dolan G, Hermans C, Holme PA, Kenet G, Mancuso ME, Marquardt N, Nunez R, Pabinger I, Rodgers R, Valk PV, Yuste VJ, Zupan IP (2022)
    Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A - A modified Delphi consensus by the ADVANCE Working Group
    Haemophilia, 29 (1), 21-32
    DOI 10.1111/hae.14674, PubMed 36271497
  38. Klintman J, Akesson KE, Holme PA, Fischer K (2022)
    Bone mineral density in haemophilia - a multicentre study evaluating the impact of different replacement regimens
    Haemophilia, 28 (2), 239-246
    DOI 10.1111/hae.14487, PubMed 34994489
  39. Koroma AS, Ellie M, Bangura K, Iversen PO, Hendrixson DT, Stephenson K, Manary MJ (2022)
    Supplementary feeding and infection control in pregnant adolescents-A secondary analysis of a randomized trial among malnourished women in Sierra Leone
    Matern Child Nutr, 19 (1), e13456
    DOI 10.1111/mcn.13456, PubMed 36349973
  40. Krausz M, Uhlmann A, Rump IC, Ihorst G, Goldacker S, Sogkas G, Posadas-Cantera S, Schmidt R, Feißt M, Alsina L, Dybedal I, Recher M, Warnatz K, Grimbacher B (2022)
    The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial
    Contemp Clin Trials Commun, 30, 101008
    DOI 10.1016/j.conctc.2022.101008, PubMed 36262801
  41. Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Osvik Velle E, Skuterud Wik H, Ghanima W, Sandset PM, Dahm AEA (2022)
    Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up
    J Thromb Haemost, 20 (5), 1166-1181
    DOI 10.1111/jth.15666, PubMed 35114046
  42. Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2022)
    "Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply
    J Thromb Haemost, 20 (8), 1937-1939
    DOI 10.1111/jth.15774, PubMed 35859282
  43. Larsen TL, Ghanima W, Sandset PM, Frøen H, Jacobsen EM, Torfoss D, Dahm AEA (2022)
    [Factor Xa inhibitors in the prevention and treatment of venous thromboembolism in cancer patients]
    Tidsskr Nor Laegeforen, 142 (1)
    DOI 10.4045/tidsskr.22.0228, PubMed 36655971
  44. Lehtinen AE, Baghaei F, Astermark J, Holme PA (2022)
    Surgical outcomes in patients with haemophilia A or B receiving extended half-life recombinant factor VIII and IX Fc fusion proteins: Real-world experience in the Nordic countries
    Haemophilia, 28 (5), 713-719
    DOI 10.1111/hae.14585, PubMed 35575446
  45. Leleu X, Martin T, Weisel K, Schjesvold F, Iida S, Malavasi F, Manier S, Chang-Ki Min, Ocio EM, Pawlyn C, Perrot A, Quach H, Richter J, Spicka I, Yong K, Richardson PG (2022)
    Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes
    Ann Hematol, 101 (10), 2123-2137
    DOI 10.1007/s00277-022-04917-5, PubMed 35943588
  46. Lindahl JP, Barlinn R, Abrahamsen IW, Spetalen S, Midtvedt K, Jenssen T (2022)
    Case Report: Pure Red Cell Aplasia Caused by Refractory Parvovirus B19 Infection After Pancreas Transplantation Alone
    Front Med (Lausanne), 9, 849783
    DOI 10.3389/fmed.2022.849783, PubMed 35372384
  47. Massey RJ, Myrdal OH, Diep PP, Burman MM, Brinch L, Gullestad LL, Ruud E, Aakhus S, Beitnes JO (2022)
    Reduced exercise capacity is associated with left ventricular systolic dysfunction in long-term survivors of allogeneic hematopoietic stem-cell transplantation
    J Clin Ultrasound, 51 (1), 5-15
    DOI 10.1002/jcu.23264, PubMed 35788941
  48. Matlary RED, Grinda N, Sayers F, Versloot O, McLaughlin P, EAHAD Physiotherapists Committee (2022)
    Promoting physical activity for people with haemophilia in the age of new treatments
    Haemophilia, 28 (6), 885-890
    DOI 10.1111/hae.14641, PubMed 35896000
  49. Matlary RED, Holme PA, Glosli H, Rueegg CS, Grydeland M (2022)
    Comparison of free-living physical activity measurements between ActiGraph GT3X-BT and Fitbit Charge 3 in young people with haemophilia
    Haemophilia, 28 (6), e172-e180
    DOI 10.1111/hae.14624, PubMed 35830613
  50. McPherson S, Mitchell AK, Sletten I, Kvande ME, Steindal SA (2022)
    Haematological nurses' experiences about palliative care trajectories of patients with life-threatening haematological malignancies: A qualitative study
    Nurs Open, 10 (5), 3094-3103
    DOI 10.1002/nop2.1558, PubMed 36539384
  51. Midtvedt Ø, Stray-Pedersen A, Andersson H, Gunnarsson R, Tveten K, Ali MM, Tjønnfjord GE (2022)
    A man in his sixties with chondritis and bone marrow failure
    Tidsskr Nor Laegeforen, 142 (4)
    DOI 10.4045/tidsskr.21.0370, PubMed 35239266
  52. Molteberg E, Taubøll E, Kverneland M, Iversen PO, Selmer KK, Nakken KO, Hofoss D, Thorsby PM (2022)
    Substantial early changes in bone and calcium metabolism among adult pharmacoresistant epilepsy patients on a modified Atkins diet
    Epilepsia, 63 (4), 880-891
    DOI 10.1111/epi.17169, PubMed 35092022
  53. Muhoozi GKM, Li K, Atukunda P, Skaare AB, Willumsen T, Enersen M, Westerberg AC, Morris A, Vieira AR, Iversen PO, Methé BA (2022)
    Child saliva microbiota and caries: a randomized controlled maternal education trial in rural Uganda
    Sci Rep, 12 (1), 7857
    DOI 10.1038/s41598-022-11979-y, PubMed 35552492
  54. Nagler A, Galimard JE, Labopin M, Blaise D, Arcese W, Trisolini SM, Wu D, Pigneux A, Van Gorkom G, Rubio MT, Gedde-Dahl T, Huynh A, Lanza F, Gorin NC, Mohty M (2022)
    Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT
    Cancer Med, 12 (2), 1482-1491
    DOI 10.1002/cam4.5039, PubMed 35891608
  55. Nagler A, Labopin M, Craddock C, Socié G, Yakoub-Agha I, Gedde-Dahl T, Niittyvuopio R, Byrne JL, Cornelissen JJ, Labussière-Wallet H, Arcese W, Milpied N, Esteve J, Canaani J, Mohty M (2022)
    Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation
    Am J Hematol, 97 (3), 274-282
    DOI 10.1002/ajh.26442, PubMed 34978724
  56. Nagler A, Ngoya M, Galimard JE, Labopin M, Kröger N, Socié G, Gedde-Dahl T, Potter V, Schroeder T, Platzbecker U, Ganser A, Blaise D, Salmenniemi U, Maertens J, Craddock C, Labussière-Wallet H, Yakoub-Agha I, Savani B, Mohty M (2022)
    Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT
    Bone Marrow Transplant, 57 (12), 1788-1796
    DOI 10.1038/s41409-022-01825-0, PubMed 36114249
  57. Nagler A, Ngoya M, Galimard JE, Labopin M, Kröger N, Socié G, Gedde-Dahl T, Potter V, Schroeder T, Platzbecker U, Ganser A, Blaise D, Salmenniemi U, Maertens J, Craddock C, Labussière-Wallet H, Yakoub-Agha I, Savani B, Mohty M (2022)
    Correction: Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT
    Bone Marrow Transplant, 57 (12), 1856
    DOI 10.1038/s41409-022-01853-w, PubMed 36280759
  58. Nahalomo A, Iversen PO, Andreassen BA, Kaaya AN, Rukooko AB, Rukundo PM (2022)
    Seasonality- and disaster effects on food variety and food insecurity coping strategies among a landslide-prone cohort
    Clin Nutr ESPEN, 52, 229-239
    DOI 10.1016/j.clnesp.2022.11.005, PubMed 36513458
  59. Nahalomo A, Iversen PO, Andreassen BA, Kaaya AN, Rukooko AB, Tushabe G, Nateme NC, Rukundo PM (2022)
    Malnutrition and Associated Risk Factors among Children 6-59 Months Old in the Landslide-Prone Bududa District, Eastern Uganda: A Cohort Study
    Curr Dev Nutr, 6 (2), nzac005
    DOI 10.1093/cdn/nzac005, PubMed 35198847
  60. Ng S, Rodger MA, Ghanima W, Kovacs MJ, Shivakumar S, Kahn SR, Sandset PM, Kearon C, Mallick R, Delluc A (2022)
    External Validation of the Patient-Reported Villalta Scale for the Diagnosis of Postthrombotic Syndrome
    Thromb Haemost, 122 (8), 1379-1383
    DOI 10.1055/a-1738-1313, PubMed 35021257
  61. Ocio EM, Nadeem O, Schjesvold F, Gay F, Touzeau C, Dimopoulos MA, Richardson PG, Mateos MV (2022)
    Melflufen for the treatment of multiple myeloma
    Expert Rev Clin Pharmacol, 15 (4), 371-382
    DOI 10.1080/17512433.2022.2075847, PubMed 35723075
  62. Pedersen S, Kverneland M, Nakken KO, Rudi K, Iversen PO, Gervin K, Selmer KK (2022)
    Genome-wide decrease in DNA methylation in adults with epilepsy treated with modified ketogenic diet: A prospective study
    Epilepsia, 63 (9), 2413-2426
    DOI 10.1111/epi.17351, PubMed 35762681
  63. Rasmussen B, Göhring G, Bernard E, Nilsson L, Tobiasson M, Jädersten M, Garelius H, Dybedal I, Grønbaek K, Ejerblad E, Lorenz F, Flogegård M, Marcher CW, Öster Fernström A, Cavelier L, Papaemmanuil E, Ebeling F, Kittang AO, Nørgaard JM, Saft L, Möllgård L, Hellström-Lindberg E (2022)
    "Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)"
    Leukemia, 36 (5), 1436-1439
    DOI 10.1038/s41375-022-01537-w, PubMed 35277655
  64. Reiter A, Schwaab J, DeAngelo DJ, Gotlib J, Deininger MW, Pettit KM, Alvarez-Twose I, Vannucchi AM, Panse J, Platzbecker U, Hermine O, Dybedal I, Lin HM, Rylova SN, Ehlert K, Dimitrijević S, Radia DH (2022)
    Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis
    Blood Adv, 6 (21), 5750-5762
    DOI 10.1182/bloodadvances.2022007539, PubMed 35640224
  65. Rempelos L, Wang J, Barański M, Watson A, Volakakis N, Hadall C, Hasanaliyeva G, Chatzidimitriou E, Magistrali A, Davis H, Vigar V, Średnicka-Tober D, Rushton S, Rosnes KS, Iversen PO, Seal CJ, Leifert C (2022)
    Diet, but not food type, significantly affects micronutrient and toxic metal profiles in urine and/or plasma; a randomized, controlled intervention trial
    Am J Clin Nutr, 116 (5), 1278-1290
    DOI 10.1093/ajcn/nqac233, PubMed 36041176
  66. Rempelos L, Wang J, Barański M, Watson A, Volakakis N, Hoppe HW, Kühn-Velten WN, Hadall C, Hasanaliyeva G, Chatzidimitriou E, Magistrali A, Davis H, Vigar V, Średnicka-Tober D, Rushton S, Iversen PO, Seal CJ, Leifert C (2022)
    Diet and food type affect urinary pesticide residue excretion profiles in healthy individuals: results of a randomized controlled dietary intervention trial
    Am J Clin Nutr, 115 (2), 364-377
    DOI 10.1093/ajcn/nqab308, PubMed 34718382
  67. Richardson PG, Perrot A, San-Miguel J, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang JS, Minarik J, Cavo M, Prince HM, Malinge L, Dubin F, van de Velde H, Anderson KC (2022)
    Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study
    Lancet Oncol, 23 (3), 416-427
    DOI 10.1016/S1470-2045(22)00019-5, PubMed 35151415
  68. Richartz N, Pietka W, Gilljam KM, Skah S, Skålhegg BS, Bhagwat S, Naderi EH, Ruud E, Blomhoff HK (2022)
    cAMP-Mediated Autophagy Promotes Cell Survival via ROS-Induced Activation of PARP1: Implications for Treatment of Acute Lymphoblastic Leukemia
    Mol Cancer Res, 20 (3), 400-411
    DOI 10.1158/1541-7786.MCR-21-0652, PubMed 34880123
  69. Røed-Undlien H, Schultz NH, Lunnan A, Husebråten IM, Wollmann BM, Molden E, Bjørnstad JL (2022)
    In Vitro Apixaban Removal By CytoSorb Whole Blood Adsorber: An Experimental Study
    J Cardiothorac Vasc Anesth, 36 (6), 1636-1644
    DOI 10.1053/j.jvca.2022.01.038, PubMed 35272914
  70. Schjesvold F, Paiva B, Ribrag V, Rodriguez-Otero P, San-Miguel JF, Robak P, Hansson M, Onishi M, Hamidi H, Malhi V, Dail M, Javery A, Ku G, Raab MS (2022)
    Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple Myeloma
    Clin Lymphoma Myeloma Leuk, 23 (1), e59-e70
    DOI 10.1016/j.clml.2022.10.006, PubMed 36450626
  71. Schjesvold F, Richardson PG, Facon T, Alegre A, Spencer A, Jurczyszyn A, Sunami K, Frenzel L, Min CK, Guillonneau S, Lin PL, Le-Guennec S, Campana F, Van de Velde H, Bensfia S, Bringhen S (2022)
    Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis
    Haematologica, 107 (3), 774-775
    DOI 10.3324/haematol.2021.279160, PubMed 35229573
  72. Schjesvold FH, Bakker NA, Sonneveld P (2022)
    Melflufen in multiple myeloma: the conclusion matters - Authors' reply
    Lancet Haematol, 9 (4), e244-e245
    DOI 10.1016/S2352-3026(22)00071-0, PubMed 35358436
  73. Schjesvold FH, Bakker NA, Sonneveld P (2022)
    Authors' reply: Perspective: The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDA
    Transl Oncol, 25, 101528
    DOI 10.1016/j.tranon.2022.101528, PubMed 36087383
  74. Schjesvold FH, Dimopoulos MA, Delimpasi S, Robak P, Coriu D, Legiec W, Pour L, Špička I, Masszi T, Doronin V, Minarik J, Salogub G, Alekseeva Y, Lazzaro A, Maisnar V, Mikala G, Rosiñol L, Liberati AM, Symeonidis A, Moody V, Thuresson M, Byrne C, Harmenberg J, Bakker NA, Hájek R et al. (2022)
    Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study
    Lancet Haematol, 9 (2), e98-e110
    DOI 10.1016/S2352-3026(21)00381-1, PubMed 35032434
  75. Schmitz A, Brøndum RF, Johnsen HE, Mellqvist UH, Waage A, Gimsing P, Op Bruinink DH, van der Velden V, van der Holt B, Hansson M, Andersen NF, Frølund UC, Helleberg C, Schjesvold FH, Ahlberg L, Gulbrandsen N, Andreasson B, Lauri B, Haukas E, Bødker JS, Roug AS, Bøgsted M, Severinsen MT, Gregersen H, Abildgaard N et al. (2022)
    Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial
    BMC Cancer, 22 (1), 147
    DOI 10.1186/s12885-022-09184-1, PubMed 35123422
  76. Schultz NH, Søraas AVL, Sørvoll IH, Akkök ÇA, Vetlesen A, Bhamra JS, Ahlen MT, Holme PA, Aamodt AH, Skagen K, Skattør TH, Skjelland M, Wiedmann MK (2022)
    Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort study
    J Stroke Cerebrovasc Dis, 32 (1), 106860
    DOI 10.1016/j.jstrokecerebrovasdis.2022.106860, PubMed 36403363
  77. Skånland SS, Inngjerdingen M, Bendiksen H, York J, Spetalen S, Munthe LA, Tjønnfjord GE (2022)
    Functional testing of relapsed chronic lymphocytic leukemia guides precision medicine and maps response and resistance mechanisms. An index case
    Haematologica, 107 (8), 1994-1998
    DOI 10.3324/haematol.2021.280393, PubMed 35236056
  78. Skånland SS, Tjønnfjord GE (2022)
    Determining drug dose in the era of targeted therapies: playing it (un)safe?
    Blood Cancer J, 12 (8), 123
    DOI 10.1038/s41408-022-00720-7, PubMed 35999205
  79. Solhaug TS, Tjønnfjord GE, Bjørgo K, Kildahl-Andersen O (2022)
    A family with cytotoxic T-lymphocyte-associated protein 4 haploinsufficiency presenting with aplastic anaemia
    BMJ Case Rep, 15 (2)
    DOI 10.1136/bcr-2021-247653, PubMed 35228238
  80. Stokke C, Nørgaard JN, Feiring Phillips H, Sherwani A, Nuruddin S, Connelly J, Schjesvold F, Revheim ME (2022)
    Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
    Mol Imaging Biol, 24 (5), 842-851
    DOI 10.1007/s11307-022-01734-0, PubMed 35501622
  81. Strømmen K, Lyche JL, Moltu SJ, Müller MHB, Blakstad EW, Brække K, Sakhi AK, Thomsen C, Nakstad B, Rønnestad AE, Drevon CA, Iversen PO (2022)
    Estimated daily intake of phthalates, parabens, and bisphenol A in hospitalised very low birth weight infants
    Chemosphere, 309 (Pt 1), 136687
    DOI 10.1016/j.chemosphere.2022.136687, PubMed 36206919
  82. Swan D, Hayden PJ, Eikema DJ, Koster L, Sauer S, Blaise D, Nicholson E, Rabin N, Touzeau C, Byrne J, Huynh A, Cornelissen JJ, Potter V, Forcade E, Parrish C, Gribben J, Chretien ML, Mielke S, Gedde-Dahl T, Reményi P, Tsirigotis P, Garcia Guiñón A, Beksac M, Schönland S, Yakoub-Agha I (2022)
    Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019
    Br J Haematol, 197 (1), 82-96
    DOI 10.1111/bjh.18025, PubMed 35166376
  83. Szanto T, Zetterberg E, Ramström S, Leinøe EB, Holme PA, Antovic JP, Holmström M, Onundarson PT, Pikta M, Vaide I, Olsson A, Magnusson M, Kärkkäinen S, Bitar M, Poulsen LH, Lassila R, Nordic Haemophilia Council (2022)
    Platelet function testing: Current practice among clinical centres in Northern Europe
    Haemophilia, 28 (4), 642-648
    DOI 10.1111/hae.14578, PubMed 35510959
  84. Tanem KE, Wilberg P, Diep PP, Ruud E, Skaare AB, Brinch L, Herlofson BB (2022)
    Oral chronic GVHD after allogeneic stem cell transplantation without total body irradiation performed at a young age
    Support Care Cancer, 30 (5), 4121-4128
    DOI 10.1007/s00520-022-06836-7, PubMed 35075489
  85. Tarasco E, von Krogh AS, Hrdlickova R, Braschler TR, Iwaniec T, Knöbl PN, Hamada E, Pikovsky O, Farese S, Gutwein O, Kessler P, Schultz NH, von Auer C, Windyga J, Friedman K, Hrachovinova I, George JN, Matsumoto M, Schneppenheim R, Lämmle B, Kremer Hovinga JA (2022)
    Hereditary thrombotic thrombocytopenic purpura and COVID-19: Impacts of vaccination and infection in this rare disease
    Res Pract Thromb Haemost, 6 (7), e12814
    DOI 10.1002/rth2.12814, PubMed 36284639
  86. Tavoly M, Asady E, Wik HS, Ghanima W (2022)
    Measuring Quality of Life after Venous Thromboembolism: Who, When, and How?
    Semin Thromb Hemost, 49 (8), 861-866
    DOI 10.1055/s-0042-1754390, PubMed 36055276
  87. Toksvang LN, Als-Nielsen B, Bacon C, Bertasiute R, Duarte X, Escherich G, Helgadottir EA, Johannsdottir IR, Jónsson ÓG, Kozlowski P, Langenskjöld C, Lepik K, Niinimäki R, Overgaard UM, Punab M, Räty R, Segers H, van der Sluis I, Smith OP, Strullu M, Vaitkevičienė G, Wik HS, Heyman M, Schmiegelow K (2022)
    Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol
    BMC Cancer, 22 (1), 483
    DOI 10.1186/s12885-022-09522-3, PubMed 35501736
  88. Trøseid M, Dahl TB, Holter JC, Kildal AB, Murphy SL, Yang K, Quiles-Jiménez A, Heggelund L, Müller KE, Tveita A, Michelsen AE, Bøe S, Holten AR, Hoel H, Mathiessen A, Aaløkken TM, Fevang B, Granerud BK, Tonby K, Henriksen KN, Lerum TV, Müller F, Skjønsberg OH, Barratt-Due A, Dyrhol-Riise AM et al. (2022)
    Persistent T-cell exhaustion in relation to prolonged pulmonary pathology and death after severe COVID-19: Results from two Norwegian cohort studies
    J Intern Med, 292 (5), 816-828
    DOI 10.1111/joim.13549, PubMed 35982589
  89. Tsykunova G, Ghanima W (2022)
    Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives
    Ther Clin Risk Manag, 18, 273-286
    DOI 10.2147/TCRM.S251672, PubMed 35386180
  90. Tveita A, Murphy SL, Holter JC, Kildal AB, Michelsen AE, Lerum TV, Kaarbø M, Heggelund L, Holten AR, Finbråten AK, Müller KE, Mathiessen A, Bøe S, Fevang B, Granerud BK, Tonby K, Lind A, Dudman SG, Henriksen KN, Müller F, Skjønsberg OH, Trøseid M, Barratt-Due A, Dyrhol-Riise AM, Aukrust P et al. (2022)
    High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19
    J Infect Dis, 226 (12), 2150-2160
    DOI 10.1093/infdis/jiac313, PubMed 35876699
  91. Ueland T, Hausberg I, Mørtberg TV, Dahl TB, Lerum TV, Michelsen A, Ranheim T, Nezvalova Henriksen K, Dyrhol-Riise AM, Holme PA, Aaløkken TM, Skjønsberg OH, Barratt-Due A, Ahlén MT, Aukrust P, Halvorsen B (2022)
    Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology
    Platelets, 33 (4), 640-644
    DOI 10.1080/09537104.2022.2042238, PubMed 35225150
  92. Vestad B, Ueland T, Lerum TV, Dahl TB, Holm K, Barratt-Due A, Kåsine T, Dyrhol-Riise AM, Stiksrud B, Tonby K, Hoel H, Olsen IC, Henriksen KN, Tveita A, Manotheepan R, Haugli M, Eiken R, Berg Å, Halvorsen B, Lekva T, Ranheim T, Michelsen AE, Kildal AB, Johannessen A, Thoresen L et al. (2022)
    Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations
    J Intern Med, 291 (6), 801-812
    DOI 10.1111/joim.13458, PubMed 35212063
  93. Warlo EMK, Bratseth V, Pettersen AR, Holme PA, Arnesen H, Seljeflot I, Opstad TB (2022)
    Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events
    Clin Appl Thromb Hemost, 28, 10760296221141893
    DOI 10.1177/10760296221141893, PubMed 36474435
  94. Wergeland D, Harsten K, Klarare A, Steindal SA (2022)
    Title authors reply to letter to Editor 'Follow-up care after stem-cell transplant'
    J Clin Nurs, 32 (13-14), 4195-4196
    DOI 10.1111/jocn.16436, PubMed 35818338
  95. Yin Y, Athanasiadis P, Karlsen L, Urban A, Xu H, Murali I, Fernandes SM, Arribas AJ, Hilli AK, Taskén K, Bertoni F, Mato AR, Normant E, Brown JR, Tjønnfjord GE, Aittokallio T, Skånland SS (2022)
    Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia
    Clin Cancer Res, 28 (20), 4444-4455
    DOI 10.1158/1078-0432.CCR-22-1221, PubMed 35998013
  96. Aasebo AT, Gedde-Dahl T, Reims HM, Baekkevold ES, Jahnsen FL (2022)
    Calprotectin Expressing Donor-Derived Macrophages Increase in Acute Gastrointestinal Graft-Versus-Host Disease
    Transplant Cell Ther, 28 (5), 248.e1-248.e8
    DOI 10.1016/j.jtct.2022.01.028, PubMed 35144036

Publications 2021

  1. Ahmed J, Stenkula C, Omar S, Ghanima J, Bremtun FF, Bergan J, Raouf N, Ghanima W (2021)
    Patient outcomes after electrical injury - a retrospective study
    Scand J Trauma Resusc Emerg Med, 29 (1), 114
    DOI 10.1186/s13049-021-00920-3, PubMed 34362435
  2. Ali M, Giannakopoulou E, Li Y, Lehander M, Virding Culleton S, Yang W, Knetter C, Odabasi MC, Bollineni RC, Yang X, Foldvari Z, Böschen ML, Taraldsrud E, Strønen E, Toebes M, Hillen A, Mazzi S, de Ru AH, Janssen GMC, Kolstad A, Tjønnfjord GE, Lie BA, Griffioen M, Lehmann S, Osnes LT et al. (2021)
    T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes
    Nat Biotechnol, 40 (4), 488-498
    DOI 10.1038/s41587-021-01089-x, PubMed 34873326
  3. Ali MM, Grønvold B, Remberger M, Abrahamsen IW, Myhre AE, Tjønnfjord GE, Fløisand Y, Gedde-Dahl T (2021)
    Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival
    Clin Lymphoma Myeloma Leuk, 21 (9), 598-605
    DOI 10.1016/j.clml.2021.05.003, PubMed 34158268
  4. Andersen AM, Bergan S, Gedde-Dahl T, Buechner J, Vethe NT (2021)
    Fast and reliable quantification of busulfan in blood plasma using two-channel liquid chromatography tandem mass spectrometry: Validation of assay performance in the presence of drug formulation excipients
    J Pharm Biomed Anal, 203, 114216
    DOI 10.1016/j.jpba.2021.114216, PubMed 34182411
  5. Andersen E, Chollet ME, Bernardi F, Branchini A, Baroni M, Mariani G, Dolce A, Batorova A, Skarpen E, Myklebust CF, Skretting G, Sandset PM (2021)
    The Factor VII Variant p.A354V-p.P464Hfs: Clinical versus Intracellular and Biochemical Phenotypes Induced by Chemical Chaperones
    Appl. Sci.-Basel, 11 (13), 5762
    DOI 10.3390/app11135762
  6. Andersen E, Chollet ME, Sletten M, Stavik B, Skarpen E, Backe PH, Thiede B, Glosli H, Henriksson CE, Iversen N (2021)
    Molecular Characterization of Two Homozygous Factor VII Variants Associated with Intracranial Bleeding
    Thromb Haemost, 121 (12), 1588-1598
    DOI 10.1055/a-1450-8568, PubMed 33742435
  7. Andresen MS, Sletten M, Sandset PM, Iversen N, Stavik B, Tinholt M (2021)
    Coagulation Factor V (F5) is an Estrogen-Responsive Gene in Breast Cancer Cells
    Thromb Haemost, 122 (8), 1288-1295
    DOI 10.1055/a-1707-2130, PubMed 34826880
  8. Asady E, Ghanima W, Jelsness-Jorgensen LP, Klok FA, Kahn SR, Stromme H, Wik HS (2021)
    Health-related quality-of-life questionnaires for deep vein thrombosis and pulmonary embolism: A systematic review on questionnaire development and methodology
    Res Pract Thromb Haemost, 5 (5), e12556
    DOI 10.1002/rth2.12556, PubMed 34278190
  9. Astermark J, Ay C, Carvalho M, D'Oiron R, Moerloose P, Dolan G, Fontana P, Hermans C, Holme PA, Katsarou O, Kenet G, Klamroth R, Mancuso ME, Marquardt N, Núñez R, Pabinger I, Tait R, Valk PV (2021)
    New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia
    Thromb Haemost, 122 (6), 905-912
    DOI 10.1055/a-1642-4067, PubMed 34507368
  10. Atukunda P, Eide WB, Kardel KR, Iversen PO, Westerberg AC (2021)
    Unlocking the potential for achievement of the UN Sustainable Development Goal 2 - 'Zero Hunger' - in Africa: targets, strategies, synergies and challenges
    Food Nutr Res, 65
    DOI 10.29219/fnr.v65.7686, PubMed 34262413
  11. Atukunda P, Ngari M, Chen X, Westerberg AC, Iversen PO, Muhoozi G (2021)
    Longitudinal assessments of child growth: A six-year follow-up of a cluster-randomized maternal education trial
    Clin Nutr, 40 (9), 5106-5113
    DOI 10.1016/j.clnu.2021.08.007, PubMed 34461584
  12. Barański M, Średnicka-Tober D, Rempelos L, Hasanaliyeva G, Gromadzka-Ostrowska J, Skwarło-Sońta K, Królikowski T, Rembiałkowska E, Hajslova J, Schulzova V, Cakmak I, Ozturk L, Hallmann E, Seal C, Iversen PO, Vigar V, Leifert C (2021)
    Feed Composition Differences Resulting from Organic and Conventional Farming Practices Affect Physiological Parameters in Wistar Rats-Results from a Factorial, Two-Generation Dietary Intervention Trial
    Nutrients, 13 (2)
    DOI 10.3390/nu13020377, PubMed 33530419
  13. Bavalia R, Bistervels IM, Boersma WG, Quere I, Brisot D, Falvo N, Stephan D, Couturaud F, Schellong S, Beyer-Westendorf J, Montaclair K, Ghanima W, Ten Wolde M, Coppens M, Ferrari E, Sanchez O, Carroll P, Roy PM, Kahn SR, Meijer K, Birocchi S, Kovacs MJ, Hugman A, Ten Cate H, Wik H et al. (2021)
    Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin
    Res Pract Thromb Haemost, 5 (5), e12566
    DOI 10.1002/rth2.12566, PubMed 34278193
  14. Berishvili E, Kaiser L, Cohen M, Berney T, Scholz H, Floisand Y, Mattsson J (2021)
    Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy
    Stem Cell Rev Rep, 17 (1), 63-70
    DOI 10.1007/s12015-020-10004-x, PubMed 32696426
  15. Bjørkto MH, Barratt-Due A, Nordøy I, Dörje C, Galteland E, Lind A, Hilli A, Aukrust P, Mjøen G (2021)
    The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report
    BMC Infect Dis, 21 (1), 137
    DOI 10.1186/s12879-021-05789-2, PubMed 33526010
  16. Bøhn SK, Thune I, Flote VG, Frydenberg H, Bertheussen GF, Husøy A, Fjeldheim F, Brunvoll SH, Hjartåker A, Mowinckel MC, Sandset PM, Iversen PO (2021)
    Effects of a 1-Year Physical Activity Intervention on Markers of Hemostasis among Breast Cancer Survivors: A Randomized Controlled Trial
    TH Open, 5 (1), e14-e23
    DOI 10.1055/s-0040-1721782, PubMed 33564742
  17. Cesaro S, Tridello G, Knelange NS, Blijlevens N, Martin M, Snowden JA, Malladi R, Ljungman P, Deconinck E, Gedde-Dahl T, Byrne J, Xhaard A, Chevallier P, Maertens J, Zuckerman T, Lioure B, Petersen E, Cornelissen JJ, Arcese W, Blaise D, Milpied N, Cahn JY, Aljurf M, de Wreede L, Mauro M et al. (2021)
    Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMT
    Bone Marrow Transplant, 56 (7), 1563-1572
    DOI 10.1038/s41409-021-01212-1, PubMed 33514919
  18. Cooper N, Cuker A, Bonner N, Ghanima W, Provan D, Morgan M, Taylor B, D'Alessio D, Arnold D, Viana R (2021)
    Qualitative study to support the content validity of the immune thrombocytopenia (ITP) Life Quality Index (ILQI)
    Br J Haematol, 194 (4), 759-766
    DOI 10.1111/bjh.17694, PubMed 34263940
  19. Cui XY, Tjønnfjord GE, Kanse SM, Dahm AEA, Iversen N, Myklebust CF, Sun L, Jiang ZX, Ueland T, Campbell JJ, Ho M, Sandset PM (2021)
    Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia
    Sci Rep, 11 (1), 5127
    DOI 10.1038/s41598-021-84695-8, PubMed 33664415
  20. Dahm AEA, Sandset PM (2021)
    Tissue factor pathway inhibitor and bleeding tendency: can hormonal state explain the differences?
    Blood Adv, 5 (11), 2516-2517
    DOI 10.1182/bloodadvances.2021004651, PubMed 34086862
  21. Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, Delforge M, Hájek R, Schjesvold F, Cavo M, Goldschmidt H, Facon T, Einsele H, Boccadoro M, San-Miguel J, Sonneveld P, Mey U (2021)
    Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
    Hemasphere, 5 (2), e528
    DOI 10.1097/HS9.0000000000000528, PubMed 33554050
  22. Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, Delforge M, Hájek R, Schjesvold F, Cavo M, Goldschmidt H, Facon T, Einsele H, Boccadoro M, San-Miguel J, Sonneveld P, Mey U, EHA Guidelines Committee ESMO Guidelines Committee. Electronic address: (2021)
    Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322]
    Ann Oncol, 33 (1), 117
    DOI 10.1016/j.annonc.2021.10.001, PubMed 34857439
  23. Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, Delforge M, Hájek R, Schjesvold F, Cavo M, Goldschmidt H, Facon T, Einsele H, Boccadoro M, San-Miguel J, Sonneveld P, Mey U, EHA Guidelines Committee. Electronic address:, ESMO Guidelines Committee. Electronic address: (2021)
    Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Ann Oncol, 32 (3), 309-322
    DOI 10.1016/j.annonc.2020.11.014, PubMed 33549387
  24. Dusingizimana T, Weber JL, Ramilan T, Iversen PO, Brough L (2021)
    A Mixed-Methods Study of Factors Influencing Access to and Use of Micronutrient Powders in Rwanda
    Glob Health Sci Pract, 9 (2), 274-285
    DOI 10.9745/GHSP-D-20-00422, PubMed 34048359
  25. Egg D, Rump IC, Mitsuiki N, Rojas-Restrepo J, Maccari ME, Schwab C, Gabrysch A, Warnatz K, Goldacker S, Patiño V, Wolff D, Okada S, Hayakawa S, Shikama Y, Kanda K, Imai K, Sotomatsu M, Kuwashima M, Kamiya T, Morio T, Matsumoto K, Mori T, Yoshimoto Y, Dybedal I, Kanariou M et al. (2021)
    Therapeutic options for CTLA-4 insufficiency
    J Allergy Clin Immunol, 149 (2), 736-746
    DOI 10.1016/j.jaci.2021.04.039, PubMed 34111452
  26. Engeseth M, Enden T, Sandset PM, Wik HS (2021)
    Predictors of long-term post-thrombotic syndrome following high proximal deep vein thrombosis: a cross-sectional study
    Thromb J, 19 (1), 3
    DOI 10.1186/s12959-020-00253-8, PubMed 33419441
  27. Fernández de Larrea C, Kyle R, Rosiñol L, Paiva B, Engelhardt M, Usmani S, Caers J, Gonsalves W, Schjesvold F, Merlini G, Lentzch S, Ocio E, Garderet L, Moreau P, Sonneveld P, Badros A, Gahrton G, Goldschmidt H, Tuchman S, Einsele H, Durie B, Wirk B, Musto P, Hayden P, Kaiser M et al. (2021)
    Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
    Blood Cancer J, 11 (12), 192
    DOI 10.1038/s41408-021-00587-0, PubMed 34857730
  28. Fiskvik H, Jacobsen AF, Iversen N, Henriksson CE, Jacobsen EM (2021)
    Treatment of Homozygous Type II Antithrombin Heparin-Binding Site Deficiency in Pregnancy
    Case Rep Obstet Gynecol, 2021, 4393821
    DOI 10.1155/2021/4393821, PubMed 34513101
  29. Flygt H, Söderlund S, Stentoft J, Richter J, Koskenvesa P, Mustjoki S, Majeed W, Lübking A, Dreimane A, Markevärn B, Stenke L, Myhr Eriksson K, Gjertsen BT, Gedde-Dahl T, Dimitrijevic A, Udby L, Olsson-Strömberg U, Hjorth-Hansen H (2021)
    Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study
    Eur J Haematol, 107 (6), 617-623
    DOI 10.1111/ejh.13699, PubMed 34418168
  30. Fløisand Y, Schroeder MA, Chevallier P, Selleslag D, Devine S, Renteria AS, Mohty M, Yakoub-Agha I, Chen C, Parfionovas A, Quadri S, Jansson J, Akbari M, Chen YB (2021)
    A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease
    Bone Marrow Transplant, 56 (10), 2477-2488
    DOI 10.1038/s41409-021-01356-0, PubMed 34108672
  31. Ghanima W, Gernsheimer T, Kuter DJ (2021)
    How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment
    Blood, 137 (20), 2736-2744
    DOI 10.1182/blood.2021010968, PubMed 33827138
  32. Gleditsch J, Jervan Ø, Tavoly M, Geier O, Holst R, Klok FA, Ghanima W, Hopp E (2021)
    Association between myocardial fibrosis, as assessed with cardiac magnetic resonance T1 mapping, and persistent dyspnea after pulmonary embolism
    Int J Cardiol Heart Vasc, 38, 100935
    DOI 10.1016/j.ijcha.2021.100935, PubMed 35005213
  33. Gotlib J, Reiter A, Radia DH, Deininger MW, George TI, Panse J, Vannucchi AM, Platzbecker U, Alvarez-Twose I, Mital A, Hermine O, Dybedal I, Hexner EO, Hicks LK, Span L, Mesa R, Bose P, Pettit KM, Heaney ML, Oh ST, Sen J, Lin HM, Mar BG, DeAngelo DJ (2021)
    Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial
    Nat Med, 27 (12), 2192-2199
    DOI 10.1038/s41591-021-01539-8, PubMed 34873345
  34. Gregersen H, Peceliunas V, Remes K, Schjesvold F, Abildgaard N, Nahi H, Andersen NF, Vangsted AJ, Klausen TW, Helleberg C, Carlson K, Frølund UC, Axelsson P, Stromberg O, Blimark CH, Crafoord J, Tsykunova G, Eshoj HR, Waage A, Hansson M, Gulbrandsen N (2021)
    Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group
    Eur J Haematol, 108 (1), 34-44
    DOI 10.1111/ejh.13709, PubMed 34536308
  35. Grønningsæter IS, Reikvam H, Aasebø E, Bartaula-Brevik S, Hernandez-Valladares M, Selheim F, Berven FS, Tvedt TH, Bruserud Ø, Hatfield KJ (2021)
    Effects of the Autophagy-Inhibiting Agent Chloroquine on Acute Myeloid Leukemia Cells; Characterization of Patient Heterogeneity
    J Pers Med, 11 (8)
    DOI 10.3390/jpm11080779, PubMed 34442423
  36. Hasanaliyeva G, Chatzidimitrou E, Wang J, Baranski M, Volakakis N, Pakos P, Seal C, Rosa EAS, Markellou E, Iversen PO, Vigar V, Willson A, Barkla B, Leifert C, Rempelos L (2021)
    Effect of Organic and Conventional Production Methods on Fruit Yield and Nutritional Quality Parameters in Three Traditional Cretan Grape Varieties: Results from a Farm Survey
    Foods, 10 (2)
    DOI 10.3390/foods10020476, PubMed 33671741
  37. Holm S, Kared H, Michelsen AE, Kong XY, Dahl TB, Schultz NH, Nyman TA, Fladeby C, Seljeflot I, Ueland T, Stensland M, Mjaaland S, Goll GL, Nissen-Meyer LS, Aukrust P, Skagen K, Gregersen I, Skjelland M, Holme PA, Munthe LA, Halvorsen B (2021)
    Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia
    Eur Heart J, 42 (39), 4064-4072
    DOI 10.1093/eurheartj/ehab506, PubMed 34405870
  38. Holstein K, Le Quellec S, Klamroth R, Batorova A, Holme PA, Jiménez-Yuste V, Astermark J (2021)
    Immune tolerance induction in the era of emicizumab - still the first choice for patients with haemophilia A and inhibitors?
    Haemophilia, 28 (2), 215-222
    DOI 10.1111/hae.14470, PubMed 34918839
  39. Ihle-Hansen H, Hagberg G, Sandset EC, Ihle-Hansen H, Amundsen EK, Sandset PM, Myrstad M (2021)
    [Anticoagulant reversal in intracerebral haemorrhage]
    Tidsskr Nor Laegeforen, 141 (2021-14)
    DOI 10.4045/tidsskr.21.0063, PubMed 34641660
  40. Ihle-Hansen H, Hagberg G, Sandset EC, Ihle-Hansen H, KoldbergAmundsen E, Sandset PM, Myrstad M (2021)
    Reversal of anticoagulant drugs in case of brain haemorrhage
    Tidsskr. Nor. Laegeforen., 141 (14), 1363-1366
  41. Iversen PO, Ngari M, Westerberg AC, Muhoozi G, Atukunda P (2021)
    Child stunting concurrent with wasting or being overweight: A 6-y follow up of a randomized maternal education trial in Uganda
    Nutrition, 89, 111281
    DOI 10.1016/j.nut.2021.111281, PubMed 34090214
  42. Jacobsen AF, Sandset PM (2021)
    Prior Thromboembolic Disease and Assisted Reproductive Therapy
    Semin Reprod Med, 39 (5-06), 180-185
    DOI 10.1055/s-0041-1732375, PubMed 34261142
  43. Jervan Ø, Gleditsch J, Tavoly M, Klok FA, Rashid D, Holst R, Steine K, Stavem K, Ghanima W (2021)
    Pulmonary and cardiac variables associated with persistent dyspnea after pulmonary embolism
    Thromb Res, 201, 90-99
    DOI 10.1016/j.thromres.2021.02.014, PubMed 33662800
  44. Jiménez-Yuste V, Rodríguez-Merchán EC, Matsushita T, Holme PA (2021)
    Concomitant use of bypassing agents with emicizumab for people with haemophilia A and inhibitors undergoing surgery
    Haemophilia, 27 (4), 519-530
    DOI 10.1111/hae.14322, PubMed 33988293
  45. Johansen S, Laegreid IJ, Ernstsen SL, Azrakhsh NA, Kittang AO, Lindås R, Gjertsen BT, Vetti N, Mørtberg TV, Sørvoll IH, Holme PA, Ahlen MT, Reikvam H (2021)
    Thrombosis and thrombocytopenia after HPV vaccination
    J Thromb Haemost, 20 (3), 700-704
    DOI 10.1111/jth.15604, PubMed 34817130
  46. Jørgensen SF, Buechner J, Myhre AE, Galteland E, Spetalen S, Kulseth MA, Sorte HS, Holla ØL, Lundman E, Alme C, Heier I, Flægstad T, Fløisand Y, Benneche A, Fevang B, Aukrust P, Stray-Pedersen A, Gedde-Dahl T, Nordøy I (2021)
    A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT
    J Clin Immunol, 42 (2), 404-420
    DOI 10.1007/s10875-021-01189-y, PubMed 34893945
  47. Kaiser M, Beksaç M, Gulbrandsen N, Schjesvold F, Hájek R, Moreau P, de la Fuente FA, Mateos MV, West S, Spencer A, Rajkumar SV, Suryanarayan K, Czorniak M, Li C, Teng Z, Labotka R, Dimopoulos MA (2021)
    Correction to: Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma
    Ann Hematol, 100 (1), 297-302
    DOI 10.1007/s00277-020-04302-0, PubMed 33106909
  48. Kakwangire P, Moss C, Matovu N, Atukunda P, Westerberg AC, Iversen PO, Muhoozi G (2021)
    The association between dietary diversity and development among children under 24 months in rural Uganda: analysis of a cluster-randomised maternal education trial
    Public Health Nutr, 24 (13), 4286-4296
    DOI 10.1017/S136898002100077X, PubMed 33706831
  49. Katenga-Kaunda LZ, Kamudoni PR, Holmboe-Ottesen G, Fjeld HE, Mdala I, Shi Z, Iversen PO (2021)
    Enhancing nutrition knowledge and dietary diversity among rural pregnant women in Malawi: a randomized controlled trial
    BMC Pregnancy Childbirth, 21 (1), 644
    DOI 10.1186/s12884-021-04117-5, PubMed 34551744
  50. Kaufman JL, Gasparetto C, Schjesvold FH, Moreau P, Touzeau C, Facon T, Boise LH, Jiang Y, Yang X, Dunbar F, Vishwamitra D, Unger S, Macartney T, Pesko J, Yu Y, Salem AH, Ross JA, Hong WJ, Maciag PC, Pauff JM, Kumar S (2021)
    Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma
    Am J Hematol, 96 (4), 418-427
    DOI 10.1002/ajh.26083, PubMed 33368455
  51. Kharfan-Dabaja MA, Labopin M, Bazarbachi A, Ciceri F, Finke J, Bruno B, Bornhäuser M, Gedde-Dahl T, Labussière-Wallet H, Niittyvuopio R, Valerius T, Angelucci E, Brecht A, Caballero D, Kuball J, Potter V, Schmid C, Tischer J, Zuckerman T, Benedetti F, Blaise D, Diez-Martin JL, Sanz J, Ruggeri A, Brissot E et al. (2021)
    Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT
    Bone Marrow Transplant, 56 (9), 2194-2202
    DOI 10.1038/s41409-021-01317-7, PubMed 33931757
  52. Khialani D, Vasan S, Cushman M, Dahm AEA, Sandset PM, Rossouw J, van Hylckama Vlieg A (2021)
    Venous thrombosis with oral postmenopausal hormone therapy: Roles of activated protein C resistance and tissue factor pathway inhibitor
    J Thromb Haemost, 19 (7), 1729-1737
    DOI 10.1111/jth.15319, PubMed 33774921
  53. Kihlberg K, Baghaei F, Bruzelius M, Funding E, Andre Holme P, Lassila R, Nummi V, Ranta S, Osooli M, Berntorp E, Astermark J (2021)
    Treatment outcomes in persons with severe haemophilia B in the Nordic region: The B-NORD study
    Haemophilia, 27 (3), 366-374
    DOI 10.1111/hae.14299, PubMed 33780113
  54. Kort R, Schlösser J, Vazquez AR, Atukunda P, Muhoozi GKM, Wacoo AP, Sybesma WFH, Westerberg AC, Iversen PO, Schoen ED (2021)
    Model Selection Reveals the Butyrate-Producing Gut Bacterium Coprococcus eutactus as Predictor for Language Development in 3-Year-Old Rural Ugandan Children
    Front Microbiol, 12, 681485
    DOI 10.3389/fmicb.2021.681485, PubMed 34149673
  55. Kvam AK, Torp HA, Iversen PO (2021)
    Life-Threatening Acute Chest Syndrome in a Patient With Sickle Cell Disease After Switching From Hydroxyurea Therapy to Partial Exchange Transfusions: A Case Report
    Cureus, 13 (12), e20236
    DOI 10.7759/cureus.20236, PubMed 35004051
  56. Lerum TV, Maltzahn NN, Aukrust P, Trøseid M, Henriksen KN, Kåsine T, Dyrhol-Riise AM, Stiksrud B, Haugli M, Blomberg B, Kittang BR, Johannessen A, Hannula R, Aballi S, Kildal AB, Eiken R, Dahl TB, Lund-Johansen F, Müller F, Rodriguez JR, Meltzer C, Einvik G, Ueland T, Olsen IC, NOR-SOLIDARITY Consortium et al. (2021)
    Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9
    Sci Rep, 11 (1), 23205
    DOI 10.1038/s41598-021-02547-x, PubMed 34853380
  57. Ludwig H, Sonneveld P, Facon T, San-Miguel J, Avet-Loiseau H, Mohty M, Mateos MV, Moreau P, Cavo M, Pawlyn C, Zweegman S, Engelhardt M, Driessen C, Cook G, Dimopoulos MA, Gay F, Einsele H, Delforge M, Caers J, Weisel K, Jackson G, Garderet L, van de Donk N, Leleu X, Goldschmidt H et al. (2021)
    COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network
    Lancet Haematol, 8 (12), e934-e946
    DOI 10.1016/S2352-3026(21)00278-7, PubMed 34756169
  58. Löwenberg B, Pabst T, Maertens J, Gradowska P, Biemond BJ, Spertini O, Vellenga E, Griskevicius L, Tick LW, Jongen-Lavrencic M, van Marwijk Kooy M, Vekemans MC, van der Velden WJFM, Beverloo B, Michaux L, Graux C, Deeren D, de Weerdt O, van Esser JWJ, Bargetzi M, Klein SK, Gadisseur A, Westerweel PE, Veelken H, Gregor M et al. (2021)
    Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial
    Blood Adv, 5 (4), 1110-1121
    DOI 10.1182/bloodadvances.2020003855, PubMed 33616652
  59. Małecka A, Trøen G, Delabie J, Małecki J, Østlie I, Tierens A, Randen U, Berentsen S, Tjønnfjord GE (2021)
    The mutational landscape of cold agglutinin disease: CARD11 and CXCR4 mutations are correlated with lower hemoglobin levels
    Am J Hematol, 96 (8), E279-E283
    DOI 10.1002/ajh.26205, PubMed 33891703
  60. Martin KA, Beyer-Westendorf J, Davidson BL, Huisman MV, Sandset PM, Moll S (2021)
    Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation
    J Thromb Haemost, 19 (8), 1874-1882
    DOI 10.1111/jth.15358, PubMed 34259389
  61. Massey RJ, Diep PP, Burman MM, Kvaslerud AB, Brinch L, Aakhus S, Gullestad L, Ruud E, Beitnes JO (2021)
    Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation
    Open Heart, 8 (2)
    DOI 10.1136/openhrt-2021-001768, PubMed 34933961
  62. Melvold K, Giliberto M, Karlsen L, Ayuda-Durán P, Hanes R, Holien T, Enserink J, Brown JR, Tjønnfjord GE, Taskén K, Skånland SS (2021)
    Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B-cell malignancies
    Mol Oncol, 16 (5), 1153-1170
    DOI 10.1002/1878-0261.13153, PubMed 34861096
  63. Mirlashari MR, Vetlesen A, Nissen-Meyer LSH, Naper C, Tjønnfjord GE, Njerve IU, Ezligini F, Landmark BF, Meinke S, Sandgren P, Höglund P, Hetland G (2021)
    HLA class I depletion by citric acid, and irradiation of apheresis platelets for transfusion of refractory patients
    Transfusion, 61 (4), 1222-1234
    DOI 10.1111/trf.16282, PubMed 33580979
  64. Moreau P, Kumar SK, San Miguel J, Davies F, Zamagni E, Bahlis N, Ludwig H, Mikhael J, Terpos E, Schjesvold F, Martin T, Yong K, Durie BGM, Facon T, Jurczyszyn A, Sidana S, Raje N, van de Donk N, Lonial S, Cavo M, Kristinsson SY, Lentzsch S, Hajek R, Anderson KC, João C et al. (2021)
    Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
    Lancet Oncol, 22 (3), e105-e118
    DOI 10.1016/S1470-2045(20)30756-7, PubMed 33662288
  65. Myrdal OH, Aaløkken TM, Diep PP, Ruud E, Brinch L, Fosså K, Mangseth H, Kongerud J, Sikkeland LI, Lund MB (2021)
    Late-Onset, Noninfectious Pulmonary Complications following Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Cohort Study of Long-Term Survivors
    Respiration, 101 (6), 544-552
    DOI 10.1159/000520824, PubMed 34937032
  66. Måseide RJ, Berntorp E, Astermark J, Hansen J, Olsson A, Bruzelius M, Frisk T, Aspdahl M, Nummi V, Tjønnfjord GE, Holme PA (2021)
    Haemophilia early arthropathy detection with ultrasound and haemophilia joint health score in the moderate haemophilia (MoHem) study
    Haemophilia, 27 (2), e253-e259
    DOI 10.1111/hae.14245, PubMed 33550602
  67. Måseide RJ, Berntorp E, Nummi V, Lassila R, Tjønnfjord GE, Holme PA (2021)
    Bleeding phenotype of patients with moderate haemophilia A and B assessed by thromboelastometry and thrombin generation
    Haemophilia, 27 (5), 793-801
    DOI 10.1111/hae.14355, PubMed 34106506
  68. Nagler A, Labopin M, Dholaria B, Wu D, Choi G, Aljurf M, Ciceri F, Gedde-Dahl T, Meijer E, Niittyvuopio R, Bondarenko S, Bourhis JH, Cornelissen JJ, Socié G, Koc Y, Canaani J, Savani B, Bug G, Spyridonidis A, Giebel S, Brissot E, Bazarbachi A, Esteve J, Mohty M (2021)
    Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation
    Transplant Cell Ther, 28 (2), 86.e1-86.e8
    DOI 10.1016/j.jtct.2021.11.013, PubMed 34856420
  69. Ngari MM, Obiero C, Mwangome MK, Nyaguara A, Mturi N, Murunga S, Otiende M, Iversen PO, Fegan GW, Walson JL, Berkley JA (2021)
    Mortality during and following hospital admission among school-aged children: a cohort study
    Wellcome Open Res, 5, 234
    DOI 10.12688/wellcomeopenres.16323.2, PubMed 33195820
  70. Quiles-Jiménez A, Gregersen I, Segers FM, Skarpengland T, Kroustallaki P, Yang K, Kong XY, Lauritzen KH, Olsen MB, Karlsen TR, Nyman TA, Sagen EL, Bjerkeli V, Suganthan R, Nygård S, Scheffler K, Prins J, Van der Veer E, Øgaard JD, Fløisand Y, Jørgensen HF, Holven KB, Biessen EA, Nilsen H, Dahl TB et al. (2021)
    DNA glycosylase Neil3 regulates vascular smooth muscle cell biology during atherosclerosis development
    Atherosclerosis, 324, 123-132
    DOI 10.1016/j.atherosclerosis.2021.02.023, PubMed 33714552
  71. Reding MT, Pabinger I, Holme PA, Poulsen L, Negrier C, Chalasani P, Maas Enriquez M, Wang M, Meijer K, Mancuso ME, Lalezari S (2021)
    Confirmed long-term safety and efficacy of prophylactic treatment with BAY 94-9027 in severe haemophilia A: final results of the PROTECT VIII extension study
    Haemophilia, 27 (3), e347-e356
    DOI 10.1111/hae.14297, PubMed 33818853
  72. Reint G, Li Z, Labun K, Keskitalo S, Soppa I, Mamia K, Tolo E, Szymanska M, Meza-Zepeda LA, Lorenz S, Cieslar-Pobuda A, Hu X, Bordin DL, Staerk J, Valen E, Schmierer B, Varjosalo M, Taipale J, Haapaniemi E (2021)
    Rapid genome editing by CRISPR-Cas9-POLD3 fusion
    Elife, 10
    DOI 10.7554/eLife.75415, PubMed 34898428
  73. Remberger M, Tjønnfjord GE, Abrahamsen IW, Ali M, Myhre AE, Gedde-Dahl T, Fløisand Y (2021)
    Superior Graft-versus-Host Disease-Free Relapse-Free Survival in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation with Anti-Thymocyte Globulin (ATG) Compared to Matched Related Donor without ATG
    Transplant Cell Ther, 27 (7), 621.e1-621.e3
    DOI 10.1016/j.jtct.2021.03.019, PubMed 33895156
  74. Richardson PG, Harrison SJ, Bringhen S, Schjesvold F, Yong K, Campana F, Le-Guennec S, Macé S, Dimopoulos MA (2021)
    Isatuximab for relapsed/refractory multiple myeloma: review of key subgroup analyses from the Phase III ICARIA-MM study
    Future Oncol, 17 (34), 4797-4812
    DOI 10.2217/fon-2021-0568, PubMed 34521277
  75. Richardson PG, Schjesvold F, Weisel K, Moreau P, Anderson LD, White D, Rodriguez-Otero P, Sonneveld P, Engelhardt M, Jenner M, Corso A, Dürig J, Pavic M, Salomo M, Beksac M, Oriol A, Lindsay J, Liberati AM, Galli M, Robak P, Larocca A, Yagci M, Vural F, Kanate AS, Jiang R et al. (2021)
    Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics
    Eur J Haematol, 108 (1), 73-83
    DOI 10.1111/ejh.13706, PubMed 34496096
  76. Richter J, Lübking A, Söderlund S, Lotfi K, Markevärn B, Själander A, Stenke L, Deneberg S, Ahlstrand E, Myhr-Eriksson K, Panayiotidis P, Gedde-Dahl T, Žáčková D, Mayer J, Olsson-Strömberg U, Mahon FX, Saussele S, Hjorth-Hansen H, Koskenvesa P (2021)
    Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI
    Leukemia, 35 (8), 2416-2418
    DOI 10.1038/s41375-021-01173-w, PubMed 33589755
  77. Rørvik SD, Larsen KS, Helgeland L, Dale H, Ivarsen B, Bruserud Ø, Tvedt THA (2021)
    Necrotizing Bacterial Myositis as the Initial Presentation of Severe Aplastic Anaemia
    Case Rep Hematol, 2021, 8276937
    DOI 10.1155/2021/8276937, PubMed 34970463
  78. Schjesvold F, Bringhen S, G Richardson P, Perrot A, Leleu X, Moreau P, A Dimopoulos M, Hulin C, Tekle C, Foster MC, Poole EM, van de Velde H, Facon T (2021)
    Isatuximab plus pomalidomide and dexamethasone in frail patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis
    Am J Hematol, 96 (11), E423-E427
    DOI 10.1002/ajh.26319, PubMed 34383345
  79. Schjesvold F, Oriol A (2021)
    Current and Novel Alkylators in Multiple Myeloma
    Cancers (Basel), 13 (10)
    DOI 10.3390/cancers13102465, PubMed 34070213
  80. Schjesvold FH, Richardson PG, Facon T, Alegre A, Spencer A, Jurczyszyn A, Sunami K, Frenzel L, Min CK, Guillonneau S, Lin PL, Le-Guennec S, Campana F, van de Velde H, Bensfia S, Bringhen S (2021)
    Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis
    Haematologica, 106 (4), 1182-1187
    DOI 10.3324/haematol.2020.253450, PubMed 32586908
  81. Schultz NH, Fareed J, Holme PA (2021)
    Investigation of the Optimal Dose aPCC in Reversing the Effect of Factor Xa Inhibitors-An In Vitro Study
    Clin Appl Thromb Hemost, 27, 10760296211021156
    DOI 10.1177/10760296211021156, PubMed 34060371
  82. Schultz NH, Glosli H, Bjørnsen S, Holme PA (2021)
    The effect of emicizumab and bypassing agents in patients with hemophilia - An in vitro study
    Res Pract Thromb Haemost, 5 (5), e12561
    DOI 10.1002/rth2.12561, PubMed 34263107
  83. Schultz NH, Sørvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, Wiedmann M, Aamodt AH, Skattør TH, Tjønnfjord GE, Holme PA (2021)
    Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
    N Engl J Med, 384 (22), 2124-2130
    DOI 10.1056/NEJMoa2104882, PubMed 33835768
  84. Sharma K, Asp NT, Harrison S, Siller R, Baumgarten SF, Gupta S, Chollet ME, Andersen E, Sullivan GJ, Simonsen A (2021)
    Autophagy modulates cell fate decisions during lineage commitment
    Autophagy, 18 (8), 1915-1931
    DOI 10.1080/15548627.2021.2008691, PubMed 34923909
  85. Skaarud KJ, Hov JR, Hansen SH, Kummen M, Valeur J, Seljeflot I, Bye A, Paulsen V, Lundin KEA, Trøseid M, Tjønnfjord GE, Iversen PO (2021)
    Mortality and microbial diversity after allogeneic hematopoietic stem cell transplantation: secondary analysis of a randomized nutritional intervention trial
    Sci Rep, 11 (1), 11593
    DOI 10.1038/s41598-021-90976-z, PubMed 34078971
  86. Sonneveld P, Dimopoulos MA, Beksac M, van der Holt B, Aquino S, Ludwig H, Zweegman S, Zander T, Zamagni E, Wester R, Hajek R, Pantani L, Dozza L, Gay F, Cafro A, De Rosa L, Morelli A, Gregersen H, Gulbrandsen N, Cornelisse P, Troia R, Oliva S, van de Velden V, Wu K, Ypma PF et al. (2021)
    Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma
    J Clin Oncol, 39 (32), 3613-3622
    DOI 10.1200/JCO.21.01045, PubMed 34520219
  87. Steenvoorden L, Bjoernestad EO, Kvesetmoen TA, Gulsvik AK (2021)
    De-labelling penicillin allergy in acutely hospitalized patients: a pilot study
    BMC Infect Dis, 21 (1), 1083
    DOI 10.1186/s12879-021-06794-1, PubMed 34670500
  88. Strømmen K, Lyche JL, Moltu SJ, Müller MHB, Blakstad EW, Almaas AN, Sakhi AK, Thomsen C, Nakstad B, Rønnestad AE, Drevon CA, Iversen PO (2021)
    High urinary concentrations of parabens and bisphenol A in very low birth weight infants
    Chemosphere, 271, 129570
    DOI 10.1016/j.chemosphere.2021.129570, PubMed 33453489
  89. Strømmen K, Lyche JL, Moltu SJ, Müller MHB, Blakstad EW, Almaas AN, Sakhi AK, Thomsen C, Nakstad B, Rønnestad AE, Drevon CA, Iversen PO (2021)
    Corrigendum to "High urinary concentrations of parabens and bisphenol A in very low birth weight infants" [Chemosphere 271 (2021) 129570]
    Chemosphere, 275, 130613
    DOI 10.1016/j.chemosphere.2021.130613, PubMed 33931266
  90. Tangen JM (2021)
    We are star dust. Nuclear physics for most people
    Tidsskr. Nor. Laegeforen., 141 (2), 178
  91. Terpos E, Zamagni E, Lentzsch S, Drake MT, García-Sanz R, Abildgaard N, Ntanasis-Stathopoulos I, Schjesvold F, de la Rubia J, Kyriakou C, Hillengass J, Zweegman S, Cavo M, Moreau P, San-Miguel J, Dimopoulos MA, Munshi N, Durie BGM, Raje N, Bone Working Group of the International Myeloma Working Group (2021)
    Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group
    Lancet Oncol, 22 (3), e119-e130
    DOI 10.1016/S1470-2045(20)30559-3, PubMed 33545067
  92. Tholin B, Ghanima W, Einvik G, Aarli B, Brønstad E, Skjønsberg OH, Stavem K (2021)
    Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis
    Br J Haematol, 194 (3), 542-546
    DOI 10.1111/bjh.17522, PubMed 34028814
  93. Tjonnfjord GE, Schjesvold FH, Gulbrandsen N, Kvam AK (2021)
    Monoclonal gammopathy of clinical importance
    Tidsskr. Nor. Laegeforen., 141 (13), 1276-1280
  94. Tjønnfjord E, Moe RB, Ghanima W, Aballi S (2021)
    Subacute thyroiditis after COVID-19
    Tidsskr Nor Laegeforen, 141 (10)
    DOI 10.4045/tidsskr.21.0169, PubMed 34182720
  95. Tjønnfjord GE, Schjesvold FH, Gulbrandsen N, Kvam AK (2021)
    [Monoclonal gammopathy of clinical importance]
    Tidsskr Nor Laegeforen, 141 (2021-13)
    DOI 10.4045/tidsskr.20.0981, PubMed 34596996
  96. Tjønnfjord SKV, Tjønnfjord EB, Konopski Z, Tjønnfjord GE (2021)
    Successful Control of Hepatitis B Virus Reactivation following Restart of Ibrutinib in Chronic Lymphocytic Leukaemia
    Case Rep Hematol, 2021, 1862446
    DOI 10.1155/2021/1862446, PubMed 34721911
  97. Tvedt THA, Steien E, Øvrebø B, Haaverstad R, Hobbs W, Wardęcki M, Tjønnfjord GE, Berentsen SA (2021)
    Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery
    Am J Hematol, 97 (2), E51-E54
    DOI 10.1002/ajh.26409, PubMed 34778998
  98. Tvedt THA, Vo AK, Bruserud Ø, Reikvam H (2021)
    Cytokine Release Syndrome in the Immunotherapy of Hematological Malignancies: The Biology behind and Possible Clinical Consequences
    J Clin Med, 10 (21)
    DOI 10.3390/jcm10215190, PubMed 34768710
  99. van Dam LF, Dronkers CEA, Gautam G, Eckerbom Å, Ghanima W, Gleditsch J, van Haren GR, von Heijne A, Huisman MV, Stöger JL, Westerlund E, Kroft LJM, Klok FA (2021)
    Detection of upper extremity deep vein thrombosis by magnetic resonance non-contrast thrombus imaging
    J Thromb Haemost, 19 (8), 1973-1980
    DOI 10.1111/jth.15394, PubMed 34018662
  100. Violette PD, Cartwright R, Devereaux PJ, Gross PL, Kaukonen KM, Sandset PM, Kilpeläinen TP, Lavikainen LI, Sallinen V, Horstia S, Guyatt GH, Tikkinen KAO (2021)
    ARTS: A Large, International Trial of Thromboprophylaxis in Intra-abdominal, Gynecologic, and Urologic Surgery
    Eur Urol Focus, 7 (6), 1222-1225
    DOI 10.1016/j.euf.2021.08.010, PubMed 34556452
  101. Waidhauser J, Labopin M, Esteve J, Kröger N, Cornelissen J, Gedde-Dahl T, Van Gorkom G, Finke J, Rovira M, Schaap N, Petersen E, Beelen D, Bunjes D, Savani B, Schmid C, Nagler A, Mohty M, Acute Leukemia Working Party of EBMT (2021)
    Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT
    Bone Marrow Transplant, 56 (10), 2445-2453
    DOI 10.1038/s41409-021-01322-w, PubMed 34059800
  102. Walladbegi J, Henriksson R, Tavelin B, Svanberg A, Larfors G, Jädersten M, Schjesvold F, Mahdi A, Garming Legert K, Peterson DE, Jontell M (2021)
    Efficacy of a novel device for cryoprevention of oral mucositis: a randomized, blinded, multicenter, parallel group, phase 3 trial
    Bone Marrow Transplant, 57 (2), 191-197
    DOI 10.1038/s41409-021-01512-6, PubMed 34728786
  103. Wang J, Barański M, Hasanaliyeva G, Korkut R, Kalee HA, Leifert A, Winter S, Janovska D, Willson A, Barkla B, Iversen PO, Seal C, Bilsborrow P, Leifert C, Rempelos L, Volakakis N (2021)
    Effect of irrigation, fertiliser type and variety on grain yield and nutritional quality of spelt wheat (Triticum spelta) grown under semi-arid conditions
    Food Chem, 358, 129826
    DOI 10.1016/j.foodchem.2021.129826, PubMed 33933964
  104. Wedge E, Hansen JW, Dybedal I, Creignou M, Ejerblad E, Lorenz F, Werlenius O, Ungerstedt J, Holm MS, Nilsson L, Kittang AO, Antunovic P, Rohon P, Andersen MK, Papaemmanuil E, Bernard E, Jädersten M, Hellström-Lindberg E, Grønbæk K, Ljungman P, Friis LS (2021)
    Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: Clinical and Molecular Genetic Prognostic Factors in a Nordic Population
    Transplant Cell Ther, 27 (12), 991.e1-991.e9
    DOI 10.1016/j.jtct.2021.08.028, PubMed 34500124
  105. Wergeland D, Harsten K, Klarare A, Steindal SA (2021)
    Hospital nurses' experiences of assessing health status changes in stem-cell transplanted patients in home care: A qualitative study
    J Clin Nurs, 31 (21-22), 3190-3199
    DOI 10.1111/jocn.16155, PubMed 34837292
  106. Wiedmann M, Skattør T, Stray-Pedersen A, Romundstad L, Antal EA, Marthinsen PB, Sørvoll IH, Leiknes Ernstsen S, Lund CG, Holme PA, Johansen TO, Brunborg C, Aamodt AH, Schultz NH, Skagen K, Skjelland M (2021)
    Vaccine Induced Immune Thrombotic Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High Fatality Rate: A Case Series
    Front Neurol, 12, 721146
    DOI 10.3389/fneur.2021.721146, PubMed 34393988
  107. Wik HS, Kahn SR, Eriksson H, Morrison D, Ghanima W, Schulman S, Sandset PM (2021)
    Post-thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long-term cross-sectional follow-up of RE-COVER study patients
    J Thromb Haemost, 19 (10), 2495-2503
    DOI 10.1111/jth.15449, PubMed 34255420
  108. Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JM, Musso M, Giebel S, Uzay A, Langmuir P, Hollaender N, Gowda M, Stefanelli T, Lee SJ, Teshima T, Locatelli F, REACH3 Investigators (2021)
    Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
    N Engl J Med, 385 (3), 228-238
    DOI 10.1056/NEJMoa2033122, PubMed 34260836

Publications 2020

  1. Andersen NG, Mowinckel MC, Sunde K, Sandset PM, Beitland S (2020)
    Utility of coagulation analyses to assess thromboprophylaxis with dalteparin in intensive care unit patients
    Acta Anaesthesiol Scand, 65 (4), 489-498
    DOI 10.1111/aas.13748, PubMed 33205407
  2. Andresen MS, Stavik B, Sletten M, Tinholt M, Sandset PM, Iversen N, Skretting G (2020)
    Indirect regulation of TFPI-2 expression by miR-494 in breast cancer cells
    Sci Rep, 10 (1), 4036
    DOI 10.1038/s41598-020-61018-x, PubMed 32132611
  3. Atukunda P, Muhoozi GK, Diep LM, Berg JP, Westerberg AC, Iversen PO (2020)
    The association of urine markers of iodine intake with development and growth among children in rural Uganda: a secondary analysis of a randomised education trial
    Public Health Nutr, 24 (12), 3730-3739
    DOI 10.1017/S1368980020001603, PubMed 32654677
  4. Backe B, Jacobsen AF, Magnussen EB, Morken NH (2020)
    Routine urine culture in pregnant women - stop it
    Tidsskr. Nor. Laegeforen., 140 (17), 1735-1736
  5. Bazarbachi A, Bug G, Baron F, Brissot E, Ciceri F, Dalle IA, Döhner H, Esteve J, Floisand Y, Giebel S, Gilleece M, Gorin NC, Jabbour E, Aljurf M, Kantarjian H, Kharfan-Dabaja M, Labopin M, Lanza F, Malard F, Peric Z, Prebet T, Ravandi F, Ruggeri A, Sanz J, Schmid C et al. (2020)
    Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Haematologica, 105 (6), 1507-1516
    DOI 10.3324/haematol.2019.243410, PubMed 32241850
  6. Berentsen S, Barcellini W, D'Sa S, Randen U, Tvedt THA, Fattizzo B, Haukås E, Kell M, Brudevold R, Dahm AEA, Dalgaard J, Frøen H, Hallstensen RF, Jæger PH, Hjorth-Hansen H, Małecka A, Oksman M, Rolke J, Sekhar M, Sørbø JH, Tjønnfjord E, Tsykunova G, Tjønnfjord GE (2020)
    Cold agglutinin disease revisited: a multinational, observational study of 232 patients
    Blood, 136 (4), 480-488
    DOI 10.1182/blood.2020005674, PubMed 32374875
  7. Berentsen S, Malecka A, Randen U, Tjønnfjord GE (2020)
    Cold agglutinin disease: where do we stand, and where are we going?
    Clin Adv Hematol Oncol, 18 (1), 35-44
    PubMed 32511221
  8. Broch K, Popperud T, Gude E, Fløisand Y, Antal EA, Bosse G, Jonsrud C, Hegard T, Skaara S, Elsais A (2020)
    A Middle-Aged Man Presenting With Progressive Heart Failure, Myopathy, and Monoclonal Gammopathy of Uncertain Significance
    JACC Case Rep, 2 (5), 785-789
    DOI 10.1016/j.jaccas.2020.02.024, PubMed 34317348
  9. Caglayan S, Hashim A, Cieslar-Pobuda A, Jensen V, Behringer S, Talug B, Chu DT, Pecquet C, Rogne M, Brech A, Brorson SH, Nagelhus EA, Hannibal L, Boschi A, Taskén K, Staerk J (2020)
    Optic Atrophy 1 Controls Human Neuronal Development by Preventing Aberrant Nuclear DNA Methylation
    iScience, 23 (6), 101154
    DOI 10.1016/j.isci.2020.101154, PubMed 32450518
  10. Cieslar-Pobuda A, Ahrens TD, Caglayan S, Behringer S, Hannibal L, Staerk J (2020)
    DNMT3B deficiency alters mitochondrial biogenesis and α-ketoglutarate levels in human embryonic stem cells
    Stem Cells, 38 (11), 1409-1422
    DOI 10.1002/stem.3256, PubMed 32652733
  11. Derolf Å, Juliusson G, Benson L, Fløisand Y, Lazarevic V, Antunovic P, Möllgård L, Lehmann S, Uggla B, Wahlin A, Höglund M, Deneberg S (2020)
    Decreasing early mortality in acute myeloid leukaemia in Sweden 1997-2014: improving performance status is a major contributing factor
    Br J Haematol, 188 (1), 187-191
    DOI 10.1111/bjh.16265, PubMed 31863470
  12. Divito SJ, Aasebø AT, Matos TR, Hsieh PC, Collin M, Elco CP, O'Malley JT, Bækkevold ES, Reims H, Gedde-Dahl T, Hagerstrom M, Hilaire J, Lian JW, Milford EL, Pinkus GS, Ho VT, Soiffer RJ, Kim HT, Mihm MC, Ritz J, Guleria I, Cutler CS, Clark RA, Jahnsen FL, Kupper TS (2020)
    Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease
    J Clin Invest, 130 (9), 4624-4636
    DOI 10.1172/JCI129965, PubMed 32516138
  13. Dusingizimana T, Weber JL, Ramilan T, Iversen PO, Brough L (2020)
    A qualitative analysis of infant and young child feeding practices in rural Rwanda
    Public Health Nutr, 24 (12), 3592-3601
    DOI 10.1017/S1368980020001081, PubMed 32611464
  14. Dusingizimana T, Weber JL, Ramilan T, Iversen PO, Brough L (2020)
    An empirical study of factors associated with height-for-age z-scores of children aged 6-23 months in northwest Rwanda: the role of care practices related to child feeding and health
    Br J Nutr, 126 (8), 1203-1214
    DOI 10.1017/S0007114520004961, PubMed 33298231
  15. Fronas SG, Dahm AEA, Wik HS, Jørgensen CT, Gleditsch J, Raouf N, Holst R, Klok FA, Ghanima W (2020)
    Safety and feasibility of rivaroxaban in deferred workup of patients with suspected deep vein thrombosis
    Blood Adv, 4 (11), 2468-2476
    DOI 10.1182/bloodadvances.2020001556, PubMed 32502267
  16. Fronas SG, Jørgensen CT, Dahm AEA, Wik HS, Gleditsch J, Raouf N, Holst R, Klok FA, Ghanima W (2020)
    Safety of a strategy combining D-dimer testing and whole-leg ultrasonography to rule out deep vein thrombosis
    Blood Adv, 4 (20), 5002-5010
    DOI 10.1182/bloodadvances.2020002173, PubMed 33057634
  17. Ghanima W, Brodin E, Schultze A, Shepherd L, Lambrelli D, Ulvestad M, Ramagopalan S, Halvorsen S (2020)
    Incidence and prevalence of venous thromboembolism in Norway 2010-2017
    Thromb Res, 195, 165-168
    DOI 10.1016/j.thromres.2020.07.011, PubMed 32707359
  18. Godolphin PJ, Bath PM, Partlett C, Berge E, Brown MM, Eliasziw M, Sandset PM, Serena J, Montgomery AA (2020)
    Outcome assessment by central adjudicators in randomised stroke trials: Simulation of differential and non-differential misclassification
    Eur Stroke J, 5 (2), 174-183
    DOI 10.1177/2396987320910047, PubMed 32637651
  19. Gorkom BL, Holme PA, Joch C, Rogosch T, Feussner A, McKeand W, Roberts J, van Heerde W (2020)
    Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency
    Hematology, 25 (1), 17-25
    DOI 10.1080/16078454.2019.1700329, PubMed 31852380
  20. Grønvold B, Ali MM, Remberger M, Mattsson J, Egeland T, Lundin KU, Myhre AE, Abrahamsen IW, Heldal D, Dybedal I, Tjønnfjord GE, Fløisand Y, Gedde-Dahl T (2020)
    HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation
    Bone Marrow Transplant, 55 (8), 1658-1661
    DOI 10.1038/s41409-020-0827-3, PubMed 32054997
  21. Hannevik TL, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Paulsen PQ, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2020)
    Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism
    Thromb Res, 196, 238-244
    DOI 10.1016/j.thromres.2020.08.042, PubMed 32919178
  22. Hasanaliyeva G, Chatzidimitrou E, Wang J, Baranski M, Volakakis N, Seal C, Rosa EAS, Iversen PO, Vigar V, Barkla B, Leifert C, Rempelos L (2020)
    Effects of Production Region, Production Systems and Grape Type/Variety on Nutritional Quality Parameters of Table Grapes; Results from a UK Retail Survey
    Foods, 9 (12)
    DOI 10.3390/foods9121874, PubMed 33339243
  23. Hetland G, Tangen JM, Mahmood F, Mirlashari MR, Nissen-Meyer LSH, Nentwich I, Therkelsen SP, Tjønnfjord GE, Johnson E (2020)
    Antitumor, Anti-Inflammatory and Antiallergic Effects of Agaricus blazei Mushroom Extract and the Related Medicinal Basidiomycetes Mushrooms, Hericium erinaceus and Grifola frondosa: A Review of Preclinical and Clinical Studies
    Nutrients, 12 (5)
    DOI 10.3390/nu12051339, PubMed 32397163
  24. Iversen PO, Atukunda P, Kort R, Ueland PM, Westerberg AC, Muhoozi GKM (2020)
    No associations between microbiota signalling substances and cognitive, language and motor development among three-year-old rural Ugandan children
    Acta Paediatr, 109 (11), 2339-2341
    DOI 10.1111/apa.15330, PubMed 32347570
  25. Iversen PO, Sioud M (2020)
    Harnessing the Antiviral-Type Responses Induced by Immunostimulatory siRNAs for Cancer Immunotherapy
    Methods Mol Biol, 2115, 281-287
    DOI 10.1007/978-1-0716-0290-4_16, PubMed 32006407
  26. Iversen PO, von Lueder TG, Kardel KR, Lien K (2020)
    Cardiac Dimensions and Function Are Not Altered among Females with the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
    Healthcare (Basel), 8 (4)
    DOI 10.3390/healthcare8040406, PubMed 33081294
  27. Jakob NN, Frida BA, Geir T, Fredrik S (2020)
    Neoplastic plasma cells with Auer rod-like inclusions
    EJHaem, 1 (1), 6-7
    DOI 10.1002/jha2.33, PubMed 35847721
  28. Kaiser M, Beksaç M, Gulbrandsen N, Schjesvold F, Hájek R, Moreau P, de Arriba de la Fuente F, Mateos MV, West S, Spencer A, Rajkumar SV, Suryanarayan K, Czorniak M, Li C, Teng Z, Labotka R, Dimopoulos MA (2020)
    Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma
    Ann Hematol, 99 (8), 1793-1804
    DOI 10.1007/s00277-020-04149-5, PubMed 32613281
  29. Kakkos SK, Gohel M, Baekgaard N, Bauersachs R, Bellmunt-Montoya S, Black SA, Ten Cate-Hoek AJ, Elalamy I, Enzmann FK, Geroulakos G, Gottsäter A, Hunt BJ, Mansilha A, Nicolaides AN, Sandset PM, Stansby G, Esvs Guidelines Committee, de Borst GJ, Bastos Gonçalves F, Chakfé N, Hinchliffe R, Kolh P, Koncar I, Lindholt JS, Tulamo R et al. (2020)
    Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis
    Eur J Vasc Endovasc Surg, 61 (1), 9-82
    DOI 10.1016/j.ejvs.2020.09.023, PubMed 33334670
  30. Kara E, Nielsen NV, Eggertsdottir B, Thiede B, Kanse SM, Løset GÅ (2020)
    Design and Characterization of a New pVII Combinatorial Phage Display Peptide Library for Protease Substrate Mining Using Factor VII Activating Protease (FSAP) as Model
    Chembiochem, 21 (13), 1875-1884
    DOI 10.1002/cbic.201900705, PubMed 32180321
  31. Kempton CL, Makris M, Holme PA (2020)
    Management of comorbidities in haemophilia
    Haemophilia, 27 Suppl 3, 37-45
    DOI 10.1111/hae.14013, PubMed 32476243
  32. Kuijlaars IAR, van der Net J, Feldman BM, Aspdahl M, Bladen M, de Boer W, Cuesta-Barriuso R, Matlary RED, Funk SM, Hilliard P, John JA, Kempton CL, de Kleijn P, Manco-Johnson M, Petrini P, Poonnoose P, St-Louis J, Thomas S, Timmer MA, Trakymiene SS, van Vlimmeren L, Fischer K (2020)
    Evaluating international Haemophilia Joint Health Score (HJHS) results combined with expert opinion: Options for a shorter HJHS
    Haemophilia, 26 (6), 1072-1080
    DOI 10.1111/hae.14180, PubMed 33058441
  33. Laubach JP, Schjesvold F, Mariz M, Dimopoulos MA, Lech-Maranda E, Spicka I, Hungria VTM, Shelekhova T, Abdo A, Jacobasch L, Polprasert C, Hájek R, Illés Á, Wróbel T, Sureda A, Beksac M, Gonçalves IZ, Bladé J, Rajkumar SV, Chari A, Lonial S, Spencer A, Maison-Blanche P, Moreau P, San-Miguel JF et al. (2020)
    Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study
    Lancet Oncol, 22 (1), 142-154
    DOI 10.1016/S1470-2045(20)30680-X, PubMed 33301738
  34. Lenartova A, Johannesen TB, Tjønnfjord GE (2020)
    Chronic lymphocytic leukemia and secondary hematological malignancies: A nation-wide cancer registry study
    Eur J Haematol, 104 (6), 546-553
    DOI 10.1111/ejh.13396, PubMed 32058605
  35. Małecka A, Delabie J, Østlie I, Tierens A, Randen U, Berentsen S, Tjønnfjord GE, Trøen G (2020)
    Cold agglutinin-associated B-cell lymphoproliferative disease shows highly recurrent gains of chromosome 3 and 12 or 18
    Blood Adv, 4 (6), 993-996
    DOI 10.1182/bloodadvances.2020001608, PubMed 32168377
  36. Marvyin K, Tjønnfjord EB, Breland UM, Tjønnfjord GE (2020)
    Transformation to plasmablastic lymphoma in CLL upon ibrutinib treatment
    BMJ Case Rep, 13 (9)
    DOI 10.1136/bcr-2020-235816, PubMed 32994268
  37. Massey RJ, Diep PP, Ruud E, Burman MM, Kvaslerud AB, Brinch L, Aakhus S, Gullestad LL, Beitnes JO (2020)
    Left Ventricular Systolic Function in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation
    JACC CardioOncol, 2 (3), 460-471
    DOI 10.1016/j.jaccao.2020.06.011, PublikaID 352
  38. Massey RJ, Diep PP, Ruud E, Burman MM, Kvaslerud AB, Brinch L, Aakhus S, Gullestad LL, Beitnes JO (2020)
    Left Ventricular Systolic Function in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation
    JACC CardioOncol, 2 (3), 460-471
    DOI 10.1016/j.jaccao.2020.06.011, PubMed 34396253
  39. Molteberg E, Thorsby PM, Kverneland M, Iversen PO, Selmer KK, Nakken KO, Taubøll E (2020)
    Effects of modified Atkins diet on thyroid function in adult patients with pharmacoresistant epilepsy
    Epilepsy Behav, 111, 107285
    DOI 10.1016/j.yebeh.2020.107285, PubMed 32698106
  40. Mpinganzima C, Haaland A, Holm AGV, Thein SL, Tjønnfjord GE, Iversen PO (2020)
    Two Consecutive Episodes of Severe Delayed Hemolytic Transfusion Reaction in a Sickle Cell Disease Patient
    Case Rep Hematol, 2020, 2765012
    DOI 10.1155/2020/2765012, PubMed 32351743
  41. Myrdal OH, Diep PP, Ruud E, Brinch L, Massey RJ, Edvardsen E, Kongerud J, Lund MB, Sikkeland LI (2020)
    Determinants of cardiorespiratory fitness in very long-term survivors of allogeneic hematopoietic stem cell transplantation: a national cohort study
    Support Care Cancer, 29 (4), 1959-1967
    DOI 10.1007/s00520-020-05644-1, PubMed 32827056
  42. Måseide RJ, Berntorp E, Astermark J, Olsson A, Bruzelius M, Frisk T, Nummi V, Lassila R, Tjønnfjord GE, Holme PA (2020)
    Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B - The MoHem study
    Haemophilia, 26 (5), 891-897
    DOI 10.1111/hae.14114, PubMed 33021747
  43. Oriol A, Larocca A, Leleu X, Hajek R, Hassoun H, Rodríguez-Otero P, Paner A, Schjesvold FH, Gullbo J, Richardson PG (2020)
    Melflufen for relapsed and refractory multiple myeloma
    Expert Opin Investig Drugs, 29 (10), 1069-1078
    DOI 10.1080/13543784.2020.1808884, PubMed 32924646
  44. Qvigstad C, Sørensen LQ, Tait RC, de Moerloose P, Holme PA, ADVANCE Working Group (2020)
    Macroscopic hematuria as a risk factor for hypertension in ageing people with hemophilia and a family history of hypertension
    Medicine (Baltimore), 99 (9), e19339
    DOI 10.1097/MD.0000000000019339, PubMed 32118768
  45. Qvigstad C, Tait RC, de Moerloose P, Holme PA, ADVANCE Working Group (2020)
    Hematuria in aging men with hemophilia: Association with factor prophylaxis
    Res Pract Thromb Haemost, 4 (2), 309-317
    DOI 10.1002/rth2.12298, PubMed 32110762
  46. Remberger M, Grønvold B, Ali M, Mattsson J, Egeland T, Lundin KU, Myhre A, Abrahamsen I, Heldal D, Dybedal I, Tjønnfjord GE, Gedde-Dahl T, Fløisand Y (2020)
    The CD34+ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors
    Clin Hematol Int, 2 (2), 74-81
    DOI 10.2991/chi.d.200221.001, PubMed 34595446
  47. Schjesvold F (2020)
    Evolution of diagnostic workup and treatment for multiple myeloma 2013-2019
    Eur J Haematol, 105 (4), 434-448
    DOI 10.1111/ejh.13464, PubMed 32557833
  48. Schjesvold F, Goldschmidt H, Maisnar V, Spicka I, Abildgaard N, Rowlings P, Cain L, Romanus D, Suryanarayan K, Rajkumar V, Odom D, Gnanasakthy A, Dimopoulos M (2020)
    Quality of life is maintained with ixazomib maintenance in post-transplant newly diagnosed multiple myeloma: The TOURMALINE-MM3 trial
    Eur J Haematol, 104 (5), 443-458
    DOI 10.1111/ejh.13379, PubMed 31880006
  49. Schjesvold F, Robak P, Pour L, Aschan J, Sonneveld P (2020)
    OCEAN: a randomized Phase III study of melflufen + dexamethasone to treat relapsed refractory multiple myeloma
    Future Oncol, 16 (11), 631-641
    DOI 10.2217/fon-2020-0024, PubMed 32141766
  50. Spyridonidis A, Labopin M, Savani BN, Niittyvuopio R, Blaise D, Craddock C, Socié G, Platzbecker U, Beelen D, Milpied N, Cornelissen JJ, Ganser A, Huynh A, Griskevicius L, Giebel S, Aljurf M, Brissot E, Malard F, Esteve J, Peric Z, Baron F, Ruggeri A, Schmid C, Gilleece M, Gorin NC et al. (2020)
    Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients
    Bone Marrow Transplant, 55 (6), 1114-1125
    DOI 10.1038/s41409-020-0803-y, PubMed 31996792
  51. Spyridonidis A, Labopin M, Savani BN, Niittyvuopio R, Blaise D, Craddock C, Socié G, Platzbecker U, Beelen D, Milpied N, Cornelissen JJ, Ganser A, Huynh A, Griskevicius L, Giebel S, Aljurf M, Brissot E, Malard F, Esteve J, Peric Z, Baron F, Ruggeri A, Schmid C, Gilleece M, Gorin NC et al. (2020)
    Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients
    Bone Marrow Transplant, 55 (6), 1213
    DOI 10.1038/s41409-020-0835-3, PubMed 32144364
  52. Tadele DS, Robertson J, Crispin R, Herrera MC, Chlubnová M, Piechaczyk L, Ayuda-Durán P, Singh SK, Gedde-Dahl T, Fløisand Y, Skavland J, Wesche J, Gjertsen BT, Enserink JM (2020)
    A cell competition-based small molecule screen identifies a novel compound that induces dual c-Myc depletion and p53 activation
    J Biol Chem, 296, 100179
    DOI 10.1074/jbc.RA120.015285, PubMed 33303632
  53. Terrell DR, Neunert CE, Cooper N, Heitink-Pollé KM, Kruse C, Imbach P, Kühne T, Ghanima W (2020)
    Immune Thrombocytopenia (ITP): Current Limitations in Patient Management
    Medicina (Kaunas), 56 (12)
    DOI 10.3390/medicina56120667, PubMed 33266286
  54. Thorsen L, Haugnes HS, Fosså SD, Brydøy M, Tandstad T, Wisløff T, Gjerset GM, Edvardsen E, Larsen KO, Sandset PM, Henriksson CE, Raastad T, Negaard HFS (2020)
    Thromboembolic events after high-intensity training during cisplatin-based chemotherapy for testicular cancer: Case reports and review of the literature
    Int J Cancer, 147 (11), 3189-3198
    DOI 10.1002/ijc.33151, PubMed 32525564
  55. Tinholt M, Stavik B, Tekpli X, Garred Ø, Borgen E, Kristensen V, Sahlberg KK, Sandset PM, Iversen N (2020)
    Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer
    Oncoimmunology, 9 (1), 1824644
    DOI 10.1080/2162402X.2020.1824644, PubMed 33457104
  56. Tjønnfjord E, Holme PA, Darne B, Khelif A, Waage A, Michel M, Ben Romdhan N, Ghanima W (2020)
    Long-term outcomes of patients treated with rituximab as second-line treatment for adult immune thrombocytopenia - Follow-up of the RITP study
    Br J Haematol, 191 (3), 460-465
    DOI 10.1111/bjh.16672, PubMed 32342497
  57. Tritschler T, Mathieu ME, Skeith L, Rodger M, Middeldorp S, Brighton T, Sandset PM, Kahn SR, Angus DC, Blondon M, Bonten MJ, Cattaneo M, Cushman M, Derde LPG, DeSancho MT, Diehl JL, Goligher E, Jilma B, Jüni P, Lawler PR, Marietta M, Marshall JC, McArthur C, Miranda CH, Mirault T et al. (2020)
    Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration
    J Thromb Haemost, 18 (11), 2958-2967
    DOI 10.1111/jth.15094, PubMed 32888372
  58. Wacoo AP, Atukunda P, Muhoozi G, Braster M, Wagner M, Broek TJVD, Sybesma W, Westerberg AC, Iversen PO, Kort R (2020)
    Aflatoxins: Occurrence, Exposure, and Binding to Lactobacillus Species from the Gut Microbiota of Rural Ugandan Children
    Microorganisms, 8 (3)
    DOI 10.3390/microorganisms8030347, PubMed 32121365
  59. Wang J, Chatzidimitriou E, Wood L, Hasanalieva G, Markelou E, Iversen PO, Seal C, Baranski M, Vigar V, Ernst L, Willson A, Thapa M, Barkla BJ, Leifert C, Rempelos L (2020)
    Effect of wheat species (Triticum aestivum vs T. spelta), farming system (organic vs conventional) and flour type (wholegrain vs white) on composition of wheat flour - Results of a retail survey in the UK and Germany - 2. Antioxidant activity, and phenolic and mineral content
    Food Chem X, 6, 100091
    DOI 10.1016/j.fochx.2020.100091, PubMed 32420543
  60. Wang J, Hasanalieva G, Wood L, Anagnostopoulos C, Ampadogiannis G, Bempelou E, Kiousi M, Markellou E, Iversen PO, Seal C, Baranski M, Vigar V, Leifert C, Rempelos L (2020)
    Effect of wheat species (Triticum aestivum vs T. spelta), farming system (organic vs conventional) and flour type (wholegrain vs white) on composition of wheat flour - Results of a retail survey in the UK and Germany - 3. Pesticide residue content
    Food Chem X, 7, 100089
    DOI 10.1016/j.fochx.2020.100089, PubMed 32637911
  61. Wang J, Hasanalieva G, Wood L, Markellou E, Iversen PO, Bernhoft A, Seal C, Baranski M, Vigar V, Ernst L, Willson A, Barkla BJ, Leifert C, Rempelos L (2020)
    Effect of wheat species (Triticum aestivum vs T. spelta), farming system (organic vs conventional) and flour type (wholegrain vs white) on composition of wheat flour; results of a retail survey in the UK and Germany - 1. Mycotoxin content
    Food Chem, 327, 127011
    DOI 10.1016/j.foodchem.2020.127011, PubMed 32438263
  62. Weum Abrahamsen I, Grønvold BC, Inderberg EM, Mensali N, Mattsson J, Gedde-Dahl T (2020)
    Posttransplantation Lymphoproliferative Disease Treated by Retransplantation
    Case Reports Immunol, 2020, 9403123
    DOI 10.1155/2020/9403123, PubMed 32158568
  63. Yin YP, Shi WH, Deng K, Liu XL, Li H, Lv XT, Lui VWY, Ding C, Hong B, Lin WC (2020)
    Combinations of proteasome inhibitors with obatoclax are effective for small cell lung cancer
    Acta Pharmacol Sin, 42 (8), 1298-1310
    DOI 10.1038/s41401-020-00544-w, PubMed 33139838
  64. Ziyenda Katenga-Kaunda L, Iversen PO, Holmboe-Ottesen G, Fjeld H, Mdala I, Kamudoni PR (2020)
    Dietary intake and processes of behaviour change in a nutrition education intervention for pregnant women in rural Malawi: a cluster-randomised controlled trial
    Public Health Nutr, 23 (13), 2345-2354
    DOI 10.1017/S1368980020000294, PubMed 32419688

Publications 2019

  1. Andersen E, Chollet ME, Baroni M, Pinotti M, Bernardi F, Skarpen E, Sandset PM, Skretting G (2019)
    The effect of the chemical chaperone 4-phenylbutyrate on secretion and activity of the p.Q160R missense variant of coagulation factor FVII
    Cell Biosci, 9, 69
    DOI 10.1186/s13578-019-0333-8, PubMed 31467667
  2. Andersen MF, Holme PA, Tjønnfjord GE (2019)
    [Surgical procedures in patients with severe haemophilia 1997–2014]
    Tidsskr Nor Laegeforen, 139 (8)
    DOI 10.4045/tidsskr.18.0592, PubMed 31062561
  3. Andersen MLF, Holme PA, Tjonnfjord GE (2019)
    Surgical intervention in patients with severe bleeding disorder 1997-2014
    Tidsskr. Nor. Laegeforen., 139 (8), 709-712
  4. Attal M, Richardson PG, Rajkumar SV, San-Miguel J, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang JS, Minarik J, Cavo M, Prince HM, Macé S, Corzo KP, Campana F, Le-Guennec S, Dubin F, Anderson KC, ICARIA-MM study group (2019)
    Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
    Lancet, 394 (10214), 2096-2107
    DOI 10.1016/S0140-6736(19)32556-5, PubMed 31735560
  5. Atukunda P, Muhoozi GKM, van den Broek TJ, Kort R, Diep LM, Kaaya AN, Iversen PO, Westerberg AC (2019)
    Child development, growth and microbiota: follow-up of a randomized education trial in Uganda
    J Glob Health, 9 (1), 010431
    DOI 10.7189/jogh.09.010431, PubMed 31131103
  6. Atukunda P, Muhoozi GKM, Westerberg AC, Iversen PO (2019)
    Nutrition, Hygiene and Stimulation Education for Impoverished Mothers in Rural Uganda: Effect on Maternal Depression Symptoms and Their Associations to Child Development Outcomes
    Nutrients, 11 (7)
    DOI 10.3390/nu11071561, PubMed 31373314
  7. Baliakas P, Tesi B, Wartiovaara-Kautto U, Stray-Pedersen A, Friis LS, Dybedal I, Hovland R, Jahnukainen K, Raaschou-Jensen K, Ljungman P, Rustad CF, Lautrup CK, Kilpivaara O, Kittang AO, Grønbæk K, Cammenga J, Hellström-Lindberg E, Andersen MK (2019)
    Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up
    Hemasphere, 3 (6), e321
    DOI 10.1097/HS9.0000000000000321, PubMed 31976490
  8. Beitland S, Wimmer H, Lorentsen T, Jacobsen D, Draegni T, Brunborg C, Kløw NE, Sandset PM, Sunde K (2019)
    Venous thromboembolism in the critically ill: A prospective observational study of occurrence, risk factors and outcome
    Acta Anaesthesiol Scand, 63 (5), 630-638
    DOI 10.1111/aas.13316, PubMed 30623406
  9. Berentsen S, Röth A, Randen U, Jilma B, Tjønnfjord GE (2019)
    Cold agglutinin disease: current challenges and future prospects
    J Blood Med, 10, 93-103
    DOI 10.2147/JBM.S177621, PubMed 31114413
  10. Birgegard G, Samuelsson J, Ahlstrand E, Ejerblad E, Enevold C, Ghanima W, Hasselbalch H, Nielsen CH, Knutsen H, Pedersen OB, Sørensen A, Andreasson B (2019)
    Inflammatory functional iron deficiency common in myelofibrosis, contributes to anaemia and impairs quality of life. From the Nordic MPN study Group
    Eur J Haematol, 102 (3), 235-240
    DOI 10.1111/ejh.13198, PubMed 30472746
  11. Blakstad EW, Korpela K, Lee S, Nakstad B, Moltu SJ, Strømmen K, Rønnestad AE, Brække K, Iversen PO, de Vos WM, Drevon CA (2019)
    Enhanced nutrient supply and intestinal microbiota development in very low birth weight infants
    Pediatr Res, 86 (3), 323-332
    DOI 10.1038/s41390-019-0412-x, PubMed 31086354
  12. Blomkvist AW, Zadig P, Christoffersen S, Kaushal S, Nordengen E, Shanmugarajah I, Ghanima W (2019)
    [Home treatment for pulmonary embolism]
    Tidsskr Nor Laegeforen, 139 (18)
    DOI 10.4045/tidsskr.19.0115, PubMed 31823570
  13. Chellappa S, Kushekhar K, Munthe LA, Tjønnfjord GE, Aandahl EM, Okkenhaug K, Taskén K (2019)
    The PI3K p110δ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function
    J Immunol, 202 (5), 1397-1405
    DOI 10.4049/jimmunol.1701703, PubMed 30692213
  14. Chowdary P, Carcao M, Holme PA, Jiménez-Yuste V, Lentz SR, Møss J, Poulsen LH, Shen C, Tosetto A, Wheeler A, Santagostino E (2019)
    Fixed doses of N8-GP prophylaxis maintain moderate-to-mild factor VIII levels in the majority of patients with severe hemophilia A
    Res Pract Thromb Haemost, 3 (3), 542-554
    DOI 10.1002/rth2.12220, PubMed 31294338
  15. Cooper N, Ghanima W (2019)
    Immune Thrombocytopenia
    N Engl J Med, 381 (10), 945-955
    DOI 10.1056/NEJMcp1810479, PubMed 31483965
  16. Cremers EMP, de Witte T, de Wreede L, Eikema DJ, Koster L, van Biezen A, Finke J, Socié G, Beelen D, Maertens J, Nagler A, Kobbe G, Ziagkos D, Itälä-Remes M, Gedde-Dahl T, Sierra J, Niederwieser D, Ljungman P, Beguin Y, Ozkurt ZN, Anagnostopoulos A, Jindra P, Robin M, Kröger N (2019)
    A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation
    Leuk Lymphoma, 60 (10), 2404-2414
    DOI 10.1080/10428194.2019.1594215, PubMed 30997844
  17. Curry N, Albayrak C, Escobar M, Andre Holme P, Kearney S, Klamroth R, Misgav M, Négrier C, Wheeler A, Santagostino E, Shima M, Landorph A, Tønder SM, Lentz SR (2019)
    Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial)
    Haemophilia, 25 (3), 373-381
    DOI 10.1111/hae.13712, PubMed 30817066
  18. Dahm AEA, Jacobsen EM, Wik HS, Jacobsen AF, Mollnes TE, Kanse SM, Sandset PM (2019)
    Elevated Complement C3 and C4 Levels are Associated with Postnatal Pregnancy-Related Venous Thrombosis
    Thromb Haemost, 119 (9), 1481-1488
    DOI 10.1055/s-0039-1692426, PubMed 31254974
  19. Eilertsen AL, Dahm AEA, Høibraaten E, Lofthus CM, Mowinckel MC, Sandset PM (2019)
    Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment
    Blood Coagul Fibrinolysis, 30 (1), 17-23
    DOI 10.1097/MBC.0000000000000784, PubMed 30507711
  20. El-Serafi I, Loy O, Zhao Y, Oerther S, Mattsson J (2019)
    Pre-formulation investigations for establishing a protocol for treosulfan handling and activation
    Pharm Dev Technol, 24 (5), 639-648
    DOI 10.1080/10837450.2018.1551903, PubMed 30474459
  21. Engeseth M, Enden T, Andersen MH, Sandset PM, Wik HS (2019)
    Does the Villalta scale capture the essence of postthrombotic syndrome? A qualitative study of patient experience and expert opinion
    J Thromb Haemost, 17 (10), 1707-1714
    DOI 10.1111/jth.14557, PubMed 31265193
  22. Engeseth M, Enden T, Sandset PM, Wik HS (2019)
    Limitations of the Villalta scale in diagnosing post-thrombotic syndrome
    Thromb Res, 184, 62-66
    DOI 10.1016/j.thromres.2019.10.018, PubMed 31707153
  23. Gamage TH, Lengle E, Gunnes G, Pullisaar H, Holmgren A, Reseland JE, Merckoll E, Corti S, Mizobuchi M, Morales RJ, Tsiokas L, Tjønnfjord GE, Lacruz RS, Lyngstadaas SP, Misceo D, Frengen E (2019)
    STIM1 R304W in mice causes subgingival hair growth and an increased fraction of trabecular bone
    Cell Calcium, 85, 102110
    DOI 10.1016/j.ceca.2019.102110, PubMed 31785581
  24. Garabet L, Ghanima W, Hellum M, Sandset PM, Bussel JB, Tran H, Henriksson CE (2019)
    Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists
    Platelets, 31 (3), 322-328
    DOI 10.1080/09537104.2019.1639655, PubMed 31280643
  25. Garabet L, Ghanima W, Rangberg A, Teruel-Montoya R, Martinez C, Lozano ML, Nystrand CF, Bussel JB, Sandset PM, Jonassen CM (2019)
    Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists
    Platelets, 31 (2), 198-205
    DOI 10.1080/09537104.2019.1585527, PubMed 30885035
  26. Garabet L, Henriksson CE, Lozano ML, Ghanima W, Bussel J, Brodin E, Fernández-Pérez MP, Martínez C, González-Conejero R, Mowinckel MC, Sandset PM (2019)
    Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists
    Thromb Res, 185, 119-124
    DOI 10.1016/j.thromres.2019.11.031, PubMed 31805421
  27. Gilleece MH, Labopin M, Savani BN, Yakoub-Agha I, Socié G, Gedde-Dahl T, Blaise D, Byrne JL, Craddock C, Cornelissen JJ, Arcese W, Forcade E, Crawley C, Polge E, Mohty M, Nagler A (2019)
    Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT
    Leukemia, 34 (1), 87-99
    DOI 10.1038/s41375-019-0527-4, PubMed 31363160
  28. Godolphin PJ, Bath PM, Algra A, Berge E, Brown MM, Chalmers J, Duley L, Eliasziw M, Gregson J, Greving JP, Hankey GJ, Hosomi N, Johnston SC, Patsko E, Ranta A, Sandset PM, Serena J, Weimar C, Montgomery AA, Adjudicating Outcomes in Stroke Trials Collaboration (2019)
    Outcome Assessment by Central Adjudicators Versus Site Investigators in Stroke Trials: A Systematic Review and Meta-Analysis
    Stroke, 50 (8), 2187-2196
    DOI 10.1161/STROKEAHA.119.025019, PubMed 33755494
  29. Gregersen I, Høibraaten E, Holven KB, Løvdahl L, Ueland T, Mowinckel MC, Dahl TB, Aukrust P, Halvorsen B, Sandset PM (2019)
    Effect of hormone replacement therapy on atherogenic lipid profile in postmenopausal women
    Thromb Res, 184, 1-7
    DOI 10.1016/j.thromres.2019.10.005, PubMed 31677448
  30. Halaburda K, Labopin M, Mailhol A, Socié G, Craddock C, Aljurf M, Beelen D, Cornelissen JJ, Bourhis JH, Labussière-Wallet H, Blaise D, Gedde-Dahl T, Gilleece M, Yakoub-Agha I, Mufti G, Esteve J, Mohty M, Nagler A (2019)
    Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Haematologica, 105 (6), 1723-1730
    DOI 10.3324/haematol.2019.222810, PubMed 31439677
  31. Hillengass J, Usmani S, Rajkumar SV, Durie BGM, Mateos MV, Lonial S, Joao C, Anderson KC, García-Sanz R, Riva E, Du J, van de Donk N, Berdeja JG, Terpos E, Zamagni E, Kyle RA, San Miguel J, Goldschmidt H, Giralt S, Kumar S, Raje N, Ludwig H, Ocio E, Schots R, Einsele H et al. (2019)
    International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
    Lancet Oncol, 20 (6), e302-e312
    DOI 10.1016/S1470-2045(19)30309-2, PubMed 31162104
  32. Johansen S, Helgeland L, Vetti N, Dybedal I, Reikvam H (2019)
    A man in his seventies with back pain, gastrointestinal symptoms and rash
    Tidsskr Nor Laegeforen, 139 (15)
    DOI 10.4045/tidsskr.18.0819, PubMed 31642632
  33. Jønsson V, Awan H, Jones ND, Johannesen TB, Steig BÁ, Andosdottir G, Tjønnfjord GE (2019)
    Inheritance of Susceptibility to Malignant Blood Disorders
    Sci Rep, 9 (1), 2444
    DOI 10.1038/s41598-019-38879-y, PubMed 30792429
  34. Kristoffersen AH, Jacobsen EM, Varsi K, Henriksson CE (2019)
    Analysis of lupus anticoagulant during ongoing anti coagulation treatment
    Tidsskr. Nor. Laegeforen., 139 (15), 1491
  35. Lalezari S, Reding MT, Pabinger I, Holme PA, Negrier C, Chalasani P, Shin HJ, Wang M, Tseneklidou-Stoeter D, Maas Enriquez M (2019)
    BAY 94-9027 prophylaxis is efficacious and well tolerated for up to >5 years with extended dosing intervals: PROTECT VIII extension interim results
    Haemophilia, 25 (6), 1011-1019
    DOI 10.1111/hae.13853, PubMed 31621991
  36. Lenartova A, Randen U, Johannesen TB, Tjønnfjord GE (2019)
    Richter syndrome epidemiology in a large population based chronic lymphocytic leukemia cohort from Norway
    Cancer Epidemiol, 60, 128-133
    DOI 10.1016/j.canep.2019.04.002, PubMed 30986631
  37. Lien K, Johansen B, Veierød MB, Haslestad AS, Bøhn SK, Melsom MN, Kardel KR, Iversen PO (2019)
    Abnormal blood lactate accumulation during repeated exercise testing in myalgic encephalomyelitis/chronic fatigue syndrome
    Physiol Rep, 7 (11), e14138
    DOI 10.14814/phy2.14138, PubMed 31161646
  38. Liu X, Wang W, Yin Y, Li M, Li H, Xiang H, Xu A, Mei X, Hong B, Lin W (2019)
    A high-throughput drug screen identifies auranofin as a potential sensitizer of cisplatin in small cell lung cancer
    Invest New Drugs, 37 (6), 1166-1176
    DOI 10.1007/s10637-019-00750-2, PubMed 30825105
  39. Ljungkvist M, Strandberg K, Berntorp E, Chaireti R, Holme PA, Larsen OH, Lassila R, Jouppila A, Szanto T, Zetterberg E (2019)
    Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram: A Nordic study
    Haemophilia, 25 (2), 334-342
    DOI 10.1111/hae.13640, PubMed 30715788
  40. Luhr M, Torgersen ML, Szalai P, Hashim A, Brech A, Staerk J, Engedal N (2019)
    The kinase PERK and the transcription factor ATF4 play distinct and essential roles in autophagy resulting from tunicamycin-induced ER stress
    J Biol Chem, 294 (20), 8197-8217
    DOI 10.1074/jbc.RA118.002829, PubMed 30926605
  41. Mateos MV, Blacklock H, Schjesvold F, Oriol A, Simpson D, George A, Goldschmidt H, Larocca A, Chanan-Khan A, Sherbenou D, Avivi I, Benyamini N, Iida S, Matsumoto M, Suzuki K, Ribrag V, Usmani SZ, Jagannath S, Ocio EM, Rodriguez-Otero P, San Miguel J, Kher U, Farooqui M, Liao J, Marinello P et al. (2019)
    Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial
    Lancet Haematol, 6 (9), e459-e469
    DOI 10.1016/S2352-3026(19)30110-3, PubMed 31327687
  42. Nielsen NV, Roedel E, Manna D, Etscheid M, Morth JP, Kanse SM (2019)
    Characterization of the enzymatic activity of the serine protease domain of Factor VII activating protease (FSAP)
    Sci Rep, 9 (1), 18990
    DOI 10.1038/s41598-019-55531-x, PubMed 31831842
  43. Passweg JR, Labopin M, Christopeit M, Cornelissen J, Pabst T, Socié G, Russel N, Yakoub-Agha I, Blaise D, Gedde-Dahl T, Labussière-Wallet H, Malladi R, Forcade E, Maury S, Polge E, Lanza F, Gorin NC, Mohty M, Nagler A (2019)
    Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
    Biol Blood Marrow Transplant, 26 (4), 659-664
    DOI 10.1016/j.bbmt.2019.11.021, PubMed 31759159
  44. Richardson PG, Oriol A, Beksac M, Liberati AM, Galli M, Schjesvold F, Lindsay J, Weisel K, White D, Facon T, San Miguel J, Sunami K, O'Gorman P, Sonneveld P, Robak P, Semochkin S, Schey S, Yu X, Doerr T, Bensmaine A, Biyukov T, Peluso T, Zaki M, Anderson K, Dimopoulos M et al. (2019)
    Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
    Lancet Oncol, 20 (6), 781-794
    DOI 10.1016/S1470-2045(19)30152-4, PubMed 31097405
  45. Rukundo PM, Rukooko B, Andreassen BA, Iversen PO (2019)
    Housing, water and sanitation implications on food insecurity and diet diversity in landslide affected communities: A cross-sectional survey of two districts in Uganda
    Clin Nutr ESPEN, 33, 47-56
    DOI 10.1016/j.clnesp.2019.07.010, PubMed 31451275
  46. Rut W, Nielsen NV, Czarna J, Poreba M, Kanse SM, Drag M (2019)
    Fluorescent activity-based probe for the selective detection of Factor VII activating protease (FSAP) in human plasma
    Thromb Res, 182, 124-132
    DOI 10.1016/j.thromres.2019.08.016, PubMed 31479940
  47. Sandset PM (2019)
    Inflammation, infection and coagulation disorders
    Hemasphere, 3 (Suppl), 88
    DOI 10.1097/HS9.0000000000000267, PubMed 35309790
  48. Sandset PM, Dahm AEA (2019)
    Is venous thromboembolism a problem in patients with cancer in palliative care?
    Lancet Haematol, 6 (2), e61-e62
    DOI 10.1016/S2352-3026(18)30218-7, PubMed 30709433
  49. Savikj M, Kostovski E, Lundell LS, Iversen PO, Massart J, Widegren U (2019)
    Altered oxidative stress and antioxidant defence in skeletal muscle during the first year following spinal cord injury
    Physiol Rep, 7 (16), e14218
    DOI 10.14814/phy2.14218, PubMed 31456346
  50. Schultz NH, Holme PA, Henriksson CE, Mowinckel MC, Sandset PM, Bratseth V, Jacobsen EM (2019)
    The influence of rivaroxaban on markers of fibrinolysis and endothelial cell activation/injury in patients with venous thrombosis
    Thromb Res, 177, 154-156
    DOI 10.1016/j.thromres.2019.03.010, PubMed 30903875
  51. Sioud M, Pettersen S, Ailte I, Fløisand Y (2019)
    Targeted Killing of Monocytes/Macrophages and Myeloid Leukemia Cells with Pro-Apoptotic Peptides
    Cancers (Basel), 11 (8)
    DOI 10.3390/cancers11081088, PubMed 31370273
  52. Skretting G, Andersen E, Myklebust CF, Sandset PM, Tinholt M, Iversen N, Stavik B (2019)
    Transcription factor FOXP3: A repressor of the TFPI gene?
    J Cell Biochem, 120 (8), 12924-12936
    DOI 10.1002/jcb.28563, PubMed 30861202
  53. Skånland SS, Cremaschi A, Bendiksen H, Hermansen JU, Thimiri Govinda Raj DB, Munthe LA, Tjønnfjord GE, Taskén K (2019)
    An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL
    Leukemia, 34 (2), 478-487
    DOI 10.1038/s41375-019-0569-7, PubMed 31471562
  54. Skaarud KJ, Veierød MB, Lergenmuller S, Bye A, Iversen PO, Tjønnfjord GE (2019)
    Body weight, body composition and survival after 1 year: follow-up of a nutritional intervention trial in allo-HSCT recipients
    Bone Marrow Transplant, 54 (12), 2102-2109
    DOI 10.1038/s41409-019-0638-6, PubMed 31455897
  55. Søraas A, Matsuyama M, de Lima M, Wald D, Buechner J, Gedde-Dahl T, Søraas CL, Chen B, Ferrucci L, Dahl JA, Horvath S, Matsuyama S (2019)
    Epigenetic age is a cell-intrinsic property in transplanted human hematopoietic cells
    Aging Cell, 18 (2), e12897
    DOI 10.1111/acel.12897, PubMed 30712319
  56. Saad A, Lamb L, Wang T, Hemmer MT, Spellman S, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Agrawal V, Aljurf M, Beitinjaneh AM, Bhatt VR, Buchbinder D, Byrne M, Cahn JY, Cairo M, Castillo P, Chhabra S, Diaz MA, Farhan S, Floisand Y, Frangoul HA, Gadalla SM, Gajewski J et al. (2019)
    Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation
    Biol Blood Marrow Transplant, 25 (9), 1875-1883
    DOI 10.1016/j.bbmt.2019.05.007, PubMed 31085303
  57. Thomas AM, Gerogianni A, McAdam MB, Fløisand Y, Lau C, Espevik T, Nilsson PH, Mollnes TE, Barratt-Due A (2019)
    Complement Component C5 and TLR Molecule CD14 Mediate Heme-Induced Thromboinflammation in Human Blood
    J Immunol, 203 (6), 1571-1578
    DOI 10.4049/jimmunol.1900047, PubMed 31413105
  58. Torkildsen S, Gorunova L, Heim S, Tjønnfjord GE, Spetalen S, Risberg B, Tran HTT, Panagopoulos I (2019)
    Molecular Genetic Characterization of Acute Myeloid Leukemia With Trisomy 4 as the Sole Chromosome Abnormality
    Cancer Genomics Proteomics, 16 (3), 175-178
    DOI 10.21873/cgp.20123, PubMed 31018948
  59. Usmani SZ, Schjesvold F, Oriol A, Karlin L, Cavo M, Rifkin RM, Yimer HA, LeBlanc R, Takezako N, McCroskey RD, Lim ABM, Suzuki K, Kosugi H, Grigoriadis G, Avivi I, Facon T, Jagannath S, Lonial S, Ghori RU, Farooqui MZH, Marinello P, San-Miguel J, KEYNOTE-185 Investigators (2019)
    Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
    Lancet Haematol, 6 (9), e448-e458
    DOI 10.1016/S2352-3026(19)30109-7, PubMed 31327689
  60. Wiktor-Jedrzejczak W, Drozd-Sokolowska J, Eikema DJ, Hoek J, Potter M, Wulf G, Sellner L, Ljungman P, Chevallier P, Volin L, Koc Y, Martin S, Bunjes D, Rovira M, Itälä-Remes M, Foá R, Deconinck E, Gedde-Dahl T, Cornelissen J, Collin M, Brecht A, Patel A, de Groot M, Reményi P, Nagler A et al. (2019)
    EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)
    Bone Marrow Transplant, 54 (9), 1391-1398
    DOI 10.1038/s41409-019-0448-x, PubMed 30664723
  61. Zhang B, Ayuda-Durán P, Piechaczyk L, Fløisand Y, Safont MM, Karlsen IT, Fandalyuk Z, Tadele D, van Mierlo P, Rowe AD, Robertson JM, Gjertsen BT, McCormack E, Enserink JM (2019)
    GRP94 rewires and buffers the FLT3-ITD signaling network and promotes survival of acute myeloid leukemic stem cells
    Haematologica, 104 (5), e229
    DOI 10.3324/haematol.2019.220533, PubMed 31040234

Publications 2018

  1. Andersen E, Chollet ME, Myklebust CF, Pinotti M, Bernardi F, Chuansumrit A, Skarpen E, Sandset PM, Skretting G (2018)
    Activation of Endoplasmic Reticulum Stress and Unfolded Protein Response in Congenital Factor VII Deficiency
    Thromb Haemost, 118 (4), 664-675
    DOI 10.1055/s-0038-1637690, PubMed 29618153
  2. Bhamra JS, Iversen PO, Titze TK, Tjønnfjord GE, Akkök ÇA (2018)
    A Case of Posttransfusion Purpura with Severe Refractory Thrombocytopenia but No Cutaneous Manifestations
    Case Rep Hematol, 2018, 8187659
    DOI 10.1155/2018/8187659, PubMed 30510818
  3. Bruserud Ø, Melve GK, Gedde-Dahl T, Tvedt THA (2018)
    Immunological heterogeneity of healthy peripheral blood stem cell donors - preharvesting donor characteristics, additional heterogeneity induced by granulocyte colony-stimulating factor and possible importance for outcome after allotransplantation
    Expert Rev Hematol, 11 (10), 757-759
    DOI 10.1080/17474086.2018.1511420, PubMed 30126308
  4. Chortatos A, Iversen PO, Haugen M, Eberhard-Gran M, Bjelland EK, Veierød MB (2018)
    Nausea and vomiting in pregnancy - association with pelvic girdle pain during pregnancy and 4-6 months post-partum
    BMC Pregnancy Childbirth, 18 (1), 137
    DOI 10.1186/s12884-018-1764-7, PubMed 29739355
  5. Danylesko I, Bukauskas A, Paulson M, Peceliunas V, Gedde-Dahl D Y T, Shimoni A, Shouval R, Griskevicius L, Floisand Y, Nagler A (2018)
    Anti-α4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease
    Bone Marrow Transplant, 54 (7), 987-993
    DOI 10.1038/s41409-018-0364-5, PubMed 30356163
  6. Diep PP, Melberg HO, Brinch L, Buechner J, Fløisand Y, Gedde-Dahl T, Loge JH, Tjønnfjord GE, Ruud E (2018)
    Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway
    Bone Marrow Transplant, 53 (5), 657-660
    DOI 10.1038/s41409-018-0091-y, PubMed 29358600
  7. Dimopoulos MA, Gay F, Schjesvold F, Beksac M, Hajek R, Weisel KC, Goldschmidt H, Maisnar V, Moreau P, Min CK, Pluta A, Chng WJ, Kaiser M, Zweegman S, Mateos MV, Spencer A, Iida S, Morgan G, Suryanarayan K, Teng Z, Skacel T, Palumbo A, Dash AB, Gupta N, Labotka R et al. (2018)
    Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
    Lancet, 393 (10168), 253-264
    DOI 10.1016/S0140-6736(18)33003-4, PubMed 30545780
  8. Enden T, Bernklev T, Jelsness-Jorgensen LP, Amdal CD (2018)
    Patients know their own health best
    Tidsskr. Nor. Laegeforen., 138 (8), 716-718
  9. Etscheid M, Subramaniam S, Lochnit G, Zabczyk M, Undas A, Lang IM, Hanschmann KM, Kanse SM (2018)
    Altered structure and function of fibrinogen after cleavage by Factor VII Activating Protease (FSAP)
    Biochim Biophys Acta Mol Basis Dis, 1864 (10), 3397-3406
    DOI 10.1016/j.bbadis.2018.07.030, PubMed 30076961
  10. Fløisand Y, Lazarevic VL, Maertens J, Mattsson J, Shah NN, Zachée P, Taylor A, Akbari M, Quadri S, Parfionovas A, Chen YB (2018)
    Safety and Effectiveness of Vedolizumab in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease: A Retrospective Record Review
    Biol Blood Marrow Transplant, 25 (4), 720-727
    DOI 10.1016/j.bbmt.2018.11.013, PubMed 30468919
  11. Fronas SG, Wik HS, Dahm AEA, Jørgensen CT, Gleditsch J, Raouf N, Klok FA, Ghanima W (2018)
    Safety of D-dimer testing as a stand-alone test for the exclusion of deep vein thrombosis as compared with other strategies
    J Thromb Haemost, 16 (12), 2471-2481
    DOI 10.1111/jth.14314, PubMed 30303610
  12. Gamage TH, Gunnes G, Lee RH, Louch WE, Holmgren A, Bruton JD, Lengle E, Kolstad TRS, Revold T, Amundsen SS, Dalen KT, Holme PA, Tjønnfjord GE, Christensen G, Westerblad H, Klungland A, Bergmeier W, Misceo D, Frengen E (2018)
    STIM1 R304W causes muscle degeneration and impaired platelet activation in mice
    Cell Calcium, 76, 87-100
    DOI 10.1016/j.ceca.2018.10.001, PubMed 30390422
  13. Gravensteen IK, Jacobsen EM, Sandset PM, Helgadottir LB, Rådestad I, Sandvik L, Ekeberg Ø (2018)
    Anxiety, depression and relationship satisfaction in the pregnancy following stillbirth and after the birth of a live-born baby: a prospective study
    BMC Pregnancy Childbirth, 18 (1), 41
    DOI 10.1186/s12884-018-1666-8, PubMed 29361916
  14. Habberstad AH, Tran HTT, Randen U, Spetalen S, Dybedal I, Tjønnfjord GE, Dahm AEA (2018)
    Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report
    J Med Case Rep, 12 (1), 105
    DOI 10.1186/s13256-018-1663-6, PubMed 29685167
  15. Hermansen JU, Tjønnfjord GE, Munthe LA, Taskén K, Skånland SS (2018)
    Cryopreservation of primary B cells minimally influences their signaling responses
    Sci Rep, 8 (1), 17651
    DOI 10.1038/s41598-018-36121-9, PubMed 30518828
  16. Holme PA, Tjønnfjord GE (2018)
    Continuous infusion of simoctocog alfa in haemophilia A patients undergoing surgeries
    Haemophilia, 25 (1), 54-59
    DOI 10.1111/hae.13625, PubMed 30394617
  17. Hope S, Nordstrom M, Retterstol K, Iversen PO, Kolset SO (2018)
    The right to a health promoting diet for people with intellectual disabilities
    Tidsskr. Nor. Laegeforen., 138 (2), 122-123
  18. Kolset SO, Nordstrøm M, Hope S, Retterstøl K, Iversen PO (2018)
    Securing rights and nutritional health for persons with intellectual disabilities - a pressing challenge
    Food Nutr Res, 62
    DOI 10.29219/fnr.v62.1268, PubMed 29899685
  19. Korpela K, Blakstad EW, Moltu SJ, Strømmen K, Nakstad B, Rønnestad AE, Brække K, Iversen PO, Drevon CA, de Vos W (2018)
    Intestinal microbiota development and gestational age in preterm neonates
    Sci Rep, 8 (1), 2453
    DOI 10.1038/s41598-018-20827-x, PubMed 29410448
  20. Kostovski E, Frigato E, Savikj M, Dahm A, Sandset PM, Mowinckel MC, Skretting G, Østerud B, Bertolucci C, Iversen PO (2018)
    Normalization of disrupted clock gene expression in males with tetraplegia: a crossover randomized placebo-controlled trial of melatonin supplementation
    Spinal Cord, 56 (11), 1076-1083
    DOI 10.1038/s41393-018-0176-x, PubMed 29985456
  21. Kverneland M, Molteberg E, Iversen PO, Veierød MB, Taubøll E, Selmer KK, Nakken KO (2018)
    Effect of modified Atkins diet in adults with drug-resistant focal epilepsy: A randomized clinical trial
    Epilepsia, 59 (8), 1567-1576
    DOI 10.1111/epi.14457, PubMed 29901816
  22. Lindgren M, Samuelsson J, Nilsson L, Knutsen H, Ghanima W, Westin J, Johansson PL, Andréasson B (2018)
    Genetic variation in IL28B (IFNL3) and response to interferon-alpha treatment in myeloproliferative neoplasms
    Eur J Haematol, 100 (5), 419-425
    DOI 10.1111/ejh.13034, PubMed 29369421
  23. Lorentino F, Labopin M, Bernardi M, Ciceri F, Socié G, Cornelissen JJ, Esteve J, Ruggeri A, Volin L, Yacoub-Agha I, Craddock C, Passweg J, Blaise D, Gedde-Dahl T, Poiani M, Fegueux N, Mohty M, Nagler A, Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2018)
    Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission
    Am J Hematol, 93 (10), 1236-1244
    DOI 10.1002/ajh.25231, PubMed 30058714
  24. Lundell LS, Savikj M, Kostovski E, Iversen PO, Zierath JR, Krook A, Chibalin AV, Widegren U (2018)
    Protein translation, proteolysis and autophagy in human skeletal muscle atrophy after spinal cord injury
    Acta Physiol (Oxf), 223 (3), e13051
    DOI 10.1111/apha.13051, PubMed 29423932
  25. McLornan DP, Szydlo R, Robin M, van Biezen A, Koster L, Blok HJP, Van Lint MT, Finke J, Vitek A, Carlson K, Griskevicius L, Holler E, Itälä-Remes M, Schaap M, Socié G, Bay JO, Beguin Y, Bruno B, Cornelissen JJ, Gedde-Dahl T, Ljungman P, Rubio MT, Yakoub-Agha I, Klyuchnikov E, Olavarria E et al. (2018)
    Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT
    Br J Haematol, 182 (3), 418-422
    DOI 10.1111/bjh.15407, PubMed 29808926
  26. Muhoozi GKM, Atukunda P, Skaare AB, Willumsen T, Diep LM, Westerberg AC, Iversen PO (2018)
    Effects of nutrition and hygiene education on oral health and growth among toddlers in rural Uganda: follow-up of a cluster-randomised controlled trial
    Trop Med Int Health, 23 (4), 391-404
    DOI 10.1111/tmi.13036, PubMed 29381827
  27. Myhrvold IK, Cremaschi A, Hermansen JU, Tjønnfjord GE, Munthe LA, Taskén K, Skånland SS (2018)
    Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia
    Oncotarget, 9 (10), 9273-9284
    DOI 10.18632/oncotarget.23949, PubMed 29507689
  28. Nahalomo A, Iversen PO, Rukundo PM, Kaaya A, Kikafunda J, Eide WB, Marais M, Wamala E, Kabahenda M (2018)
    Realization of the right to adequate food and the nutritional status of land evictees: a case for mothers/caregivers and their children in rural Central Uganda
    BMC Int Health Hum Rights, 18 (1), 21
    DOI 10.1186/s12914-018-0162-6, PubMed 29793472
  29. Navarro-Fernández J, Eugenia de la Morena-Barrio M, Martínez-Alonso E, Dybedal I, Toderici M, Bohdan N, Miñano A, Heimdal K, Abildgaard U, Martínez-Menárguez JÁ, Corral J, Vicente V (2018)
    Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family
    Oncotarget, 9 (69), 33202-33214
    DOI 10.18632/oncotarget.26059, PubMed 30237862
  30. Nesvold MB, Jensen JL, Hove LH, Singh PB, Young A, Palm Ø, Andersen LF, Carlsen MH, Iversen PO (2018)
    Dietary Intake, Body Composition, and Oral Health Parameters among Female Patients with Primary Sjögren's Syndrome
    Nutrients, 10 (7)
    DOI 10.3390/nu10070866, PubMed 29973575
  31. Ngari MM, Iversen PO, Thitiri J, Mwalekwa L, Timbwa M, Fegan GW, Berkley JA (2018)
    Linear growth following complicated severe malnutrition: 1-year follow-up cohort of Kenyan children
    Arch Dis Child, 104 (3), 229-235
    DOI 10.1136/archdischild-2018-315641, PubMed 30266874
  32. Ngari MM, Mwalekwa L, Timbwa M, Hamid F, Ali R, Iversen PO, Fegan GW, Berkley JA (2018)
    Changes in susceptibility to life-threatening infections after treatment for complicated severe malnutrition in Kenya
    Am J Clin Nutr, 107 (4), 626-634
    DOI 10.1093/ajcn/nqy007, PubMed 29635501
  33. Olsson M, Stanne TM, Pedersen A, Lorentzen E, Kara E, Martinez-Palacian A, Rønnow Sand NP, Jacobsen AF, Sandset PM, Sidelmann JJ, Engström G, Melander O, Kanse SM, Jern C (2018)
    Genome-wide analysis of genetic determinants of circulating factor VII-activating protease (FSAP) activity
    J Thromb Haemost, 16 (10), 2024-2034
    DOI 10.1111/jth.14258, PubMed 30070759
  34. Panagopoulos I, Gorunova L, Jacobsen EM, Andersen K, Micci F, Heim S (2018)
    RUNX1-PDCD6 fusion resulting from a novel t(5;21)(p15;q22) chromosome translocation in myelodysplastic syndrome secondary to chronic lymphocytic leukemia
    PLoS One, 13 (4), e0196181
    DOI 10.1371/journal.pone.0196181, PubMed 29672642
  35. Pathak M, Diep PP, Lai X, Brinch L, Ruud E, Drolsum L (2018)
    Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation
    Bone Marrow Transplant, 53 (7), 863-872
    DOI 10.1038/s41409-018-0090-z, PubMed 29382955
  36. Qvigstad C, Tait RC, Rauchensteiner S, Berntorp E, de Moerloose P, Schutgens RE, Holme PA, ADVANCE Working Group (2018)
    The elevated prevalence of risk factors for chronic liver disease among ageing people with hemophilia and implications for treatment
    Medicine (Baltimore), 97 (39), e12551
    DOI 10.1097/MD.0000000000012551, PubMed 30278553
  37. Reikvam H, Skavland J, Gullaksen SE, Hovland R, Gedde-Dahl T, Bruserud Ø, Gjertsen BT (2018)
    Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation
    Case Rep Hematol, 2018, 2045985
    DOI 10.1155/2018/2045985, PubMed 30345125
  38. Rogne M, Svaerd O, Madsen-Østerbye J, Hashim A, Tjønnfjord GE, Staerk J (2018)
    Cytokinesis arrest and multiple centrosomes in B cell chronic lymphocytic leukaemia
    J Cell Mol Med, 22 (5), 2846-2855
    DOI 10.1111/jcmm.13579, PubMed 29516674
  39. Sacco S, Merki-Feld GS, Ægidius KL, Bitzer J, Canonico M, Gantenbein AR, Kurth T, Lampl C, Lidegaard Ø, Anne MacGregor E, MaassenVanDenBrink A, Mitsikostas DD, Nappi RE, Ntaios G, Paemeleire K, Sandset PM, Terwindt GM, Vetvik KG, Martelletti P, European Headache Federation (EHF), the European Society of Contraception and Reproductive Health (ESCRH) (2018)
    Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)
    J Headache Pain, 19 (1), 76
    DOI 10.1186/s10194-018-0896-5, PubMed 30171365
  40. Sacco S, Merki-Feld GS, Ægidius KL, Bitzer J, Canonico M, Kurth T, Lampl C, Lidegaard Ø, Anne MacGregor E, MaassenVanDenBrink A, Mitsikostas DD, Nappi RE, Ntaios G, Sandset PM, Martelletti P, European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC) (2018)
    Correction to: Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
    J Headache Pain, 19 (1), 81
    DOI 10.1186/s10194-018-0912-9, PubMed 30203397
  41. Savikj M, Ruby MA, Kostovski E, Iversen PO, Zierath JR, Krook A, Widegren U (2018)
    Retained differentiation capacity of human skeletal muscle satellite cells from spinal cord-injured individuals
    Physiol Rep, 6 (12), e13739
    DOI 10.14814/phy2.13739, PubMed 29906337
  42. Schultz NH, Holme PA, Bjørnsen S, Henriksson CE, Sandset PM, Jacobsen EM (2018)
    The impact of rivaroxaban on primary hemostasis in patients with venous thrombosis
    Platelets, 31 (1), 43-47
    DOI 10.1080/09537104.2018.1557618, PubMed 30569801
  43. Schultz NH, Lundblad R, Holme PA (2018)
    Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series
    J Med Case Rep, 12 (1), 138
    DOI 10.1186/s13256-018-1660-9, PubMed 29764497
  44. Schwab C, Gabrysch A, Olbrich P, Patiño V, Warnatz K, Wolff D, Hoshino A, Kobayashi M, Imai K, Takagi M, Dybedal I, Haddock JA, Sansom DM, Lucena JM, Seidl M, Schmitt-Graeff A, Reiser V, Emmerich F, Frede N, Bulashevska A, Salzer U, Schubert D, Hayakawa S, Okada S, Kanariou M et al. (2018)
    Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects
    J Allergy Clin Immunol, 142 (6), 1932-1946
    DOI 10.1016/j.jaci.2018.02.055, PubMed 29729943
  45. Shapiro AD, Nakar C, Parker JM, Albert GR, Moran JE, Thibaudeau K, Thukral N, Hardesty BM, Laurin P, Sandset PM (2018)
    Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency
    Blood, 131 (12), 1301-1310
    DOI 10.1182/blood-2017-09-806729, PubMed 29321155
  46. Sioud M, Westby P, Vasovic V, Fløisand Y, Peng Q (2018)
    Development of a new high-affinity human antibody with antitumor activity against solid and blood malignancies
    FASEB J, 32 (9), 5063-5077
    DOI 10.1096/fj.201701544R, PubMed 29913558
  47. Skaarud KJ, Hjermstad MJ, Bye A, Veierød MB, Gudmundstuen AM, Lundin KEA, Distante S, Brinch L, Tjønnfjord GE, Iversen PO (2018)
    Effects of individualized nutrition after allogeneic hematopoietic stem cell transplantation following myeloablative conditioning; a randomized controlled trial
    Clin Nutr ESPEN, 28, 59-66
    DOI 10.1016/j.clnesp.2018.08.002, PubMed 30390894
  48. Subramaniam S, Kanse SM, Kothari H, Reinhardt C, Fletcher C (2018)
    Post-transcriptional, post-translational and pharmacological regulation of tissue factor pathway inhibitor
    Blood Coagul Fibrinolysis, 29 (8), 668-682
    DOI 10.1097/MBC.0000000000000775, PubMed 30439766
  49. Tangen JM, Tjønnfjord GE, Gulbrandsen N, Gedde-Dahl T, Stormorken E, Anderson K, Vo CD, Schjesvold FH, For Oslo Myeloma Center (2018)
    Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001-2010: a retrospective, population based analysis
    BMC Cancer, 18 (1), 801
    DOI 10.1186/s12885-018-4722-x, PubMed 30089450
  50. Tavoly M, Wik HS, Sirnes PA, Jelsness-Jørgensen LP, Ghanima JP, Klok FA, Sandset PM, Ghanima W (2018)
    The impact of post-pulmonary embolism syndrome and its possible determinants
    Thromb Res, 171, 84-91
    DOI 10.1016/j.thromres.2018.09.048, PubMed 30267974
  51. Tinholt M, Garred Ø, Borgen E, Beraki E, Schlichting E, Kristensen V, Sahlberg KK, Iversen N (2018)
    Subtype-specific clinical and prognostic relevance of tumor-expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study
    J Thromb Haemost, 16 (7), 1347-1356
    DOI 10.1111/jth.14151, PubMed 29766637
  52. Tulstrup M, Grosjean M, Nielsen SN, Grell K, Wolthers BO, Wegener PS, Jonsson OG, Lund B, Harila-Saari A, Abrahamsson J, Vaitkeviciene G, Pruunsild K, Toft N, Holm M, Hulegårdh E, Liestøl S, Griskevicius L, Punab M, Wang J, Carroll WL, Zhang Z, Dalgaard MD, Gupta R, Nersting J, Schmiegelow K (2018)
    NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia
    Leukemia, 32 (12), 2527-2535
    DOI 10.1038/s41375-018-0245-3, PubMed 30201983
  53. Utne KK, Dahm A, Wik HS, Jelsness-Jørgensen LP, Sandset PM, Ghanima W (2018)
    Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome
    Thromb Res, 163, 6-11
    DOI 10.1016/j.thromres.2018.01.013, PubMed 29324334
  54. Zhang B, Durán PA, Piechaczyk L, Fløisand Y, Safont MMS, Karlsen IT, Fandalyuk Z, Tadele D, Mierlo PV, Rowe AD, Robertson JM, Gjertsen BT, McCormack E, Enserink JM, Bjørn Tore Gjertsen Group, Emmet McCormack Group (2018)
    GRP94 rewires and buffers the FLT3-ITD signaling network and promotes survival of acute myeloid leukemic stem cells
    Haematologica, Online ahead of print (in press) (Retracted)
    DOI 10.3324/haematol.2018.189399, PubMed 29748445

Publications 2017

  1. Andresen MS, Ali HO, Myklebust CF, Sandset PM, Stavik B, Iversen N, Skretting G (2017)
    Estrogen induced expression of tissue factor pathway inhibitor-2 in MCF7 cells involves lysine-specific demethylase 1
    Mol Cell Endocrinol, 443, 80-88
    DOI 10.1016/j.mce.2017.01.016, PubMed 28088469
  2. Berentsen S, Randen U, Oksman M, Birgens H, Tvedt THA, Dalgaard J, Galteland E, Haukås E, Brudevold R, Sørbø JH, Næss IA, Malecka A, Tjønnfjord GE (2017)
    Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial
    Blood, 130 (4), 537-541
    DOI 10.1182/blood-2017-04-778175, PubMed 28533306
  3. Berntorp E, Dargaud Y, Hart D, Lobet S, Mancuso ME, d'Oiron R, Perry D, Pollard D, van den Berg M, Blatný J, Chambost H, Doria AS, Holme PA, Kaczmarek R, Mantovani L, McLaughlin P, Nanayakkara L, Petrini P, Sannié T, Laane E, Maia R, Dettoraki A, Farrell A, Halimeh S, Raza S et al. (2017)
    The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany
    Eur J Haematol, 98 Suppl 85, 1-15
    DOI 10.1111/ejh.12828, PubMed 28101938
  4. Byskov K, Boettger T, Ruehle PF, Nielsen NV, Etscheid M, Kanse SM (2017)
    Factor VII activating protease (FSAP) regulates the expression of inflammatory genes in vascular smooth muscle and endothelial cells
    Atherosclerosis, 265, 133-139
    DOI 10.1016/j.atherosclerosis.2017.08.029, PubMed 28881271
  5. Canaani J, Beohou E, Labopin M, Socié G, Huynh A, Volin L, Cornelissen J, Milpied N, Gedde-Dahl T, Deconinck E, Fegueux N, Blaise D, Mohty M, Nagler A (2017)
    Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT
    Am J Hematol, 92 (4), 344-350
    DOI 10.1002/ajh.24640, PubMed 28052366
  6. Canaani J, Labopin M, Socié G, Nihtinen A, Huynh A, Cornelissen J, Deconinck E, Gedde-Dahl T, Forcade E, Chevallier P, Bourhis JH, Blaise D, Mohty M, Nagler A (2017)
    Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT
    Am J Hematol, 92 (7), 653-659
    DOI 10.1002/ajh.24737, PubMed 28370339
  7. Chollet ME, Andersen E, Skarpen E, Myklebust CF, Koehler C, Morth JP, Chuansumrit A, Pinotti M, Bernardi F, Thiede B, Sandset PM, Skretting G (2017)
    Factor VII deficiency: Unveiling the cellular and molecular mechanisms underlying three model alterations of the enzyme catalytic domain
    Biochim Biophys Acta Mol Basis Dis, 1864 (3), 660-667
    DOI 10.1016/j.bbadis.2017.12.016, PubMed 29246447
  8. Cui XY, Skretting G, Tinholt M, Stavik B, Dahm AEA, Sahlberg KK, Kanse S, Iversen N, Sandset PM (2017)
    A novel hypoxia response element regulates oxygen-related repression of tissue factor pathway inhibitor in the breast cancer cell line MCF-7
    Thromb Res, 157, 111-116
    DOI 10.1016/j.thromres.2017.07.013, PubMed 28734156
  9. Espada S, Stavik B, Holm S, Sagen EL, Bjerkeli V, Skjelland M, Dahl TB, Espevik T, Kanse S, Sandset PM, Skretting G, Halvorsen B (2017)
    Tissue factor pathway inhibitor attenuates ER stress-induced inflammation in human M2-polarized macrophages
    Biochem Biophys Res Commun, 491 (2), 442-448
    DOI 10.1016/j.bbrc.2017.07.070, PubMed 28712870
  10. Garabet L, Ghanima W, Monceyron Jonassen C, Skov V, Holst R, Mowinckel MC, C Hasselbalch H, A Kruse T, Thomassen M, Liebman H, Bussel JB, Sandset PM (2017)
    Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia
    Platelets, 30 (2), 206-212
    DOI 10.1080/09537104.2017.1394451, PubMed 29215956
  11. Ghanima W, Wik HS, Tavoly M, Enden T, Jelsness-Jørgensen LP (2017)
    Late consequences of venous thromboembolism: Measuring quality of life after deep vein thrombosis and pulmonary embolism
    Thromb Res, 164, 170-176
    DOI 10.1016/j.thromres.2017.07.025, PubMed 28760416
  12. Gjevestad GO, Ottestad I, Biong AS, Iversen PO, Retterstøl K, Raastad T, Skålhegg BS, Ulven SM, Holven KB (2017)
    Consumption of protein-enriched milk has minor effects on inflammation in older adults-A 12-week double-blind randomized controlled trial
    Mech Ageing Dev, 162, 1-8
    DOI 10.1016/j.mad.2017.01.011, PubMed 28163108
  13. Grasso S, Neumann A, Lang IM, Etscheid M, von Köckritz-Blickwede M, Kanse SM (2017)
    Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs)
    Thromb Res, 161, 36-42
    DOI 10.1016/j.thromres.2017.11.012, PubMed 29178989
  14. Gravensteen IK (2017)
    Author's reply re: Healthcare utilisation, induced labour and caesarean section in the pregnancy after stillbirth: a prospective study
    BJOG, 125 (1), 92
    DOI 10.1111/1471-0528.14787, PubMed 28791796
  15. Gravensteen IK, Jacobsen EM, Sandset PM, Helgadottir LB, Rådestad I, Sandvik L, Ekeberg Ø (2017)
    Healthcare utilisation, induced labour and caesarean section in the pregnancy after stillbirth: a prospective study
    BJOG, 125 (2), 202-210
    DOI 10.1111/1471-0528.14750, PubMed 28516500
  16. Gullaksen SE, Skavland J, Gavasso S, Tosevski V, Warzocha K, Dumrese C, Ferrant A, Gedde-Dahl T, Hellmann A, Janssen J, Labar B, Lang A, Majeed W, Mihaylov G, Stentoft J, Stenke L, Thaler J, Thielen N, Verhoef G, Voglova J, Ossenkoppele G, Hochhaus A, Hjorth-Hansen H, Mustjoki S, Sopper S et al. (2017)
    Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib
    Haematologica, 102 (8), 1361-1367
    DOI 10.3324/haematol.2017.167080, PubMed 28522574
  17. Gustavsen A, Skattum L, Bergseth G, Lorentzen B, Floisand Y, Bosnes V, Mollnes TE, Barratt-Due A (2017)
    Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome: A case report
    Medicine (Baltimore), 96 (11), e6338
    DOI 10.1097/MD.0000000000006338, PubMed 28296762
  18. Herold J, Nowak S, Kostin S, Daniel JM, Francke A, Subramaniam S, Braun-Dullaeus RC, Kanse SM (2017)
    Factor VII activating protease (FSAP) influences vascular remodeling in the mouse hind limb ischemia model
    Am J Transl Res, 9 (6), 3084-3095
    PubMed 28670395
  19. Holme PA, Tjønnfjord GE, Batorova A (2017)
    Continuous infusion of coagulation factor concentrates during intensive treatment
    Haemophilia, 24 (1), 24-32
    DOI 10.1111/hae.13331, PubMed 28873263
  20. Klohe K, Prazeres da Costa C, Lien N, Holmboe-Ottesen G, Rychlik M, Haavardsson I, Stordalen G, Singh S, Engebretsen I, Iversen PO, Winkler AS (2017)
    [Not Available]
    Tidsskr Nor Laegeforen, 137 (23-24)
    DOI 10.4045/tidsskr.17.0679, PubMed 29231665
  21. Komperød MJ, Sommer C, Mellin-Olsen T, Iversen PO, Røseth AG, Valeur J (2017)
    Persistent symptoms in patients with Crohn's disease in remission: An exploratory study on the role of diet
    Scand J Gastroenterol, 53 (5), 573-578
    DOI 10.1080/00365521.2017.1397736, PubMed 29168412
  22. Krishnan K, Jusufovic M, Sandset PM, Sandset EC (2017)
    Antiplatelet Therapy in Noncardioembolic Stroke: A Review of Current Evidence
    Semin Neurol, 37 (3), 366-375
    DOI 10.1055/s-0037-1603469, PubMed 28759917
  23. Lazarevic VL, Labopin M, Depei W, Yakoub-Agha I, Huynh A, Ljungman P, Schaap N, Cornelissen JJ, Maillard N, Pioltelli P, Gedde-Dahl T, Lenhoff S, Houhou M, Esteve J, Mohty M, Nagler A (2017)
    Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)
    Am J Hematol, 93 (1), 31-39
    DOI 10.1002/ajh.24928, PubMed 28971504
  24. Małecka A, Trøen G, Tierens A, Østlie I, Małecki J, Randen U, Wang J, Berentsen S, Tjønnfjord GE, Delabie JMA (2017)
    Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease
    Br J Haematol, 183 (5), 838-842
    DOI 10.1111/bjh.15063, PubMed 29265349
  25. Muhoozi GKM, Atukunda P, Diep LM, Mwadime R, Kaaya AN, Skaare AB, Willumsen T, Westerberg AC, Iversen PO (2017)
    Nutrition, hygiene, and stimulation education to improve growth, cognitive, language, and motor development among infants in Uganda: A cluster-randomized trial
    Matern Child Nutr, 14 (2), e12527
    DOI 10.1111/mcn.12527, PubMed 28925580
  26. Ngari MM, Thitiri J, Mwalekwa L, Timbwa M, Iversen PO, Fegan GW, Berkley JA (2017)
    The impact of rickets on growth and morbidity during recovery among children with complicated severe acute malnutrition in Kenya: A cohort study
    Matern Child Nutr, 14 (2), e12569
    DOI 10.1111/mcn.12569, PubMed 29178404
  27. Olsen MB, Hildrestrand GA, Scheffler K, Vinge LE, Alfsnes K, Palibrk V, Wang J, Neurauter CG, Luna L, Johansen J, Øgaard JDS, Ohm IK, Slupphaug G, Kuśnierczyk A, Fiane AE, Brorson SH, Zhang L, Gullestad L, Louch WE, Iversen PO, Østlie I, Klungland A, Christensen G, Sjaastad I, Sætrom P et al. (2017)
    NEIL3-Dependent Regulation of Cardiac Fibroblast Proliferation Prevents Myocardial Rupture
    Cell Rep, 18 (1), 82-92
    DOI 10.1016/j.celrep.2016.12.009, PubMed 28052262
  28. Osooli M, Steen Carlsson K, Baghaei F, Holmström M, Rauchensteiner S, Holme PA, Hvitfeldt L, Astermark J, Berntorp E (2017)
    The association between health utility and joint status among people with severe haemophilia A: findings from the KAPPA register
    Haemophilia, 23 (3), e180-e187
    DOI 10.1111/hae.13231, PubMed 28393468
  29. Ottestad I, Løvstad AT, Gjevestad GO, Hamarsland H, Šaltytė Benth J, Andersen LF, Bye A, Biong AS, Retterstøl K, Iversen PO, Raastad T, Ulven SM, Holven KB (2017)
    Intake of a Protein-Enriched Milk and Effects on Muscle Mass and Strength. A 12-Week Randomized Placebo Controlled Trial among Community-Dwelling Older Adults
    J Nutr Health Aging, 21 (10), 1160-1169
    DOI 10.1007/s12603-016-0856-1, PubMed 29188875
  30. Pahnke S, Larfors G, Axdorph-Nygell U, Fischer-Nielsen A, Haastrup E, Heldal D, Itälä-Remes M, Johansson JE, Kauppila M, Lenhoff S, Ljungman P, Niittyvuopio R, Sandstedt A, Hägglund H (2017)
    Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors
    J Clin Apher, 33 (3), 226-235
    DOI 10.1002/jca.21576, PubMed 28833474
  31. Panagopoulos I, Gorunova L, Torkildsen S, Tierens A, Heim S, Micci F (2017)
    FAM53B truncation caused by t(10;19)(q26;q13) chromosome translocation in acute lymphoblastic leukemia
    Oncol Lett, 13 (4), 2216-2220
    DOI 10.3892/ol.2017.5705, PubMed 28454383
  32. Panagopoulos I, Gorunova L, Torkildsen S, Tjønnfjord GE, Micci F, Heim S (2017)
    DEK-NUP214-Fusion Identified by RNA-Sequencing of an Acute Myeloid Leukemia with t(9;12)(q34;q15)
    Cancer Genomics Proteomics, 14 (6), 437-443
    DOI 10.21873/cgp.20053, PubMed 29109093
  33. Prebensen C, Trøseid M, Ueland T, Dahm A, Sandset PM, Aaberge I, Waalen K, Dyrhol-Riise AM, Taskén K, Kvale D (2017)
    Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial
    PLoS One, 12 (5), e0176527
    DOI 10.1371/journal.pone.0176527, PubMed 28464042
  34. Retterstøl K, Narverud I, Selmer R, Berge KE, Osnes IV, Ulven SM, Halvorsen B, Aukrust P, Holven KB, Iversen PO (2017)
    Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics
    Lipids Health Dis, 16 (1), 115
    DOI 10.1186/s12944-017-0511-9, PubMed 28606150
  35. Ringdén O, Labopin M, Sadeghi B, Mailhol A, Beelen D, Fløisand Y, Ghavamzadeh A, Finke J, Ehninger G, Volin L, Socié G, Kröger N, Stuhler G, Ganser A, Schmid C, Giebel S, Mohty M, Nagler A (2017)
    What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?
    J Intern Med, 283 (2), 166-177
    DOI 10.1111/joim.12695, PubMed 29027756
  36. Robin M, Porcher R, Zinke-Cerwenka W, van Biezen A, Volin L, Mufti G, Craddock C, Finke J, Richard C, Passweg J, Peniket A, Maertens J, Sucak G, Gedde-Dahl T, Vitek A, Nagler A, Blaise D, Beelen D, Maillard N, Schwerdtfeger R, de Witte T, Kroger N (2017)
    Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT
    Bone Marrow Transplant, 52 (7), 1081
    DOI 10.1038/bmt.2017.86, PubMed 28677682
  37. Rørholt M, Ghanima W, Farkas DK, Nørgaard M (2017)
    Risk of cardiovascular events and pulmonary hypertension following splenectomy - a Danish population-based cohort study from 1996-2012
    Haematologica, 102 (8), 1333-1341
    DOI 10.3324/haematol.2016.157008, PubMed 28572164
  38. Sacco S, Merki-Feld GS, Ægidius KL, Bitzer J, Canonico M, Kurth T, Lampl C, Lidegaard Ø, Anne MacGregor E, MaassenVanDenBrink A, Mitsikostas DD, Nappi RE, Ntaios G, Sandset PM, Martelletti P, European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC) (2017)
    Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
    J Headache Pain, 18 (1), 108
    DOI 10.1186/s10194-017-0815-1, PubMed 29086160
  39. Sagedal S, Sandvik L, Klingenberg O, Sandset PM (2017)
    β-Thromboglobulin may not reflect platelet activation during haemodialysis with the HeprAN membrane
    Scand J Clin Lab Invest, 77 (8), 679-684
    DOI 10.1080/00365513.2017.1397288, PubMed 29117741
  40. Schultz NH, Tran HTT, Bjørnsen S, Henriksson CE, Sandset PM, Holme PA (2017)
    The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor
    Thromb J, 15, 6
    DOI 10.1186/s12959-017-0129-1, PubMed 28239301
  41. Schultz NH, Tran HTT, Bjørnsen S, Henriksson CE, Sandset PM, Holme PA (2017)
    The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII in apixaban-treated patients in vitro
    Res Pract Thromb Haemost, 1 (1), 49-56
    DOI 10.1002/rth2.12015, PubMed 30046673
  42. Server A, Bargalló N, Fløisand Y, Sponheim J, Graus F, Hald JK (2017)
    Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation
    Neuroradiology, 59 (2), 105-126
    DOI 10.1007/s00234-017-1804-4, PubMed 28255902
  43. Sperling C, Maitz MF, Grasso S, Werner C, Kanse SM (2017)
    A Positively Charged Surface Triggers Coagulation Activation Through Factor VII Activating Protease (FSAP)
    ACS Appl Mater Interfaces, 9 (46), 40107-40116
    DOI 10.1021/acsami.7b14281, PubMed 29091393
  44. Stavik B, Holm S, Espada S, Iversen N, Sporsheim B, Bjerkeli V, Dahl TB, Sandset PM, Skjelland M, Espevik T, Skretting G, Halvorsen B (2017)
    Increased expression of TFPI in human carotid stenosis
    Thromb Res, 155, 31-37
    DOI 10.1016/j.thromres.2017.04.024, PubMed 28482260
  45. Steffensen IL, Frølich W, Dahl KH, Iversen PO, Lyche JL, Lillegaard ITL, Alexander J (2017)
    Benefit and risk assessment of increasing potassium intake by replacement of sodium chloride with potassium chloride in industrial food products in Norway
    Food Chem Toxicol, 111, 329-340
    DOI 10.1016/j.fct.2017.11.044, PubMed 29175183
  46. Strømmen K, Haag A, Moltu SJ, Veierød MB, Blakstad EW, Nakstad B, Almaas AN, Brække K, Rønnestad AE, Daniel H, Drevon CA, Iversen PO (2017)
    Enhanced nutrient supply to very low birth weight infants is associated with higher blood amino acid concentrations and improved growth
    Clin Nutr ESPEN, 18, 16-22
    DOI 10.1016/j.clnesp.2017.01.003, PubMed 29132733
  47. Tikkinen KAO, Craigie S, Agarwal A, Siemieniuk RAC, Cartwright R, Violette PD, Novara G, Naspro R, Agbassi C, Ali B, Imam M, Ismaila N, Kam D, Gould MK, Sandset PM, Guyatt GH (2017)
    Procedure-specific Risks of Thrombosis and Bleeding in Urological Non-cancer Surgery: Systematic Review and Meta-analysis
    Eur Urol, 73 (2), 236-241
    DOI 10.1016/j.eururo.2017.02.025, PubMed 28284738
  48. Tikkinen KAO, Craigie S, Agarwal A, Violette PD, Novara G, Cartwright R, Naspro R, Siemieniuk RAC, Ali B, Eryuzlu L, Geraci J, Winkup J, Yoo D, Gould MK, Sandset PM, Guyatt GH (2017)
    Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysis
    Eur Urol, 73 (2), 242-251
    DOI 10.1016/j.eururo.2017.03.008, PubMed 28342641
  49. Tjønnfjord E, Vengen ØA, Berentsen S, Tjønnfjord GE (2017)
    Prophylactic use of eculizumab during surgery in chronic cold agglutinin disease
    BMJ Case Rep, 2017
    DOI 10.1136/bcr-2016-219066, PubMed 28487302
  50. Torkildsen S, Brunetti M, Gorunova L, Spetalen S, Beiske K, Heim S, Panagopoulos I (2017)
    Rearrangement of the Chromatin Organizer Special AT-rich Binding Protein 1 Gene, SATB1, Resulting from a t(3;5)(p24;q14) Chromosomal Translocation in Acute Myeloid Leukemia
    Anticancer Res, 37 (2), 693-698
    DOI 10.21873/anticanres.11365, PubMed 28179318
  51. Vojdeman FJ, Herman SEM, Kirkby N, Wiestner A, van T' Veer MB, Tjønnfjord GE, Itälä-Remes MA, Kimby E, Farooqui MZ, Polliack A, Wu KL, Doorduijn JK, Alemayehu WG, Wittebol S, Kozak T, Walewski J, Abrahamse-Testroote MCJ, van Oers MHJ, Geisler CH, Niemann CU (2017)
    Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia
    Leuk Lymphoma, 58 (10), 2356-2362
    DOI 10.1080/10428194.2017.1285027, PubMed 28278728
  52. Wang D, Fløisand Y, Myklebust CV, Bürgler S, Parente-Ribes A, Hofgaard PO, Bogen B, Taskén K, Tjønnfjord GE, Schjesvold F, Dalgaard J, Tveita A, Munthe LA (2017)
    Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice
    Leukemia, 31 (10), 2114-2121
    DOI 10.1038/leu.2017.69, PubMed 28232741
  53. Wik HS, Enden TR, Ghanima W, Engeseth M, Kahn SR, Sandset PM (2017)
    Diagnostic scales for the post-thrombotic syndrome
    Thromb Res, 164, 110-115
    DOI 10.1016/j.thromres.2017.10.022, PubMed 29126608
  54. Wik HS, Ghanima W, Sandset PM, Kahn SR (2017)
    Scoring Systems for Postthrombotic Syndrome
    Semin Thromb Hemost, 43 (5), 500-504
    DOI 10.1055/s-0037-1599142, PubMed 28470653

Publications 2016

  1. Ali HO, Arroyo AB, González-Conejero R, Stavik B, Iversen N, Sandset PM, Martínez C, Skretting G (2016)
    The role of microRNA-27a/b and microRNA-494 in estrogen-mediated downregulation of tissue factor pathway inhibitor α
    J Thromb Haemost, 14 (6), 1226-37
    DOI 10.1111/jth.13321, PubMed 26999003
  2. Ali HO, Stavik B, Myklebust CF, Andersen E, Dahm AE, Iversen N, Sandset PM, Skretting G (2016)
    Oestrogens Downregulate Tissue Factor Pathway Inhibitor through Oestrogen Response Elements in the 5'-Flanking Region
    PLoS One, 11 (3), e0152114
    DOI 10.1371/journal.pone.0152114, PubMed 26999742
  3. Barratt-Due A, Fløisand Y, Orrem HL, Kvam AK, Holme PA, Bergseth G, Tjønnfjord GE, Mollnes TE (2016)
    Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
    Rheumatology (Oxford), 55 (7), 1337-9
    DOI 10.1093/rheumatology/kew040, PubMed 27105662
  4. Bates SM, Alonso-Coello P, Tikkinen KA, Ebrahim S, Lopes LC, McDonald SD, Zhou Q, Akl EA, Neumann I, Jacobsen AF, Zhang Y, Santamaría A, Annichino-Bizzacchi JM, Sandset PM, Bitar W, Eckman MH, Guyatt GH (2016)
    Women's values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview
    Thromb Res, 140, 22-9
    DOI 10.1016/j.thromres.2015.12.015, PubMed 27500301
  5. Berger K, Schopohl D, Lowe G, Holme PA, Tait RC, Combescure C, Rauchensteiner S, Klamroth R (2016)
    How to compare cardiovascular disease and risk factors in elderly patients with haemophilia with the general population
    Haemophilia, 22 (5), e406-16
    DOI 10.1111/hae.13069, PubMed 27650262
  6. Biegstraaten M, Cox TM, Belmatoug N, Berger MG, Collin-Histed T, Vom Dahl S, Di Rocco M, Fraga C, Giona F, Giraldo P, Hasanhodzic M, Hughes DA, Iversen PO, Kiewiet AI, Lukina E, Machaczka M, Marinakis T, Mengel E, Pastores GM, Plöckinger U, Rosenbaum H, Serratrice C, Symeonidis A, Szer J, Timmerman J et al. (2016)
    Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease
    Blood Cells Mol Dis, 68, 203-208
    DOI 10.1016/j.bcmd.2016.10.008, PubMed 28274788
  7. Bleker SM, Buchmüller A, Chauleur C, Ní Áinle F, Donnelly J, Verhamme P, Jacobsen AF, Ganzevoort W, Prins M, Beyer-Westendorf J, DeSancho M, Konstantinides S, Pabinger I, Rodger M, Decousus H, Middeldorp S (2016)
    Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses
    Thromb Res, 144, 62-8
    DOI 10.1016/j.thromres.2016.06.001, PubMed 27289488
  8. Broesby-Olsen S, Dybedal I, Gülen T, Kristensen TK, Møller MB, Ackermann L, Sääf M, Karlsson MA, Agertoft L, Brixen K, Hermann P, Stylianou E, Mortz CG, Torfing T, Havelund T, Sander B, Bergström A, Bendix M, Garvey LH, Bjerrum OW, Valent P, Bindslev-Jensen C, Nilsson G, Vestergaard H, Hägglund H (2016)
    Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus
    Acta Derm Venereol, 96 (5), 602-12
    DOI 10.2340/00015555-2325, PubMed 26694951
  9. Bustamante A, Díaz-Fernández B, Giralt D, Boned S, Pagola J, Molina CA, García-Berrocoso T, Kanse SM, Montaner J (2016)
    Factor seven activating protease (FSAP) predicts response to intravenous thrombolysis in acute ischemic stroke
    Int J Stroke, 11 (6), 646-55
    DOI 10.1177/1747493016641949, PubMed 27073188
  10. Bye A, Wesseltoft-Rao N, Iversen PO, Skjegstad G, Holven KB, Ulven S, Hjermstad MJ (2016)
    Alterations in inflammatory biomarkers and energy intake in cancer cachexia: a prospective study in patients with inoperable pancreatic cancer
    Med Oncol, 33 (6), 54
    DOI 10.1007/s12032-016-0768-2, PubMed 27119533
  11. Cui XY, Tinholt M, Stavik B, Dahm AE, Kanse S, Jin Y, Seidl S, Sahlberg KK, Iversen N, Skretting G, Sandset PM (2016)
    Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer
    J Thromb Haemost, 14 (2), 387-96
    DOI 10.1111/jth.13206, PubMed 26598923
  12. Daniel JM, Reichel CA, Schmidt-Woell T, Dutzmann J, Zuchtriegel G, Krombach F, Herold J, Bauersachs J, Sedding DG, Kanse SM (2016)
    Factor VII-activating protease deficiency promotes neointima formation by enhancing leukocyte accumulation
    J Thromb Haemost, 14 (10), 2058-2067
    DOI 10.1111/jth.13417, PubMed 27431088
  13. Fløisand Y, Lundin KEA, Lazarevic V, Kristiansen JD, Osnes LTN, Tjønnfjord GE, Reims HM, Gedde-Dahl T (2016)
    Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease
    Biol Blood Marrow Transplant, 23 (1), 172-175
    DOI 10.1016/j.bbmt.2016.10.009, PubMed 27777142
  14. Garabet L, Gilboe IM, Mowinckel MC, Jacobsen AF, Mollnes TE, Sandset PM, Jacobsen EM (2016)
    Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus
    Scand J Immunol, 84 (2), 95-9
    DOI 10.1111/sji.12445, PubMed 27135178
  15. Haig Y, Enden T, Grøtta O, Kløw NE, Slagsvold CE, Ghanima W, Sandvik L, Hafsahl G, Holme PA, Holmen LO, Njaaastad AM, Sandbæk G, Sandset PM, CaVenT Study Group (2016)
    Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial
    Lancet Haematol, 3 (2), e64-71
    DOI 10.1016/S2352-3026(15)00248-3, PubMed 26853645
  16. Hjorth-Hansen H, Stentoft J, Richter J, Koskenvesa P, Höglund M, Dreimane A, Porkka K, Gedde-Dahl T, Gjertsen BT, Gruber FX, Stenke L, Eriksson KM, Markevärn B, Lübking A, Vestergaard H, Udby L, Bjerrum OW, Persson I, Mustjoki S, Olsson-Strömberg U (2016)
    Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients
    Leukemia, 30 (9), 1853-60
    DOI 10.1038/leu.2016.121, PubMed 27133821
  17. Holstein K, Batorova A, Carvalho M, Fijnvandraat K, Holme P, Kavakli K, Lambert T, Rocino A, Jiménez-Yuste V, Astermark J, European Haemophilia Therapy Strategy Board (EHTSB) (2016)
    Current view and outcome of ITI therapy - A change over time?
    Thromb Res, 148, 38-44
    DOI 10.1016/j.thromres.2016.10.015, PubMed 27770665
  18. Ilander M, Olsson-Strömberg U, Schlums H, Guilhot J, Brück O, Lähteenmäki H, Kasanen T, Koskenvesa P, Söderlund S, Höglund M, Markevärn B, Själander A, Lotfi K, Dreimane A, Lübking A, Holm E, Björeman M, Lehmann S, Stenke L, Ohm L, Gedde-Dahl T, Majeed W, Ehrencrona H, Koskela S, Saussele S et al. (2016)
    Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
    Leukemia, 31 (5), 1108-1116
    DOI 10.1038/leu.2016.360, PubMed 27890936
  19. James PD, Mahlangu J, Bidlingmaier C, Mingot-Castellano ME, Chitlur M, Fogarty PF, Cuker A, Mancuso ME, Holme PA, Grabell J, Satkunam N, Hopman WM, Mathew P, Global Emerging HEmostasis Experts Panel (GEHEP) (2016)
    Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study
    Haemophilia, 22 (6), 912-918
    DOI 10.1111/hae.13089, PubMed 27868369
  20. Kaur P, Bergrem A, Gerlyng P, Reims HM, Leh S, Valeur J (2016)
    A methadone user with anaemia, skeletal pain and altered appearance
    Tidsskr Nor Laegeforen, 136 (10), 925-9
    DOI 10.4045/tidsskr.15.0692, PubMed 27272371
  21. Koenecke C, Heim D, van Biezen A, Heuser M, Aljurf M, Kyrcz-Krzemien S, Volin L, de Souza CA, Gedde-Dahl T, Sengeloev H, Schanz U, Komarnicki M, Arroyo CH, Tholouli E, Gluckman E, Esquirol A, Yakoub-Agha I, Gürman G, Olavarria E, Kröger N (2016)
    Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party
    Bone Marrow Transplant, 51 (9), 1259-61
    DOI 10.1038/bmt.2016.97, PubMed 27111041
  22. Kontro M, Kumar A, Majumder MM, Eldfors S, Parsons A, Pemovska T, Saarela J, Yadav B, Malani D, Fløisand Y, Höglund M, Remes K, Gjertsen BT, Kallioniemi O, Wennerberg K, Heckman CA, Porkka K (2016)
    HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia
    Leukemia, 31 (2), 301-309
    DOI 10.1038/leu.2016.222, PubMed 27499136
  23. Leiting S, Seidl S, Martinez-Palacian A, Muhl L, Kanse SM (2016)
    Transforming Growth Factor-β (TGF-β) Inhibits the Expression of Factor VII-activating Protease (FSAP) in Hepatocytes
    J Biol Chem, 291 (40), 21020-21028
    DOI 10.1074/jbc.M116.744631, PubMed 27462075
  24. Lenartova A, Johannesen TB, Tjønnfjord GE (2016)
    National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953-2012: a systematic analysis of population-based data
    Cancer Med, 5 (12), 3588-3595
    DOI 10.1002/cam4.849, PubMed 27925456
  25. Małecka A, Trøen G, Tierens A, Østlie I, Małecki J, Randen U, Berentsen S, Tjønnfjord GE, Delabie JM (2016)
    Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity
    Haematologica, 101 (9), e361-4
    DOI 10.3324/haematol.2016.146126, PubMed 27198717
  26. Martin K, Beyer-Westendorf J, Davidson BL, Huisman MV, Sandset PM, Moll S (2016)
    Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH
    J Thromb Haemost, 14 (6), 1308-13
    DOI 10.1111/jth.13323, PubMed 27299806
  27. Muhoozi GK, Atukunda P, Mwadime R, Iversen PO, Westerberg AC (2016)
    Nutritional and developmental status among 6- to 8-month-old children in southwestern Uganda: a cross-sectional study
    Food Nutr Res, 60, 30270
    DOI 10.3402/fnr.v60.30270, PubMed 27238555
  28. Mundal L, Veierød MB, Halvorsen T, Holven KB, Ose L, Iversen PO, Tell GS, Leren TP, Retterstøl K (2016)
    Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study
    Eur J Prev Cardiol, 23 (18), 1962-1969
    DOI 10.1177/2047487316666371, PubMed 27558979
  29. Nordheim T, Rustøen T, Iversen PO, Nakstad B (2016)
    Quality of life in parents of preterm infants in a randomized nutritional intervention trial
    Food Nutr Res, 60, 32162
    DOI 10.3402/fnr.v60.32162, PubMed 27839532
  30. Panagopoulos I, Torkildsen S, Gorunova L, Ulvmoen A, Tierens A, Zeller B, Heim S (2016)
    RUNX1 truncation resulting from a cryptic and novel t(6;21)(q25;q22) chromosome translocation in acute myeloid leukemia: A case report
    Oncol Rep, 36 (5), 2481-2488
    DOI 10.3892/or.2016.5119, PubMed 27667292
  31. Robin M, Porcher R, Zinke-Cerwenka W, van Biezen A, Volin L, Mufti G, Craddock C, Finke J, Richard C, Passweg J, Peniket A, Maertens J, Sucak G, Gedde-Dahl T, Vitek A, Nagler A, Blaise D, Beelen D, Maillard N, Schwerdtfeger R, de Witte T, Kroger N (2016)
    Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT
    Bone Marrow Transplant, 52 (2), 209-215
    DOI 10.1038/bmt.2016.266, PubMed 27819688
  32. Rukundo PM, Andreassen BA, Kikafunda J, Rukooko B, Oshaug A, Iversen PO (2016)
    Household food insecurity and diet diversity after the major 2010 landslide disaster in Eastern Uganda: a cross-sectional survey
    Br J Nutr, 115 (4), 718-29
    DOI 10.1017/S0007114515004961, PubMed 26777212
  33. Rukundo PM, Oshaug A, Andreassen BA, Kikafunda J, Rukooko B, Iversen PO (2016)
    Food variety consumption and household food insecurity coping strategies after the 2010 landslide disaster - the case of Uganda
    Public Health Nutr, 19 (17), 3197-3209
    DOI 10.1017/S1368980016001397, PubMed 27278061
  34. Skarpengland T, Holm S, Scheffler K, Gregersen I, Dahl TB, Suganthan R, Segers FM, Østlie I, Otten JJ, Luna L, Ketelhuth DF, Lundberg AM, Neurauter CG, Hildrestrand G, Skjelland M, Bjørndal B, Svardal AM, Iversen PO, Hedin U, Nygård S, Olstad OK, Krohg-Sørensen K, Slupphaug G, Eide L, Kuśnierczyk A et al. (2016)
    Neil3-dependent base excision repair regulates lipid metabolism and prevents atherosclerosis in Apoe-deficient mice
    Sci Rep, 6, 28337
    DOI 10.1038/srep28337, PubMed 27328939
  35. Stavik B, Espada S, Cui XY, Iversen N, Holm S, Mowinkel MC, Halvorsen B, Skretting G, Sandset PM (2016)
    EPAS1/HIF-2 alpha-mediated downregulation of tissue factor pathway inhibitor leads to a pro-thrombotic potential in endothelial cells
    Biochim Biophys Acta, 1862 (4), 670-678
    DOI 10.1016/j.bbadis.2016.01.017, PubMed 26826018
  36. Tavoly M, Utne KK, Jelsness-Jørgensen LP, Wik HS, Klok FA, Sandset PM, Ghanima W (2016)
    Health-related quality of life after pulmonary embolism: a cross-sectional study
    BMJ Open, 6 (11), e013086
    DOI 10.1136/bmjopen-2016-013086, PubMed 27810979
  37. Tekpli X, Urbanucci A, Hashim A, Vågbø CB, Lyle R, Kringen MK, Staff AC, Dybedal I, Mills IG, Klungland A, Staerk J (2016)
    Changes of 5-hydroxymethylcytosine distribution during myeloid and lymphoid differentiation of CD34+ cells
    Epigenetics Chromatin, 9, 21
    DOI 10.1186/s13072-016-0070-8, PubMed 27252783
  38. Tinholt M, Sandset PM, Iversen N (2016)
    Polymorphisms of the coagulation system and risk of cancer
    Thromb Res, 140 Suppl 1, S49-54
    DOI 10.1016/S0049-3848(16)30098-6, PubMed 27067978
  39. Tinholt M, Sandset PM, Mowinckel MC, Garred Ø, Sahlberg KK, Kristensen VN, Børresen-Dale AL, Jacobsen AF, Skretting G, Iversen N (2016)
    Determinants of acquired activated protein C resistance and D-dimer in breast cancer
    Thromb Res, 145, 78-83
    DOI 10.1016/j.thromres.2016.08.003, PubMed 27505249
  40. Tiscia GL, Dørum E, Myklebust CF, Grandone E, Sandset PM, Skretting G (2016)
    Functional characterization of annexin A5 gene promoter allelic variants
    Thromb Res, 144, 93-9
    DOI 10.1016/j.thromres.2016.06.009, PubMed 27318245
  41. Torfoss D, Fladhagen T, Holte H, Brinch L, Schjesvold FH, Fløisand Y, Nyquist E, Dalgaard J, Meyer P, Lehmann AK, Hammerstrøm J, Skjelbakken T, Høiby EA, Sandvik L, Kvaløy S (2016)
    Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial
    Clin Microbiol Infect, 23 (3), 179-187
    DOI 10.1016/j.cmi.2016.10.019, PubMed 27793737
  42. Utne KK, Tavoly M, Wik HS, Jelsness-Jørgensen LP, Holst R, Sandset PM, Ghanima W (2016)
    Health-related quality of life after deep vein thrombosis
    Springerplus, 5 (1), 1278
    DOI 10.1186/s40064-016-2949-z, PubMed 27547653
  43. Vandraas K, Tjønnfjord GE, Johannesen TB, Brandal P (2016)
    Persistent bone marrow depression following short-term treatment with temozolomide
    BMJ Case Rep, 2016
    DOI 10.1136/bcr-2016-215797, PubMed 27130558
  44. Vojdeman FJ, Van't Veer MB, Tjønnfjord GE, Itälä-Remes M, Kimby E, Polliack A, Wu KL, Doorduijn JK, Alemayehu WG, Wittebol S, Kozak T, Walewski J, Abrahamse-Testroote MC, van Oers MH, Geisler CH (2016)
    The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia
    Leuk Lymphoma, 58 (3), 594-600
    DOI 10.1080/10428194.2016.1213831, PubMed 27484290
  45. von Krogh AS, Quist-Paulsen P, Waage A, Langseth ØO, Thorstensen K, Brudevold R, Tjønnfjord GE, Largiadèr CR, Lämmle B, Kremer Hovinga JA (2016)
    High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence
    J Thromb Haemost, 14 (1), 73-82
    DOI 10.1111/jth.13186, PubMed 26566785
  46. Yin Y, Yang Y, Xiang X, Wang Q, Yang ZN, Blevins J, Lou Y, Yang XF (2016)
    Insight into the Dual Functions of Bacterial Enhancer-Binding Protein Rrp2 of Borrelia burgdorferi
    J Bacteriol, 198 (10), 1543-52
    DOI 10.1128/JB.01010-15, PubMed 26977110

Publications 2015

  1. Bazarbachi A, Labopin M, Kharfan-Dabaja MA, Schwerdtfeger R, Volin L, Bourhis JH, Socié G, Daguindau E, Gedde-Dahl T, Rambaldi A, Karas M, Schlimok G, Blaise D, Chevallier P, Malard F, Schmid C, Esteve J, Nagler A, Mohty M (2015)
    Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status
    Haematologica, 101 (1), e34-7
    DOI 10.3324/haematol.2015.135681, PubMed 26405153
  2. Beitland S, Sandven I, Kjærvik LK, Sandset PM, Sunde K, Eken T (2015)
    Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis
    Intensive Care Med, 41 (7), 1209-19
    DOI 10.1007/s00134-015-3840-z, PubMed 25971389
  3. Berentsen S, Randen U, Tjønnfjord GE (2015)
    Cold agglutinin-mediated autoimmune hemolytic anemia
    Hematol Oncol Clin North Am, 29 (3), 455-71
    DOI 10.1016/j.hoc.2015.01.002, PubMed 26043385
  4. Berntsen CF, Kristiansen A, Akl EA, Sandset PM, Jacobsen EM, Guyatt G, Vandvik PO (2015)
    Compression Stockings for Preventing the Postthrombotic Syndrome in Patients with Deep Vein Thrombosis
    Am J Med, 129 (4), 447.e1-447.e20
    DOI 10.1016/j.amjmed.2015.11.031, PubMed 26747198
  5. Boon H, Sjögren RJ, Massart J, Egan B, Kostovski E, Iversen PO, Hjeltnes N, Chibalin AV, Widegren U, Zierath JR (2015)
    MicroRNA-208b progressively declines after spinal cord injury in humans and is inversely related to myostatin expression
    Physiol Rep, 3 (11)
    DOI 10.14814/phy2.12622, PubMed 26603456
  6. Bremer S, Fløisand Y, Brinch L, Gedde-Dahl T, Bergan S (2015)
    Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning
    Ther Drug Monit, 37 (4), 493-500
    DOI 10.1097/FTD.0000000000000180, PubMed 25565670
  7. Chollet ME, Skarpen E, Iversen N, Sandset PM, Skretting G (2015)
    The chemical chaperone sodium 4-phenylbutyrate improves the secretion of the protein CA267T mutant in CHO-K1 cells trough the GRASP55 pathway
    Cell Biosci, 5, 57
    DOI 10.1186/s13578-015-0048-4, PubMed 26457178
  8. Chortatos A, Haugen M, Iversen PO, Vikanes Å, Eberhard-Gran M, Bjelland EK, Magnus P, Veierød MB (2015)
    Pregnancy complications and birth outcomes among women experiencing nausea only or nausea and vomiting during pregnancy in the Norwegian Mother and Child Cohort Study
    BMC Pregnancy Childbirth, 15, 138
    DOI 10.1186/s12884-015-0580-6, PubMed 26100060
  9. Chortatos A, Haugen M, Iversen PO, Vikanes Å, Eberhard-Gran M, Bjelland EK, Magnus P, Veierød MB (2015)
    Erratum: Pregnancy complications and birth outcomes among women experiencing nausea only or nausea and vomiting during pregnancy in the Norwegian Mother and Child Cohort Study
    BMC Pregnancy Childbirth, 15, 167
    DOI 10.1186/s12884-015-0596-y, PubMed 26268704
  10. Comerota AJ, Sandset PM, Konstantinides S, de Graaf R, Wakefield TW, Arnoldussen CW, Lam YL, van Gent WB, de Wolf MA, Catarinella FS, Kurstjens RL, Alshabatat A, Wittens CH (2015)
    Theme 4: Invasive management of (recurrent) VTE and PTS
    Thromb Res, 136 Suppl 1, S19-25
    DOI 10.1016/j.thromres.2015.07.037, PubMed 26387732
  11. Craigie S, Tsui JF, Agarwal A, Sandset PM, Guyatt GH, Tikkinen KA (2015)
    Adherence to mechanical thromboprophylaxis after surgery: A systematic review and meta-analysis
    Thromb Res, 136 (4), 723-6
    DOI 10.1016/j.thromres.2015.06.023, PubMed 26140737
  12. Dahm AE, Tiscia G, Holmgren A, Jacobsen AF, Skretting G, Grandone E, Sandset PM (2015)
    Genetic variations in the annexin A5 gene and the risk of pregnancy-related venous thrombosis
    J Thromb Haemost, 13 (3), 409-13
    DOI 10.1111/jth.12817, PubMed 25495894
  13. Eckman MH, Alonso-Coello P, Guyatt GH, Ebrahim S, Tikkinen KA, Lopes LC, Neumann I, McDonald SD, Zhang Y, Zhou Q, Akl EA, Jacobsen AF, Santamaría A, Annichino-Bizzacchi JM, Bitar W, Sandset PM, Bates SM (2015)
    Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities
    Thromb Res, 136 (2), 341-7
    DOI 10.1016/j.thromres.2015.05.020, PubMed 26033397
  14. Fogarty PF, Mancuso ME, Kasthuri R, Bidlingmaier C, Chitlur M, Gomez K, Holme PA, James P, Kruse-Jarres R, Mahlangu J, Mingot-Castellano ME, Soni A, Global Emerging Hemophilia Panel (GEHEP) (2015)
    Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10-year survey
    Haemophilia, 21 (5), 589-97
    DOI 10.1111/hae.12652, PubMed 25689278
  15. Ghanima W, Khelif A, Waage A, Michel M, Tjønnfjord GE, Romdhan NB, Kahrs J, Darne B, Holme PA, RITP study group (2015)
    Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
    Lancet, 385 (9978), 1653-61
    DOI 10.1016/S0140-6736(14)61495-1, PubMed 25662413
  16. Gimsing P, Hjertner Ø, Abildgaard N, Andersen NF, Dahl TG, Gregersen H, Klausen TW, Mellqvist UH, Linder O, Lindås R, Tøffner Clausen N, Lenhoff S (2015)
    Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial
    Bone Marrow Transplant, 50 (10), 1306-11
    DOI 10.1038/bmt.2015.125, PubMed 26121108
  17. Holme PA, Combescure C, Tait RC, Berntorp E, Rauchensteiner S, de Moerloose P, ADVANCE Working Group (2015)
    Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe
    Haemophilia, 22 (2), 248-255
    DOI 10.1111/hae.12847, PubMed 27880029
  18. Høyvoll LR, Fløisand Y, Orrem HL, Gunnarsson R, Landrø L, Brevig T, Gaustad P, Nordøy I (2015)
    Hemophagocytic lymphohistiocytosis in leprosy
    Lepr Rev, 86 (4), 403-6
    PubMed 26964439
  19. Iversen PO, Dahm A, Skretting G, Mowinckel MC, Stranda A, Østerud B, Sandset PM, Kostovski E (2015)
    Reduced peak, but no diurnal variation, in thrombin generation upon melatonin supplementation in tetraplegia. A randomised, placebo-controlled study
    Thromb Haemost, 114 (5), 964-8
    DOI 10.1160/TH15-05-0396, PubMed 26202881
  20. Iversen PO, Sioud M (2015)
    Engineering therapeutic cancer vaccines that activate antitumor immunity
    Methods Mol Biol, 1218, 263-8
    DOI 10.1007/978-1-4939-1538-5_15, PubMed 25319656
  21. Johnson KC, Aragaki AK, Jackson R, Reiner A, Sandset PM, Rosing J, Dahm AE, Rosendaal F, Manson JE, Martin LW, Liu S, Kuller LH, Cushman M, Rossouw JE (2015)
    Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy
    Arterioscler Thromb Vasc Biol, 36 (2), 418-24
    DOI 10.1161/ATVBAHA.115.306905, PubMed 26681757
  22. Kostovski E, Dahm AE, Mowinckel MC, Stranda A, Skretting G, Østerud B, Sandset PM, Iversen PO (2015)
    Circadian rhythms of hemostatic factors in tetraplegia: a double-blind, randomized, placebo-controlled cross-over study of melatonin
    Spinal Cord, 53 (4), 285-90
    DOI 10.1038/sc.2014.243, PubMed 25644388
  23. Narverud I, van Lennep JR, Christensen JJ, Versmissen J, Gran JM, Iversen PO, Aukrust P, Halvorsen B, Ueland T, Ulven SM, Ose L, Veierød MB, Sijbrands E, Retterstøl K, Holven KB (2015)
    Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia
    Atherosclerosis, 243 (1), 155-60
    DOI 10.1016/j.atherosclerosis.2015.09.014, PubMed 26386212
  24. Nissen-Meyer LS, Tjønnfjord GE, Golebiowska E, Kjeldsen-Kragh J, Akkök ÇA (2015)
    Paroxysmal nocturnal haemoglobinuria at Oslo University Hospital 2000-2010
    Tidsskr Nor Laegeforen, 135 (11), 1039-43
    DOI 10.4045/tidsskr.14.0444, PubMed 26080779
  25. Parente-Ribes A, Skånland SS, Bürgler S, Os A, Wang D, Bogen B, Tjønnfjord GE, Taskén K, Munthe LA (2015)
    Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells
    Haematologica, 101 (2), e59-62
    DOI 10.3324/haematol.2015.135590, PubMed 26589914
  26. Rukundo PM, Iversen PO, Andreassen BA, Oshaug A, Kikafunda J, Rukooko B (2015)
    Perceptions on the right to adequate food after a major landslide disaster: a cross-sectional survey of two districts in Uganda
    BMC Int Health Hum Rights, 15, 9
    DOI 10.1186/s12914-015-0047-x, PubMed 25909355
  27. Sandset EC, Jusufovic M, Sandset PM, Bath PM, Berge E, SCAST Study Group (2015)
    Effects of blood pressure-lowering treatment in different subtypes of acute ischemic stroke
    Stroke, 46 (3), 877-9
    DOI 10.1161/STROKEAHA.114.008512, PubMed 25657183
  28. Skuterud Wik H, Flem Jacobsen A, Morten Sandset P (2015)
    Long-term outcome after pregnancy-related venous thrombosis
    Thromb Res, 135 Suppl 1, S1-4
    DOI 10.1016/S0049-3848(15)50430-1, PubMed 25903525
  29. Tangen JM (2015)
    Radiation What it is, what you need to know
    Tidsskr. Nor. Laegeforen., 135 (15), 1387
    DOI 10.4045/tidsskr.15.0405
  30. Tangen JM, Tierens A, Caers J, Binsfeld M, Olstad OK, Trøseid AM, Wang J, Tjønnfjord GE, Hetland G (2015)
    Immunomodulatory effects of the Agaricus blazei Murrill-based mushroom extract AndoSan in patients with multiple myeloma undergoing high dose chemotherapy and autologous stem cell transplantation: a randomized, double blinded clinical study
    Biomed Res Int, 2015, 718539
    DOI 10.1155/2015/718539, PubMed 25664323
  31. Tinholt M, Stavik B, Louch W, Carlson CR, Sletten M, Ruf W, Skretting G, Sandset PM, Iversen N (2015)
    Syndecan-3 and TFPI colocalize on the surface of endothelial-, smooth muscle-, and cancer cells
    PLoS One, 10 (1), e0117404
    DOI 10.1371/journal.pone.0117404, PubMed 25617766
  32. Tinholt M, Vollan HK, Sahlberg KK, Jernström S, Kaveh F, Lingjærde OC, Kåresen R, Sauer T, Kristensen V, Børresen-Dale AL, Sandset PM, Iversen N (2015)
    Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF
    Breast Cancer Res, 17 (1), 44
    DOI 10.1186/s13058-015-0548-5, PubMed 25882602
  33. Tjelle TE, Holtung L, Bøhn SK, Aaby K, Thoresen M, Wiik SÅ, Paur I, Karlsen AS, Retterstøl K, Iversen PO, Blomhoff R (2015)
    Polyphenol-rich juices reduce blood pressure measures in a randomised controlled trial in high normal and hypertensive volunteers
    Br J Nutr, 114 (7), 1054-63
    DOI 10.1017/S0007114515000562, PubMed 26227795
  34. Torkildsen S, Gorunova L, Beiske K, Tjønnfjord GE, Heim S, Panagopoulos I (2015)
    Novel ZEB2-BCL11B Fusion Gene Identified by RNA-Sequencing in Acute Myeloid Leukemia with t(2;14)(q22;q32)
    PLoS One, 10 (7), e0132736
    DOI 10.1371/journal.pone.0132736, PubMed 26186352
  35. Utne KK, Ghanima W, Foyn S, Kahn S, Sandset PM, Wik HS (2015)
    Development and validation of a tool for patient reporting of symptoms and signs of the post-thrombotic syndrome
    Thromb Haemost, 115 (2), 361-367
    DOI 10.1160/th15-04-0318, PubMed 26422814
  36. Valentino LA, Holme PA (2015)
    Should anti-inhibitor coagulant complex and tranexamic acid be used concomitantly?
    Haemophilia, 21 (6), 709-14
    DOI 10.1111/hae.12723, PubMed 26036756
  37. Wennström L, Edslev PW, Abrahamsson J, Nørgaard JM, Fløisand Y, Forestier E, Gustafsson G, Heldrup J, Hovi L, Jahnukainen K, Jonsson OG, Lausen B, Palle J, Zeller B, Holmberg E, Juliusson G, Stockelberg D, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO), Danish Acute Leukemia Group, Swedish Acute Myeloid Leukemia Group (2015)
    Acute Myeloid Leukemia in Adolescents and Young Adults Treated in Pediatric and Adult Departments in the Nordic Countries
    Pediatr Blood Cancer, 63 (1), 83-92
    DOI 10.1002/pbc.25713, PubMed 26281822
  38. Wesseltoft-Rao N, Hjermstad MJ, Ikdahl T, Dajani O, Ulven SM, Iversen PO, Bye A (2015)
    Comparing two classifications of cancer cachexia and their association with survival in patients with unresected pancreatic cancer
    Nutr Cancer, 67 (3), 472-80
    DOI 10.1080/01635581.2015.1004728, PubMed 25710201
  39. Wik HS, Jacobsen AF, Mowinckel MC, Sandset PM (2015)
    The role of inflammation in post-thrombotic syndrome after pregnancy-related deep vein thrombosis: A population-based, cross-sectional study
    Thromb Res, 138, 16-21
    DOI 10.1016/j.thromres.2015.12.014, PubMed 26826503

Publications 2014

  1. Akkök ÇA, Bergrem A, Tangen JM (2014)
    Tidsskr Nor Laegeforen, 134 (14), 1365
    DOI 10.4045/tidsskr.13.1559, PubMed 25096431
  2. Ali HO, Stavik B, Dørum E, Iversen N, Sandset PM, Skretting G (2014)
    Oestrogen induced downregulation of TFPI expression is mediated by ERα
    Thromb Res, 134 (1), 138-43
    DOI 10.1016/j.thromres.2014.04.004, PubMed 24785473
  3. Bruserud Ø, Tvedt TH, Paulsen PQ, Ahmed AB, Gedde-Dahl T, Tjønnfjord GE, Slåstad H, Heldal D, Reikvam H (2014)
    Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies
    Cancer Immunol Immunother, 63 (8), 757-77
    DOI 10.1007/s00262-014-1578-z, PubMed 24997173
  4. Bürgler S, Gimeno A, Parente-Ribes A, Wang D, Os A, Devereux S, Jebsen P, Bogen B, Tjønnfjord GE, Munthe LA (2014)
    Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-γ by a T-bet-dependent mechanism
    J Immunol, 194 (2), 827-35
    DOI 10.4049/jimmunol.1401350, PubMed 25505279
  5. Döhner H, Lübbert M, Fiedler W, Fouillard L, Haaland A, Brandwein JM, Lepretre S, Reman O, Turlure P, Ottmann OG, Müller-Tidow C, Krämer A, Raffoux E, Döhner K, Schlenk RF, Voss F, Taube T, Fritsch H, Maertens J (2014)
    Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
    Blood, 124 (9), 1426-33
    DOI 10.1182/blood-2014-03-560557, PubMed 25006120
  6. Eide NA, Baerland TP, Sauesund E, Lømo J, Lund-Iversen M, Liestøl S (2014)
    Relapse of acute lymphoblastic leukaemia (ALL)
    Acta Ophthalmol, 93 (5), e395-e396
    DOI 10.1111/aos.12619, PubMed 25495443
  7. Geisler CH, van T' Veer MB, Jurlander J, Walewski J, Tjønnfjord G, Itälä Remes M, Kimby E, Kozak T, Polliack A, Wu KL, Wittebol S, Abrahamse-Testroote MC, Doorduijn J, Ghidey Alemayehu W, van Oers MH (2014)
    Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL
    Blood, 123 (21), 3255-62
    DOI 10.1182/blood-2014-01-547737, PubMed 24735962
  8. Haig Y, Enden T, Slagsvold CE, Sandvik L, Sandset PM, Kløw NE (2014)
    Residual rates of reflux and obstruction and their correlation to post-thrombotic syndrome in a randomized study on catheter-directed thrombolysis for deep vein thrombosis
    J Vasc Surg Venous Lymphat Disord, 2 (2), 123-30
    DOI 10.1016/j.jvsv.2013.10.054, PubMed 26993176
  9. Hallstensen RF, Bergseth G, Foss S, Jæger S, Gedde-Dahl T, Holt J, Christiansen D, Lau C, Brekke OL, Armstrong E, Stefanovic V, Andersen JT, Sandlie I, Mollnes TE (2014)
    Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn
    Immunobiology, 220 (4), 452-9
    DOI 10.1016/j.imbio.2014.11.003, PubMed 25468724
  10. Hjorth-Hansen H, Stenke L, Söderlund S, Dreimane A, Ehrencrona H, Gedde-Dahl T, Gjertsen BT, Höglund M, Koskenvesa P, Lotfi K, Majeed W, Markevärn B, Ohm L, Olsson-Strömberg U, Remes K, Suominen M, Simonsson B, Porkka K, Mustjoki S, Richter J, Nordic CML Study Group (2014)
    Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)
    Eur J Haematol, 94 (3), 243-50
    DOI 10.1111/ejh.12423, PubMed 25082346
  11. Husøy MA, Brinch L, Tjønnfjord GE, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I, Kolstad A, Akkök ÇA, Rollag H, Gaustad P, Bergan S, Egeland T, Josefsen D, Kvalheim G, Fløisand Y (2014)
    [Allogeneic stem-cell transplantation in adults 1985-2012: results and development]
    Tidsskr Nor Laegeforen, 134 (16), 1569-75
    DOI 10.4045/tidsskr.13.1415, PubMed 25178233
  12. Knudsen E, Carlsen H, Bøyum A, Benestad HB, Iversen PO (2014)
    No major role for the transcription factor NF-κB in bone marrow function during peritonitis in the mouse
    Int J Hematol, 100 (2), 111-8
    DOI 10.1007/s12185-014-1598-7, PubMed 24859830
  13. Kostovski E, Hjeltnes N, Eriksen EF, Kolset SO, Iversen PO (2014)
    Differences in bone mineral density, markers of bone turnover and extracellular matrix and daily life muscular activity among patients with recent motor-incomplete versus motor-complete spinal cord injury
    Calcif Tissue Int, 96 (2), 145-54
    DOI 10.1007/s00223-014-9947-3, PubMed 25539858
  14. Kristiansen A, Brandt L, Agoritsas T, Akl EA, Berge E, Bondi J, Dahm AE, Granan LP, Halvorsen S, Holme PA, Flem Jacobsen A, Jacobsen EM, Neumann I, Sandset PM, Sætre T, Tveit A, Vartdal T, Guyatt G, Vandvik PO (2014)
    Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process
    Chest, 146 (3), 727-734
    DOI 10.1378/chest.13-2828, PubMed 25180723
  15. Kristiansen HA, Spetalen S, Fløisand Y, Heldal D (2014)
    Eltrombopag in Good's Syndrome
    Case Rep Hematol, 2014, 172139
    DOI 10.1155/2014/172139, PubMed 25389501
  16. Kverneland M, Taubøll E, Selmer KK, Iversen PO, Nakken KO (2014)
    Modified Atkins diet may reduce serum concentrations of antiepileptic drugs
    Acta Neurol Scand, 131 (3), 187-90
    DOI 10.1111/ane.12330, PubMed 25312999
  17. Misceo D, Holmgren A, Louch WE, Holme PA, Mizobuchi M, Morales RJ, De Paula AM, Stray-Pedersen A, Lyle R, Dalhus B, Christensen G, Stormorken H, Tjønnfjord GE, Frengen E (2014)
    A dominant STIM1 mutation causes Stormorken syndrome
    Hum Mutat, 35 (5), 556-64
    DOI 10.1002/humu.22544, PubMed 24619930
  18. Moltu SJ, Sachse D, Blakstad EW, Strømmen K, Nakstad B, Almaas AN, Westerberg AC, Rønnestad A, Brække K, Veierød MB, Iversen PO, Rise F, Berg JP, Drevon CA (2014)
    Urinary metabolite profiles in premature infants show early postnatal metabolic adaptation and maturation
    Nutrients, 6 (5), 1913-30
    DOI 10.3390/nu6051913, PubMed 24824288
  19. Mundal L, Sarancic M, Ose L, Iversen PO, Borgan JK, Veierød MB, Leren TP, Retterstøl K (2014)
    Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010
    J Am Heart Assoc, 3 (6), e001236
    DOI 10.1161/JAHA.114.001236, PubMed 25468658
  20. Narverud I, Retterstøl K, Iversen PO, Halvorsen B, Ueland T, Ulven SM, Ose L, Aukrust P, Veierød MB, Holven KB (2014)
    Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review
    Atherosclerosis, 235 (2), 299-309
    DOI 10.1016/j.atherosclerosis.2014.05.917, PubMed 24908240
  21. Panagopoulos I, Torkildsen S, Gorunova L, Tierens A, Tjønnfjord GE, Heim S (2014)
    Comparison between karyotyping-FISH-reverse transcription PCR and RNA-sequencing-fusion gene identification programs in the detection of KAT6A-CREBBP in acute myeloid leukemia
    PLoS One, 9 (5), e96570
    DOI 10.1371/journal.pone.0096570, PubMed 24798186
  22. Pettersson H, Knutsen H, Holmberg E, Andréasson B (2014)
    Increased incidence of another cancer in myeloproliferative neoplasms patients at the time of diagnosis
    Eur J Haematol, 94 (2), 152-6
    DOI 10.1111/ejh.12410, PubMed 25039361
  23. Pitkänen H, Jouppila A, Mowinckel MC, Lemponen M, Patiwael S, Sandset PM, Lassila R, Brinkman HJ (2014)
    Enhanced thrombin generation and reduced intact protein S in processed solvent detergent plasma
    Thromb Res, 135 (1), 167-74
    DOI 10.1016/j.thromres.2014.10.020, PubMed 25466844
  24. Ruffini PA, Os A, Dolcetti R, Tjønnfjord GE, Munthe LA, Bogen B (2014)
    Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice
    J Transl Med, 12, 207
    DOI 10.1186/1479-5876-12-207, PubMed 25059102
  25. Samarakoon PS, Sorte HS, Kristiansen BE, Skodje T, Sheng Y, Tjønnfjord GE, Stadheim B, Stray-Pedersen A, Rødningen OK, Lyle R (2014)
    Identification of copy number variants from exome sequence data
    BMC Genomics, 15 (1), 661
    DOI 10.1186/1471-2164-15-661, PubMed 25102989
  26. Sandset PM (2014)
    Combined oral contraceptives increase risk of venous thrombosis according to oestrogen dose and type of progestogen
    Evid Based Med, 19 (5), 194
    DOI 10.1136/ebmed-2014-110011, PubMed 24948124
  27. Subramaniam S, Thielmann I, Morowski M, Pragst I, Sandset PM, Nieswandt B, Etscheid M, Kanse SM (2014)
    Defective thrombus formation in mice lacking endogenous factor VII activating protease (FSAP)
    Thromb Haemost, 113 (4), 870-80
    DOI 10.1160/TH14-06-0519, PubMed 25427855
  28. Taraldsrud E, Fevang B, Aukrust P, Beiske KH, Fløisand Y, Frøland S, Rollag H, Olweus J (2014)
    Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9
    Clin Exp Immunol, 175 (3), 439-48
    DOI 10.1111/cei.12239, PubMed 24237110
  29. Tavoly M, Jelsness-Jørgensen LP, Wik HS, Roaldsnes C, Sandset PM, Ghanima W (2014)
    Quality of life after pulmonary embolism: first cross-cultural evaluation of the pulmonary embolism quality-of-life (PEmb-QoL) questionnaire in a Norwegian cohort
    Qual Life Res, 24 (2), 417-25
    DOI 10.1007/s11136-014-0779-4, PubMed 25120017
  30. Tikkinen KA, Agarwal A, Craigie S, Cartwright R, Gould MK, Haukka J, Naspro R, Novara G, Sandset PM, Siemieniuk RA, Violette PD, Guyatt GH (2014)
    Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology
    Syst Rev, 3, 150
    DOI 10.1186/2046-4053-3-150, PubMed 25540016
  31. Tinholt M, Viken MK, Dahm AE, Vollan HK, Sahlberg KK, Garred O, Børresen-Dale AL, Jacobsen AF, Kristensen V, Bukholm I, Kåresen R, Schlichting E, Skretting G, Lie BA, Sandset PM, Iversen N (2014)
    Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study
    BMC Cancer, 14, 845
    DOI 10.1186/1471-2407-14-845, PubMed 25407022
  32. Tobiasson M, Dybedahl I, Holm MS, Karimi M, Brandefors L, Garelius H, Grövdal M, Högh-Dufva I, Grønbæk K, Jansson M, Marcher C, Nilsson L, Kittang AO, Porwit A, Saft L, Möllgård L, Hellström-Lindberg E (2014)
    Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial
    Blood Cancer J, 4 (3), e189
    DOI 10.1038/bcj.2014.8, PubMed 24608733
  33. Tran HTT, Sørensen B, Bjørnsen S, Pripp AH, Tjønnfjord GE, Andre Holme P (2014)
    Monitoring bypassing agent therapy - a prospective crossover study comparing thromboelastometry and thrombin generation assay
    Haemophilia, 21 (2), 275-283
    DOI 10.1111/hae.12570, PubMed 25521720
  34. Tvedt TH, Holme PA, Bruserud Ø (2014)
    [A man in his 80s with muscle stiffness and skin bleeding]
    Tidsskr Nor Laegeforen, 134 (10), 1058-61
    DOI 10.4045/tidsskr.13.0817, PubMed 24865732
  35. Tveita AA, Schjesvold FH, Sundnes O, Haabeth OA, Haraldsen G, Bogen B (2014)
    Indirect CD4+ T-cell-mediated elimination of MHC II(NEG) tumor cells is spatially restricted and fails to prevent escape of antigen-negative cells
    Eur J Immunol, 44 (9), 2625-37
    DOI 10.1002/eji.201444659, PubMed 24846412
  36. Vangen S, Ellingsen L, Andersgaard AB, Jacobsen AF, Lorentzen B, Nyfløt LT, Rygh AB, Skulstad SM, Tappert C, Øian P (2014)
    Maternal deaths in Norway 2005-2009
    Tidsskr Nor Laegeforen, 134 (8), 836-9
    DOI 10.4045/tidsskr.13.0203, PubMed 24780982
  37. von Krogh AS, Kremer Hovinga JA, Tjønnfjord GE, Ringen IM, Lämmle B, Waage A, Quist-Paulsen P (2014)
    The impact of congenital thrombotic thrombocytopenic purpura on pregnancy complications
    Thromb Haemost, 111 (6), 1180-3
    DOI 10.1160/TH13-08-0713, PubMed 24499950
  38. Woll PS, Kjällquist U, Chowdhury O, Doolittle H, Wedge DC, Thongjuea S, Erlandsson R, Ngara M, Anderson K, Deng Q, Mead AJ, Stenson L, Giustacchini A, Duarte S, Giannoulatou E, Taylor S, Karimi M, Scharenberg C, Mortera-Blanco T, Macaulay IC, Clark SA, Dybedal I, Josefsen D, Fenaux P, Hokland P et al. (2014)
    Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
    Cancer Cell, 25 (6), 794-808
    DOI 10.1016/j.ccr.2014.03.036, PubMed 24835589
  39. Zeidler C, Grote UA, Nickel A, Brand B, Carlsson G, Cortesão E, Dufour C, Duhem C, Notheis G, Papadaki HA, Tamary H, Tjønnfjord GE, Tucci F, Van Droogenbroeck J, Vermylen C, Voglova J, Xicoy B, Welte K (2014)
    Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutropenia International Registry
    Haematologica, 99 (8), 1395-402
    DOI 10.3324/haematol.2013.099101, PubMed 24997149

Publications 2013

  1. Cui XY, Skretting G, Jing Y, Sun H, Sandset PM, Sun L (2013)
    Hypoxia influences stem cell-like properties in multidrug resistant K562 leukemic cells
    Blood Cells Mol Dis, 51 (3), 177-84
    DOI 10.1016/j.bcmd.2013.05.003, PubMed 23725749
  2. Dahm A (2013)
    [A. Dahm replies]
    Tidsskr Nor Laegeforen, 133 (16), 1687
    DOI 10.4045/tidsskr.13.1020, PubMed 24005699
  3. Enden T, Kløw NE, Sandset PM (2013)
    Symptom burden and job absenteeism after treatment with additional catheter-directed thrombolysis for deep vein thrombosis
    Patient Relat Outcome Meas, 4, 55-9
    DOI 10.2147/PROM.S47233, PubMed 24082798
  4. Enden T, Resch S, White C, Wik HS, Kløw NE, Sandset PM (2013)
    Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis
    J Thromb Haemost, 11 (6), 1032-42
    DOI 10.1111/jth.12184, PubMed 23452204
  5. Enden T, Wik HS, Kvam AK, Haig Y, Kløw NE, Sandset PM (2013)
    Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study
    BMJ Open, 3 (8), e002984
    DOI 10.1136/bmjopen-2013-002984, PubMed 23988361
  6. Fernandes AM, Herlofsen SR, Karlsen TA, Küchler AM, Fløisand Y, Brinchmann JE (2013)
    Similar properties of chondrocytes from osteoarthritis joints and mesenchymal stem cells from healthy donors for tissue engineering of articular cartilage
    PLoS One, 8 (5), e62994
    DOI 10.1371/journal.pone.0062994, PubMed 23671648
  7. Gerull S, Stern M, Apperley J, Beelen D, Brinch L, Bunjes D, Butler A, Ganser A, Ghavamzadeh A, Koh MB, Komarnicki M, Kröger N, Maertens J, Maschan A, Peters C, Rovira M, Sengeløv H, Socié G, Tischer J, Oneto R, Passweg J, Marsh J (2013)
    Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow Transplantation
    Haematologica, 98 (11), 1804-9
    DOI 10.3324/haematol.2013.091074, PubMed 23894010
  8. Ghanima W, Atar D, Sandset PM (2013)
    New oral anticoagulants--a review
    Tidsskr Nor Laegeforen, 133 (18), 1940-5
    DOI 10.4045/tidsskr.12.1111, PubMed 24084970
  9. Ghanima W, Knutsen H, Delabie J, Bruserud Ø (2013)
    [Primary myelofibrosis--pathogenesis, diagnosis and treatment]
    Tidsskr Nor Laegeforen, 133 (18), 1946-50
    DOI 10.4045/tidsskr.12.1106, PubMed 24084971
  10. Gravensteen IK, Helgadóttir LB, Jacobsen EM, Rådestad I, Sandset PM, Ekeberg O (2013)
    Women's experiences in relation to stillbirth and risk factors for long-term post-traumatic stress symptoms: a retrospective study
    BMJ Open, 3 (10), e003323
    DOI 10.1136/bmjopen-2013-003323, PubMed 24154514
  11. Grundlingh H, Herselman M, Iversen PO (2013)
    An assessment of the implementation of the National Therapeutic Programme for pregnant women within the City of Cape Town district
    S Afr Med J, 103 (8), 549-51
    DOI 10.7196/samj.6670, PubMed 23885737
  12. Helgadóttir LB, Turowski G, Skjeldestad FE, Jacobsen AF, Sandset PM, Roald B, Jacobsen EM (2013)
    Classification of stillbirths and risk factors by cause of death--a case-control study
    Acta Obstet Gynecol Scand, 92 (3), 325-33
    DOI 10.1111/aogs.12044, PubMed 23157574
  13. Holm AM, Riise GC, Brinch L, Bjørtuft O, Iversen M, Simonsen S, Fløisand Y (2013)
    Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: unresolved questions
    Transplantation, 96 (4), e21-2
    DOI 10.1097/TP.0b013e31829df2c0, PubMed 23958883
  14. Iversen PO, Negaard H, Østenstad B, Sandset PM, Kolset SO (2013)
    Evidence for long-term hypercoagulopathy, but normalization of markers of extracellular matrix turnover, in patients with non-Hodgkin lymphoma
    Leuk Lymphoma, 56 (8), 2479-81
    DOI 10.3109/10428194.2013.803227, PubMed 23656198
  15. Kostovski E, Boon H, Hjeltnes N, Lundell LS, Ahlsén M, Chibalin AV, Krook A, Iversen PO, Widegren U (2013)
    Altered content of AMP-activated protein kinase isoforms in skeletal muscle from spinal cord injured subjects
    Am J Physiol Endocrinol Metab, 305 (9), E1071-80
    DOI 10.1152/ajpendo.00132.2013, PubMed 24022865
  16. Mathijssen NC, Masereeuw R, Holme PA, van Kraaij MG, Laros-van Gorkom BA, Peyvandi F, van Heerde WL (2013)
    Increased volume of distribution for recombinant activated factor VII and longer plasma-derived factor VII half-life may explain their long lasting prophylactic effect
    Thromb Res, 132 (2), 256-62
    DOI 10.1016/j.thromres.2013.05.027, PubMed 23834817
  17. Mellqvist UH, Gimsing P, Hjertner O, Lenhoff S, Laane E, Remes K, Steingrimsdottir H, Abildgaard N, Ahlberg L, Blimark C, Dahl IM, Forsberg K, Gedde-Dahl T, Gregersen H, Gruber A, Guldbrandsen N, Haukås E, Carlson K, Kvam AK, Nahi H, Lindås R, Andersen NF, Turesson I, Waage A, Westin J et al. (2013)
    Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
    Blood, 121 (23), 4647-54
    DOI 10.1182/blood-2012-11-464503, PubMed 23616624
  18. Moore KL, Kildahl-Andersen O, Kildahl-Andersen R, Tjønnfjord GE (2013)
    Uncommon adverse effect of a common medication
    Tidsskr Nor Laegeforen, 133 (2), 165
    DOI 10.4045/tidsskr.12.0494, PubMed 23344600
  19. Mustjoki S, Richter J, Barbany G, Ehrencrona H, Fioretos T, Gedde-Dahl T, Gjertsen BT, Hovland R, Hernesniemi S, Josefsen D, Koskenvesa P, Dybedal I, Markevärn B, Olofsson T, Olsson-Strömberg U, Rapakko K, Thunberg S, Stenke L, Simonsson B, Porkka K, Hjorth-Hansen H, Nordic CML Study Group (NCMLSG) (2013)
    Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
    Leukemia, 27 (7), 1520-6
    DOI 10.1038/leu.2013.19, PubMed 23328954
  20. Os A, Bürgler S, Ribes AP, Funderud A, Wang D, Thompson KM, Tjønnfjord GE, Bogen B, Munthe LA (2013)
    Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells
    Cell Rep, 4 (3), 566-77
    DOI 10.1016/j.celrep.2013.07.011, PubMed 23933259
  21. Randen U, Tierens AM, Tjønnfjord GE, Delabie J (2013)
    Bone marrow histology in monoclonal B-cell lymphocytosis shows various B-cell infiltration patterns
    Am J Clin Pathol, 139 (3), 390-5
    DOI 10.1309/AJCPPHSUQM8XBJH7, PubMed 23429376
  22. Randen U, Trøen G, Tierens A, Steen C, Warsame A, Beiske K, Tjønnfjord GE, Berentsen S, Delabie J (2013)
    Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma
    Haematologica, 99 (3), 497-504
    DOI 10.3324/haematol.2013.091702, PubMed 24143001
  23. Raps M, Helmerhorst FM, Fleischer K, Dahm AE, Rosendaal FR, Rosing J, Reitsma P, Sandset PM, van Vliet HA (2013)
    The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI
    Thromb Haemost, 109 (4), 606-13
    DOI 10.1160/TH12-10-0771, PubMed 23407778
  24. Sandset PM (2013)
    Mechanisms of hormonal therapy related thrombosis
    Thromb Res, 131 Suppl 1, S4-7
    DOI 10.1016/S0049-3848(13)70009-4, PubMed 23452740
  25. Sandset PM (2013)
    Genotype of proband and thrombophilia screening
    Blood, 122 (15), 2528-9
    DOI 10.1182/blood-2013-08-519801, PubMed 24113791
  26. Schjesvold F, Wiencke K, Tjønnfjord GE (2013)
    [Investigation of anemia]
    Tidsskr Nor Laegeforen, 133 (6), 610
    DOI 10.4045/tidsskr.13.0256, PubMed 23552139
  27. Schjesvold FH (2013)
    [Investigation of amyloidosis]
    Tidsskr Nor Laegeforen, 133 (3), 266
    DOI 10.4045/tidsskr.13.0044, PubMed 23381155
  28. Stavik B, Tinholt M, Sletten M, Skretting G, Sandset PM, Iversen N (2013)
    TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity
    J Hematol Oncol, 6, 5
    DOI 10.1186/1756-8722-6-5, PubMed 23320987
  29. Tran HT, Sørensen B, Rea CJ, Bjørnsen S, Ueland T, Pripp AH, Tjønnfjord GE, Holme PA (2013)
    Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors
    Haemophilia, 20 (3), 369-75
    DOI 10.1111/hae.12318, PubMed 24251535
  30. Tran HT, Tjønnfjord GE, Holme PA (2013)
    Use of thromboelastography and thrombin generation assay to predict clinical phenotype in patients with severe FVII deficiency
    Haemophilia, 20 (1), 141-6
    DOI 10.1111/hae.12256, PubMed 23992369
  31. van Geffen M, Mathijssen NC, Holme PA, Laros-van Gorkom BA, van Kraaij MG, Masereeuw R, Peyvandi F, van Heerde WL (2013)
    Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients
    Thromb Res, 132 (1), 116-22
    DOI 10.1016/j.thromres.2013.04.021, PubMed 23731565
  32. Vojdeman FJ, Jurlander J, van't Veer M, Itälä-Remes M, Kimby E, Tjønnfjord GE, Walewski J, Kozák T, Polliack A, Montagna M, Regazzi M, Kirkby N, van Oers M, Geisler CH (2013)
    Plasma alemtuzumab levels in patients with chronic lymphocytic leukemia treated with alemtuzumab combined with chemotherapy reflect the efficacy of the treatment: a hypothesis
    Leuk Lymphoma, 54 (4), 790-3
    DOI 10.3109/10428194.2012.720373, PubMed 23025267
  33. Westberg M, Paus AC, Holme PA, Tjønnfjord GE (2013)
    Haemophilic arthropathy: long-term outcomes in 107 primary total knee arthroplasties
    Knee, 21 (1), 147-50
    DOI 10.1016/j.knee.2013.09.010, PubMed 24156923
  34. Whiteley WN, Adams HP, Bath PM, Berge E, Sandset PM, Dennis M, Murray GD, Wong KS, Sandercock PA (2013)
    Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials
    Lancet Neurol, 12 (6), 539-45
    DOI 10.1016/S1474-4422(13)70079-6, PubMed 23642343
  35. Wik HS, Jacobsen AF, Fagerland MW, Sandvik L, Sandset PM (2013)
    Long-term mortality and incidence of cancer after pregnancy-related venous thrombosis: results of a population-based cohort study
    Thromb Res, 131 (6), 497-501
    DOI 10.1016/j.thromres.2013.04.035, PubMed 23726964
  36. Aamodt AH, Sandset PM, Atar D, Tveit A, Russell D (2013)
    [Atrial fibrillation and stroke]
    Tidsskr Nor Laegeforen, 133 (14), 1453-7
    DOI 10.4045/tidsskr.12.0850, PubMed 23929293

Publications 2012

  1. Abildgaard U, Heimdal K (2012)
    Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review
    Eur J Obstet Gynecol Reprod Biol, 166 (2), 117-23
    DOI 10.1016/j.ejogrb.2012.09.026, PubMed 23107053
  2. Akkök CA, Haugaa H, Galgerud A, Brinch L (2012)
    Severe hemolytic transfusion reaction due to anti-A1 following allogeneic stem cell transplantation with minor ABO incompatibility
    Transfus Apher Sci, 48 (1), 63-6
    DOI 10.1016/j.transci.2012.07.006, PubMed 22902604
  3. Bastani NE, Kostovski E, Sakhi AK, Karlsen A, Carlsen MH, Hjeltnes N, Blomhoff R, Iversen PO (2012)
    Reduced antioxidant defense and increased oxidative stress in spinal cord injured patients
    Arch Phys Med Rehabil, 93 (12), 2223-8.e2
    DOI 10.1016/j.apmr.2012.06.021, PubMed 22772083
  4. Batorova A, Holme P, Gringeri A, Richards M, Hermans C, Altisent C, Lopez-Fernández M, Fijnvandraat K, European Haemophilia Treatment Standardisation Board (2012)
    Continuous infusion in haemophilia: current practice in Europe
    Haemophilia, 18 (5), 753-9
    DOI 10.1111/j.1365-2516.2012.02810.x, PubMed 22530687
  5. Berentsen S, Tjønnfjord GE (2012)
    Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia
    Blood Rev, 26 (3), 107-15
    DOI 10.1016/j.blre.2012.01.002, PubMed 22330255
  6. Bergrem A, Dahm AE, Jacobsen AF, Sandvik L, Sandset PM (2012)
    Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism: a population-based case-control study
    Thromb Haemost, 108 (6), 1165-71
    DOI 10.1160/TH12-05-0350, PubMed 23015030
  7. Biedron R, Tangen JM, Maresz K, Hetland G (2012)
    Agaricus blazei Murill - immunomodulatory properties and health benefits
    Funct. Foods Health Dis., 2 (11), 428-447
    DOI 10.31989/ffhd.v2i11.72
  8. Boon H, Kostovski E, Pirkmajer S, Song M, Lubarski I, Iversen PO, Hjeltnes N, Widegren U, Chibalin AV (2012)
    Influence of chronic and acute spinal cord injury on skeletal muscle Na+-K+-ATPase and phospholemman expression in humans
    Am J Physiol Endocrinol Metab, 302 (7), E864-71
    DOI 10.1152/ajpendo.00625.2011, PubMed 22275761
  9. Bye A, Jordhøy MS, Skjegstad G, Ledsaak O, Iversen PO, Hjermstad MJ (2012)
    Symptoms in advanced pancreatic cancer are of importance for energy intake
    Support Care Cancer, 21 (1), 219-27
    DOI 10.1007/s00520-012-1514-8, PubMed 22684989
  10. Cesaro S, Pillon M, Tridello G, Aljurf M, Martino R, Schroyens W, Nozzoli C, Barba P, Faraci M, Fagioli F, Cappelli B, Cordonnier C, Al-Mohareb F, Floisand Y, Greil J, Panizzolo IS, Santarone S (2012)
    Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow Transplantation
    Bone Marrow Transplant, 48 (6), 809-13
    DOI 10.1038/bmt.2012.247, PubMed 23222380
  11. Dahm AE, Bezemer ID, Bergrem A, Jacobsen AF, Jacobsen EM, Skretting G, Rosendaal FR, Sandset PM (2012)
    Candidate gene polymorphisms and the risk for pregnancy-related venous thrombosis
    Br J Haematol, 157 (6), 753-61
    DOI 10.1111/j.1365-2141.2012.09121.x, PubMed 22533697
  12. Dahm AE, Eilertsen AL, Goeman J, Olstad OK, Ovstebø R, Kierulf P, Mowinckel MC, Skretting G, Sandset PM (2012)
    A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women
    Thromb Res, 130 (1), 45-51
    DOI 10.1016/j.thromres.2011.12.009, PubMed 22217510
  13. Enden T, Klow NE, Sandset PM (2012)
    Catheter-directed thrombolysis for acute deep vein thrombosis Reply
    Lancet, 379 (9828), 1786-1787
    DOI 10.1016/S0140-6736(12)60754-5
  14. Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE, Dybedal I, Holte H, Heldal D, Torfoss D, Aurlien E, Lauritzsen GF, Fosså A, Lehne G, Baggerød E, Kvalheim G, Egeland T, Bishop MR, Fowler DH, Kolstad A (2012)
    Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation
    Bone Marrow Transplant, 47 (12), 1552-7
    DOI 10.1038/bmt.2012.63, PubMed 22522568
  15. Fløisand Y, Tjønnfjord G, Beiske K (2012)
    [Invasive fungal infection]
    Tidsskr Nor Laegeforen, 132 (23-24), 2618
    DOI 10.4045/tidsskr.12.0603, PubMed 23338093
  16. Ghanima W, Lee SY, Barsam S, Miller A, Sandset PM, Bussel JB (2012)
    Venous thromboembolism and coagulation activity in patients with immune thrombocytopenia treated with thrombopoietin receptor agonists
    Br J Haematol, 158 (6), 811-4
    DOI 10.1111/j.1365-2141.2012.09227.x, PubMed 22816787
  17. Gravensteen IK, Helgadottir LB, Jacobsen EM, Sandset PM, Ekeberg Ø (2012)
    Long-term impact of intrauterine fetal death on quality of life and depression: a case-control study
    BMC Pregnancy Childbirth, 12, 43
    DOI 10.1186/1471-2393-12-43, PubMed 22676992
  18. Haig Y, Enden T, Slagsvold CE, Sandvik L, Sandset PM, Kløw NE (2012)
    Determinants of early and long-term efficacy of catheter-directed thrombolysis in proximal deep vein thrombosis
    J Vasc Interv Radiol, 24 (1), 17-24; quiz 26
    DOI 10.1016/j.jvir.2012.09.023, PubMed 23176966
  19. Hjorth M, Hjertner Ø, Knudsen LM, Gulbrandsen N, Holmberg E, Pedersen PT, Andersen NF, Andréasson B, Billström R, Carlson K, Carlsson MS, Flogegård M, Forsberg K, Gimsing P, Karlsson T, Linder O, Nahi H, Othzén A, Swedin A, Nordic Myeloma Study Group (NMSG) (2012)
    Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study
    Eur J Haematol, 88 (6), 485-96
    DOI 10.1111/j.1600-0609.2012.01775.x, PubMed 22404182
  20. Holm AM, Riise GC, Hansson L, Brinch L, Bjørtuft O, Iversen M, Simonsen S, Fløisand Y (2012)
    Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT
    Bone Marrow Transplant, 48 (5), 703-7
    DOI 10.1038/bmt.2012.197, PubMed 23064037
  21. Holmström M, Tran HT, Holme PA (2012)
    Combined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A--a two-centre experience
    Haemophilia, 18 (4), 544-9
    DOI 10.1111/j.1365-2516.2012.02748.x, PubMed 22348384
  22. IST-3 collaborative group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A (2012)
    The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
    Lancet, 379 (9834), 2352-63
    DOI 10.1016/S0140-6736(12)60768-5, PubMed 22632908
  23. Jacobsen AF, Sandset PM (2012)
    Venous thromboembolism associated with pregnancy and hormonal therapy
    Best Pract Res Clin Haematol, 25 (3), 319-32
    DOI 10.1016/j.beha.2012.07.006, PubMed 22959548
  24. Moltu SJ, Strømmen K, Blakstad EW, Almaas AN, Westerberg AC, Brække K, Rønnestad A, Nakstad B, Berg JP, Veierød MB, Haaland K, Iversen PO, Drevon CA (2012)
    Enhanced feeding in very-low-birth-weight infants may cause electrolyte disturbances and septicemia--a randomized, controlled trial
    Clin Nutr, 32 (2), 207-12
    DOI 10.1016/j.clnu.2012.09.004, PubMed 23043722
  25. Narverud I, Iversen PO, Aukrust P, Halvorsen B, Ueland T, Johansen SG, Nenseter MS, Sandset PM, Ulven SM, Ose L, Retterstøl K, Holven KB (2012)
    Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH
    Thromb Res, 131 (2), 178-82
    DOI 10.1016/j.thromres.2012.11.008, PubMed 23199546
  26. Nyquist KB, Panagopoulos I, Thorsen J, Roberto R, Wik HS, Tierens A, Heim S, Micci F (2012)
    t(12;13)(q14;q31) leading to HMGA2 upregulation in acute myeloid leukaemia
    Br J Haematol, 157 (6), 769-71
    DOI 10.1111/j.1365-2141.2012.09081.x, PubMed 22404713
  27. Ringdén O, Labopin M, Beelen DW, Volin L, Ehninger G, Finke J, Greinix HT, Kyrcz-Krzemien S, Bunjes D, Brinch L, Niederwieser D, Arnold R, Mohty M, Rocha V, Acute Leukaemia Working Party of European Group for Blood and Marrow Transplantation (EBMT) (2012)
    Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients
    J Intern Med, 272 (5), 472-83
    DOI 10.1111/j.1365-2796.2012.02547.x, PubMed 22519980
  28. Rossouw JE, Johnson KC, Pettinger M, Cushman M, Sandset PM, Kuller L, Rosendaal F, Rosing J, Wasserthal-Smoller S, Martin LW, Manson JE, Lakshminarayan K, Merino JG, Lynch J (2012)
    Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy
    Stroke, 43 (4), 952-7
    DOI 10.1161/STROKEAHA.111.643072, PubMed 22363056
  29. Ruud E, Kanellopoulos A, Zeller B, Widing E, Tjønnfjord GE, Fosså SD (2012)
    Patient knowledge of late effects of acute lymphoblastic leukaemia
    Tidsskr Nor Laegeforen, 132 (18), 2052-5
    DOI 10.4045/tidsskr.12.0153, PubMed 23038194
  30. Sandset EC, Murray GD, Bath PM, Kjeldsen SE, Berge E, Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group (2012)
    Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome
    Stroke, 43 (8), 2108-14
    DOI 10.1161/STROKEAHA.111.647362, PubMed 22627991
  31. Sandset PM (2012)
    CXCL4-platelet factor 4, heparin-induced thrombocytopenia and cancer
    Thromb Res, 129 Suppl 1, S97-100
    DOI 10.1016/S0049-3848(12)70026-9, PubMed 22682144
  32. Skretting G, Iversen N, Myklebust CF, Dahm AE, Sandset PM (2012)
    Overexpression of tissue factor pathway inhibitor in CHO-K1 cells results in increased activation of NF-κB and apoptosis mediated by a caspase-3 independent pathway
    Mol Biol Rep, 39 (12), 10089-96
    DOI 10.1007/s11033-012-1882-7, PubMed 22932941
  33. Stavik B, Skretting G, Olstad OK, Sletten M, Dehli Vigeland M, Sandset PM, Iversen N (2012)
    TFPI alpha and beta regulate mRNAs and microRNAs involved in cancer biology and in the immune system in breast cancer cells
    PLoS One, 7 (10), e47184
    DOI 10.1371/journal.pone.0047184, PubMed 23071754
  34. Thorsen J, Aamot HV, Roberto R, Tjønnfjord GE, Micci F, Heim S (2012)
    Myelodysplastic syndrome with a t(2;11)(p21;q23-24) and translocation breakpoint close to miR-125b-1
    Cancer Genet, 205 (10), 528-32
    DOI 10.1016/j.cancergen.2012.06.003, PubMed 22944560
  35. Tjønnfjord GE, Jønsson V, Ly BE, Johannesen TB (2012)
    Familial occurrence of chronic lymphocytic leukaemia in Norway
    Tidsskr Nor Laegeforen, 132 (18), 2060-3
    DOI 10.4045/tidsskr.11.1350, PubMed 23038196
  36. Tjønnfjord GE, Ly BE, Johannesen TB, Tierens A, Beiske K, Heim S, Jønsson V (2012)
    Chronic lymphocytic leukaemia in Norway--incidence and prognostic markers at diagnosis
    Tidsskr Nor Laegeforen, 132 (18), 2056-9
    DOI 10.4045/tidsskr.11.1349, PubMed 23038195
  37. Turowski G, Berge LN, Helgadottir LB, Jacobsen EM, Roald B (2012)
    A new, clinically oriented, unifying and simple placental classification system
    Placenta, 33 (12), 1026-35
    DOI 10.1016/j.placenta.2012.10.002, PubMed 23110739
  38. Vandvik PO, Sandset PM (2012)
    [Confusion regarding evidence-based advice]
    Tidsskr Nor Laegeforen, 132 (10), 1204
    DOI 10.4045/tidsskr.12.0490, PubMed 22669369
  39. Whiteley WN, Slot KB, Fernandes P, Sandercock P, Wardlaw J (2012)
    Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies
    Stroke, 43 (11), 2904-9
    DOI 10.1161/STROKEAHA.112.665331, PubMed 22996959
  40. Wik HS, Jacobsen AF, Sandvik L, Sandset PM (2012)
    Prevalence and predictors for post-thrombotic syndrome 3 to 16 years after pregnancy-related venous thrombosis: a population-based, cross-sectional, case-control study
    J Thromb Haemost, 10 (5), 840-7
    DOI 10.1111/j.1538-7836.2012.04690.x, PubMed 22452811
  41. Wik HS, Jacobsen AF, Sandvik L, Sandset PM (2012)
    Long-term impact of pregnancy-related venous thrombosis on quality-of-life, general health and functioning: results of a cross-sectional, case-control study
    BMJ Open, 2 (6)
    DOI 10.1136/bmjopen-2012-002048, PubMed 23144263
  42. Woldt E, Terrand J, Mlih M, Matz RL, Bruban V, Coudane F, Foppolo S, El Asmar Z, Chollet ME, Ninio E, Bednarczyk A, Thiersé D, Schaeffer C, Van Dorsselaer A, Boudier C, Wahli W, Chambon P, Metzger D, Herz J, Boucher P (2012)
    The nuclear hormone receptor PPARγ counteracts vascular calcification by inhibiting Wnt5a signalling in vascular smooth muscle cells
    Nat Commun, 3, 1077
    DOI 10.1038/ncomms2087, PubMed 23011131

Publications 2011

  1. Abelsson J, Merup M, Birgegård G, WeisBjerrum O, Brinch L, Brune M, Johansson P, Kauppila M, Lenhoff S, Liljeholm M, Malm C, Remes K, Vindelöv L, Andréasson B, Nordic MPD Study Group (2011)
    The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries
    Bone Marrow Transplant, 47 (3), 380-6
    DOI 10.1038/bmt.2011.91, PubMed 21552298
  2. Alatri A, Armstrong AE, Greinacher A, Koster A, Kozek-Langenecker SA, Lancé MD, Link A, Nielsen JD, Sandset PM, Spanjersberg AJ, Spannagl M (2011)
    Results of a consensus meeting on the use of argatroban in patients with heparin-induced thrombocytopenia requiring antithrombotic therapy - a European Perspective
    Thromb Res, 129 (4), 426-33
    DOI 10.1016/j.thromres.2011.11.041, PubMed 22178575
  3. Andresen MS, Sandven I, Brunborg C, Njaastad AM, Strekerud F, Abdelnoor M, Smith P, Abildgaard U (2011)
    Mortality and recurrence after treatment of VTE: long term follow-up of patients with good life-expectancy
    Thromb Res, 127 (6), 540-6
    DOI 10.1016/j.thromres.2011.02.017, PubMed 21435698
  4. Bergrem A, Dahm AE, Jacobsen AF, Mowinckel MC, Sandvik L, Sandset PM (2011)
    Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism
    Br J Haematol, 154 (2), 241-7
    DOI 10.1111/j.1365-2141.2011.08712.x, PubMed 21564075
  5. Enden T, Haig Y, Kløw NE, Slagsvold CE, Sandvik L, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbæk G, Sandset PM, CaVenT Study Group (2011)
    Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial
    Lancet, 379 (9810), 31-8
    DOI 10.1016/S0140-6736(11)61753-4, PubMed 22172244
  6. Fløisand Y, Delabie J, Fosså A, Helseth E, Jacobsen EA, Rolke J, Tjønnfjord GE (2011)
    Richter syndrome presenting as a solitary cerebellar tumor during first-line treatment for chronic lymphocytic leukemia
    Leuk Lymphoma, 52 (10), 2007-9
    DOI 10.3109/10428194.2011.580480, PubMed 21663503
  7. Frøyland M, Ruffini PA, Thompson KM, Gedde-Dahl T, Fredriksen AB, Bogen B (2011)
    Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing
    Eur J Haematol, 86 (5), 385-95
    DOI 10.1111/j.1600-0609.2011.01590.x, PubMed 21332794
  8. Ghanima W, Kleven IW, Enden T, Rosales A, Wik HS, Pederstad L, Holme PA, Sandset PM (2011)
    Recurrent venous thrombosis, post-thrombotic syndrome and quality of life after catheter-directed thrombolysis in severe proximal deep vein thrombosis
    J Thromb Haemost, 9 (6), 1261-3
    DOI 10.1111/j.1538-7836.2011.04298.x, PubMed 21489133
  9. Gruber FX, Lundán T, Goll R, Silye A, Mikkola I, Rekvig OP, Knuutila S, Remes K, Gedde-Dahl T, Porkka K, Hjorth-Hansen H (2011)
    BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations?
    Med Oncol, 29 (1), 219-26
    DOI 10.1007/s12032-010-9781-z, PubMed 21221851
  10. Haugen F, Labori KJ, Noreng HJ, Buanes T, Iversen PO, Drevon CA (2011)
    Altered expression of genes in adipose tissues associated with reduced fat mass in patients with pancreatic cancer
    Arch Physiol Biochem, 117 (2), 78-87
    DOI 10.3109/13813455.2011.560609, PubMed 21457003
  11. Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM (2011)
    Incidence and risk factors of fetal death in Norway: a case-control study
    Acta Obstet Gynecol Scand, 90 (4), 390-7
    DOI 10.1111/j.1600-0412.2011.01079.x, PubMed 21306337
  12. Helgadottir LB, Skjeldestad FE,